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Abstract 
 
Invasive migration plays a crucial role not only during development and homeostasis but also in 
pathological states, such as tumor metastasis. Drosophila macrophage migration into the 
extended germband is an interesting system to study invasive migration. It carries similarities to 
immune cell transmigration and cancer cell invasion, therefore studying this process could also 
bring new understanding of invasion in higher organisms. In our work, we uncover a highly 
conserved member of the major facilitator family that plays a role in tissue invasion through 
regulation of glycosylation on a subgroup of proteins and/or by aiding the precise timing of DN-
Cadherin downregulation.  
Aberrant display of the truncated core1 O-glycan T-antigen is a common feature of human 
cancer cells that correlates with metastasis. Here we show that T-antigen in Drosophila 
melanogaster macrophages is involved in their developmentally programmed tissue invasion. 
Higher macrophage T-antigen levels require an atypical major facilitator superfamily (MFS) 
member that we named Minerva which enables macrophage dissemination and invasion. We 
characterize for the first time the T and Tn glycoform O-glycoproteome of the Drosophila 
melanogaster embryo, and determine that Minerva increases the presence of T-antigen on 
proteins in pathways previously linked to cancer, most strongly on the sulfhydryl oxidase Qsox1 
which we show is required for macrophage tissue entry. Minerva’s vertebrate ortholog, MFSD1, 
rescues the minerva mutant’s migration and T-antigen glycosylation defects. We thus identify  
a key conserved regulator that orchestrates O-glycosylation on a protein subset to activate  
a program governing migration steps important for both development and cancer metastasis.  
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Chapter 1: Introduction 
Regulation of cell migration by glycosylation and adhesion to the 
components of extracellular matrix (ECM) 
 
Cell migration is crucial for many physiological processes such as organismal development, tissue 
homeostasis, wound healing or inflammation but at the same time it plays a critical role in cancer 
metastasis. Therefore, gaining as deep understanding as is possible of this dynamic and very 
adaptive process has been a top of priority of many researchers. In this introduction, I will try to 
summarize the basics of the current knowledge of the regulation of directed cell migration with 
a focus on migration modes that are relevant for the later described project: namely the invasive 
migration of metastatic cells and immune cell transmigration, glycosylation as a regulator of 
(invasive) migration and the role of the ECM and adhesion to it. 
To migrate persistently and in directed manner in response to an external stimulus, a 
migrating cell requires an internal program to generate forces in a specific direction to move the 
cell forward (Mak et al., 2016). The classical image that is based mainly on in vitro studies with 
cells plated on 2D substrates describes actin-driven protrusions at the front and myosin-driven 
detachment at the rear (Lauffenburger and Horwitz, 1996). A combination of protrusions and 
firm adhesions at the cell front and contractions and detachment at the rear makes the cell to 
move forward (Mak et al., 2016). Protrusions are driven by the polymerization of actin filaments, 
namely the addition of monomeric G actin at the barbed end of F actin. This is activated mainly 
by Cdc42 and Rac1 signaling at the leading edge by nucleation promoting factors like Wasp/Wave 
and Arp2/3 (Kraynov et al., 2000; Ma et al., 1998; Machesky and Insall, 1998; Mak et al., 2016; 
Mullins et al., 1998; Pankov et al., 2005). At the rear of the cell, RhoA activates contractile forces 
from myosin II motors that in combination with the turnover of old adhesions lead to forward 
movement (Mak et al., 2016). However, in 3D migration, many components may be altered as 
well as their interaction and the exact mechanism is context dependent (Petrie and Yamada, 
2016). 
 
Regulation of transmigration of immune cells 
 
Getting to the site of inflammation is a key process of high importance for the organism. At the 
same time, the whole process has to be tightly regulated to prevent prolonged or incorrectly 
localized inflammation and the associated pathology. In this part, I will shortly describe the 
transmigration of immune cells and compare them with our model system, hemocyte invasion 
into the extended germband. 
Getting to the site of inflammation actually consists of a sequence of adhesive steps in 
which leukocytes: 
1. attach to the vessel wall 
2. locomote along the wall to the endothelial borders 
3. traverse the endothelium and the subendothelial basement membrane 
4. migrate through the interstitial tissue  (Muller, 2013). 
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Transendothelial migration mainly happens at the boundaries between endothelial cells 
and therefore is called paracellular transmigration. Later, a more rare migration through the 
endothelial cellular body, so called transcellular migration, was discovered (Carman and Springer, 
2008). 
Leukocytes passively move in the blood stream so the first step is to capture them. To do 
so, contact with the blood vessel has to occur which is enhanced by a local decrease in blood 
streaming at the site of inflammation (Muller, 2013). Inflammatory reactions induce the release 
of pathogen-associated molecular pattern from microorganism or damage-associated molecular 
patterns from injured tissue cells. These stimulate resident components of the innate immune 
system and result in the secretion of cytokines that activate nearby endothelial cells (Vestweber, 
2015). Therefore endothelial Ca2+-dependent lectins, P- and E-selectins, are induced on the 
surface of endothelial cells (McEver, 2015). Selectins bind sialylated fucosylated carbohydrate 
residues of the Lewis x blood group family (Muller, 2013). 
The subsequent process, associated with a high on and off binding rate of selectins, is 
called rolling, resulting in a slowing down of the immune cell movement or so called ‘slow rolling’ 
(Muller, 2013) that is mediated by E-selectin (Kunkel and Ley, 1996). This process allows further 
activation of leukocytes by chemokines and other proinflammatory agents on the surface of 
endothelial cells (Muller, 2013). Chemokines through their receptors activate leukocyte adhesion 
receptors – integrins (more details on integrin structure and function, see later) in so called 
‘inside-out’ integrin activation (Ginsberg, 2014). 
Activated integrins bind to a member of the immunoglobulin superfamily – ICAM1 and 
VCAM1- on endothelial cells which leads to the next step, arrest followed up by crawling (Dustin 
and Springer, 1988; Muller, 2013) in search for a nearby endothelial cell border. Binding of a 
leukocyte to ICAM1 and VCAM1 causes tyrosine dephosphorylation in the cytoplasmic domain of 
the VE-Cadherin and therefore allows opening of endothelial junctions (Shaw et al., 2001; 
Vestweber, 2015). 
While previous steps are reversible, the commitment to the next step means no return 
(Muller, 2013). The whole process is regulated by a big set of receptors expressed on the surface 
of endothelial cells, and in the case of the more common paracellular migration, on endothelial 
cell contacts: JAMA-C, ESAM, PECAM1, ICAM2, CD99, PVR (Nasdala et al., 2002; Schenkel et al., 
2002; Vestweber, 2015; Woodfin et al., 2011, 2009). Diapedesis itself is a sequential process 
(Schenkel et al., 2002), consisting of the following steps: luminal association with endothelial cells 
apically of endothelial cell junctions (ICAM2), engagement between junctions (JAMA), 
accumulation between endothelial cells and the basement membrane (PECAM1 and CD99). 
(Vestweber, 2015) 
Once the basal side of the endothelial cell is reached, leukocytes have to dissociate and 
cross the basement membrane. This process is not so deeply studied as previous steps.  
Neutrophils and monocytes migrate through areas in the basement membrane of the least 
resistance - where collagen IV and laminin 10 are expressed at relatively low density. (Muller, 
2013; Voisin et al., 2009; Wang et al., 2006). 
In our model system, no blood stream occurs, therefore the first steps are different as 
hemocytes need to delaminate from head mesoderm rather than being captured from the flow. 
Based on BLAST analysis, there are no known P- and E-selectins in Drosophila genome. However, 
the following up processes carry some similarities to above described transendothelial migration: 
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1. The involvement of integrins – hemocyte migration into the extended germband is also 
integrin-dependent process (Siekhaus et al., 2010) 
2. TNF signaling – as TNF signaling is one of the signals for extravasation, the tissue where 
hemocytes enter is also ‘getting ready’ for their entrance thanks to TNF signaling 
(Ratheesh et al., 2018a) 
3. Interaction with ECM - although Drosophila stage 11/12 embryos do not have formed 
basement membrane (Matsubayashi et al., 2017), hemocytes have to interact with ECM 
components that are already deposited on their path (Ratheesh et al., 2018a; Sánchez-
Sánchez et al., 2017) as well as they deposit it on their own (Fessler and Fessler, 1989; 
Matsubayashi et al., 2017; Ratheesh et al., 2018a). As it is shown also in this work, this 
ECM components actually influence their migration. 
 
Properties and regulation of metastasis 
 
Metastasis is a very complex, diverse and inefficient process. It is a multistep process that 
involves: 
1. Local infiltration of tumor cells into the surrounding tissue 
2. Transendothelial migration into the vessels 
3. Survival in circulatory system 
4. Extravasation 
5. Proliferation in the competent organ leading to colonization (van Zijl et al., 2011) 
Metastases account for the majority of cancer deaths (Chambers et al., 2002), therefore 
they are potential therapeutic target. In this part of the introduction, I will shortly described the 
initial step(s) of metastasis – on the invasion of tumor cells in its surroundings as it might be 
similar to our model system. 
Metastasis is a very diverse process, demonstrated already on the first step: invasion into 
surrounding tissues. Cancer cells can invade either collectively (in sheets or clusters) (Rørth, 
2009) or as single cells (mesenchymal or amoeboid cells) (van Zijl et al., 2011). To do so, they 
commonly undergo phenotypical conversions, such as an epithelial to mesenchymal transition 
(EMT) (Nieto et al., 2016), a collective to amoeboid transition (CAT) (Krakhmal et al., 2015) and a 
mesenchymal to amoeboid  transition (MAT) (Wolf et al., 2003). 
Collective cell migration is migration of a whole group of cells. A moving cell group has a 
leading edge/front that resembles mesenchymal cells and followers that are more tightly packed. 
Leading cells use integrins to adhere and perform proteolytic degradation of the extracellular 
matrix (Krakhmal et al., 2015). Collective migration is connected to EMT, although there is an 
ongoing discussion about role of EMT in cancer progression (Fischer et al., 2015; Zheng et al., 
2015). 
The execution of EMT in cancer is not homogeneous, therefore EMT should be seen as a 
spectrum of intermediate states (Nieto et al., 2016). On a molecular level, EMT means a loss of 
an epithelial character and a gain of a mesenchymal program, e.g. downregulation or loss of E-
cadherin and subsequent upregulation of vimentin and N-Cadherin (so called cadherin switch) 
(van Zijl et al., 2011). This leads to an enhanced motility of cancer cells (Yilmaz and Christofori, 
2010). This transition is induced by transcription factors, such as twist and snail (Nieto et al., 
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2016). At the secondary site, an opposite transition (mesenchymal to epithelial) allows 
colonization (van Zijl et al., 2011). 
Due to its heterogenic character, it is difficult to compare cancer cell invasion and invasion 
of hemocytes into the extended germband. It is still not confirmed whether hemocytes migrate 
into the germband collectively. It was observed that they form a stream (Siekhaus et al., 2010) 
that resembles the initial steps of metastasis but whether it is a classical collective migration 
including defined leading cell(s) is not clear. Similar to collective migration of metastatic cells, 
hemocytes use integrins (Siekhaus et al., 2010). There is also a change in the expression of 
cadherins, however DN-Cadherin is actually downregulated (see Chapter 2). However, whether 
there are similarities between our system and the initial steps of metastasis that would allow the 
translation of results from Drosophila to human carcinogenesis has to be tested experimentally 
and this testing is in progress in our group. 
 Migration can be regulated on different levels. Intracellularly, through the regulation of 
the cytoskeleton, the regulation of signaling, protein phosphorylation or the general 
transcriptome/ proteome. It can also be regulated by signals coming from outside, such as 
signaling molecules or the properties of the surroundings. I would like to discuss two regulators 
relevant for the following work – protein glycosylation that can be inside or on the surface of the 
cell but also on its surroundings and the extracellular matrix (ECM) and adhesion connected to 
it.  
 
Protein glycosylation 
 
Protein glycosylation is a common posttranslational modification in which different types of 
sugars are added on a protein in the endoplasmatic reticulum (ER) and/or in the Golgi apparatus. 
The most common types of protein glycosylation are N- and O-glycosylation. On the top of these 
two main types of glycosylation, a lot of unusual and rare forms of glycosylation exists. Thirteen 
naturally occurring aminoacids contain various functional groups in their side chains that present 
potential sites for glycosylation, unusual N-bonds (amido group on Arginine, Lysine, Tryptophan 
and Histidine) or O-bonds (hydroxyl group on the Tyrosine, Hydroxyproline or Hydroxylysine), as 
well as C- and S-bound glycans (Lafite and Daniellou, 2012).  
 N-glycosylation in eukaryotes starts on the cytoplasmic side of the ER by the assembly of 
a precursor bound to the dolichol that serves as a carrier. After the precursor is made, dolichol is 
translocated and the rest of glycosylation happens in the lumen of the ER and Golgi apparatus 
(Burda and Aebi, 1999). First, the whole precursor is transferred to the amido group of an 
asparagine in a protein (Bhagavan, 2002). The glycosylation site is context dependent, the typical 
sequence being NxS/T XP site (Aebi, 2013). After the addition of the precursor, the sugar chain 
is trimmed and extended/modified by a toolkit of enzymes as it is passing through the ER and 
Golgi apparatus (Bhagavan, 2002). 
 In contrast to N-glycosylation, O-glycosylation can be initiated in the ER (except O-GalNAc 
and O-Xyl) but occurs mainly in the Golgi (with some exceptions, e.g. O-GlcNAc glycosylation on 
cytoplasmic and nuclear proteins) and therefore on folded proteins (Comer and Hart, 2000; Roth, 
1984). O-glycosylation is not as easily predictable as N-glycosylation since a conserved sequence 
for O-glycosylation has not yet been identified. Some types of O-glycosylation happen on folded 
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proteins and therefore folding influences which sites are accessible (Christlet and Veluraja, 2001). 
O-glycosylation encompasses a broad group of different types of glycosylation in which sugar 
group is added on the hydroxyl group of a serine or threonine of a protein (Christlet and Veluraja, 
2001; Steen et al., 1998). While O-GlcNAc glycosylation happens in the cytoplasm and nucleus 
results in the addition of a single sugar group per site (Copeland et al., 2013), the major types of 
O-glycosylation (O-Man, O-GalNAc, O-Fuc, O-Glc, O-GlcNAc, O-Xyl and Hyl O-Gal) occur in the ER 
but mainly in the Golgi (Joshi et al., 2018).   
 
Protein glycosylation in insects 
Glycosylation is a very complex type of modification that usually involves a lot of steps and 
therefore interpretation of the results, especially when working with mutants in the involved 
enzymes, is complicated. Therefore, there is a constant search for an easier system in which to 
study different types of glycosylation. On the one side, single-cloned mammalian cell lines offer 
the option of decreased (genetic) variability and together with CRISPR based approaches has 
already uncovered a lot (Narimatsu et al., 2018). However, the problem with a complex pattern 
of glycosylation remains. The attempt to overcome this problem is SimpleCell technology 
developed and already successfully used for studying O-GalNAc (Steentoft et al., 2013a; 
Vakhrushev et al., 2013). However, interpretation of how in vitro studies can predict results 
within an in vivo context is complicated and many times, it has been shown that an in vivo context 
changes even the substrate specificity of some enzymes and in vivo, many glycosyl-transferases 
are more restricted in what they actually modify e.g.(Breloy et al., 2016b; Kim et al., 2003). 
Therefore, an in vivo model with a simpler version of glycosylation would be very useful. 
In general, insect glycosylation could be considered to be a simpler version of the 
mammalian one. In mammals, the complex N-glycans are the most common type of N-
glycosylation. In Drosophila, truncated, paucimannosidic (Man1-3 GlcNAc2) or oligomannosidic 
glycans (Man5-9 GlcNAc2) are more common than complex N-glycans that make up only a minor 
fraction of the insect N-glycomes (1-20%) (Chung et al., 2017; Schiller et al., 2012). Another 
feature characteristic for insect N-glycosylation is the presence of up to two core fucose residues 
α-1,6-linked and α-1,3-linked, to the innermost GlcNAc (Chung et al., 2017; Fabini et al., 2001). 
The α-1,3-linked core fucose residue is typical for insect but not for humans (Chung et al., 2017).  
A similar conclusion can be reached about insect O-glycosylation. Although 90% of 
detected O-glycoproteins are O-GalNAc (Aoki et al., 2008), except Hyl O-Gal, all types of O-
glycosylation are conserved (Joshi et al., 2018). However, everything is ‘reduced’- the number of 
genes involved in initiation is generally smaller and O-GalNAc as well as O-Man complex 
structures are fully missing (or have not been identified as of now) (Aoki et al., 2008). Sialylation 
of O-glycans was also never detected in Drosophila. However, this type of final modification 
seems to be functionally ‘replaced’ by addition of glucuronic acid (GlcA) that is also negatively 
charged and therefore could fulfill similar functions as sialic acid (Aoki and Tiemeyer, 2010a).  
To sum up, Drosophila has a less complex glycosylation that usually happens with the 
assistance of less enzymes. Combined with the classical advantages of Drosophila as a model 
organism, I consider it to be an interesting model to study the role of glycosylation during cell 
migration and embryonic development. The existence of only shorter versions that are at least 
for O-GalNAc glycosylation more typical for cancer cells also opens the option of interpreting data 
from normal developmental regulation to the process of tumorigenesis and metastasis.  
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Mucin-type or O-GalNAc glycosylation 
O-GalNAc glycosylation, or so called mucin-type as it is abundant on mucins, is initiated by the 
polypeptide α-N-acetylgalactosaminyltransferase (ppGalNAcT) that adds GalNAc in an α-
configuration on Serine or Threonine residues (Sugiura et al., 1982; Tenno et al., 2007). From the 
first step on, O-GalNAc glycosylation is happening only in the Golgi apparatus (Roth, 1984) and 
therefore on folded proteins (with one exception, the GALA pathway, see later). The first formed 
structure is called Tn antigen (see Fig 1A, Chapter 2) which is further extended by Gal, GlcNAc or 
GalNAc to form core 1 (Galβ1-3GalNAcα1-O-Ser/Thr , also called T antigen), core 2, core 3, core 
4 and core 5 that can be further modified by the addition of GlcNAc and Gal and terminally 
decorated by sialic acid, a sulfate group, GalNAc or Fuc (Fu et al., 2016; Ten Hagen et al., 2003a).   
To synthesize core 1, a T-synthase adds Gal on GalNAcα1-O-Ser/Thr. In mammals, only 
one gene, C1GalT1, encodes T-synthase (Ju et al., 2002a, 2002b). The proper folding of C1GalT1 
depends on Cosmc, a single protein chaperone (Ju and Cummings, 2002; Wang et al., 2010). In 
the case Cosmc is absent, there is no functional C1GalT1 produced in the ER and as the system is 
not redundant, there is no Core 1 and higher structures that depend on it (Wang et al., 2010). 
On top of the previously mentioned enzymes, also core 3 β1,3-N-acetylglucosaminyl-
transferase (core 3 β3GlcNAcT), which synthesizes core 3 structure and sialyltransferase 
ST6GalNAc-I are needed to synthesize the whole range of O-GalNAc structures in mammals (Fu 
et al., 2016). 
In Drosophila, only short forms of O-GalNAc glycans were detected: Tn and T antigen. 
Sialylation of O-glycans in Drosophila was never confirmed but in contrast to mammals, T and Tn 
antigen can be glucuronylated (Aoki and Tiemeyer, 2010a; Ghosh, 2018; Repnikova et al., 2010). 
Mammals have at least 15 ppGalNAcTs (Ten Hagen et al., 2003a) while Drosophila has only 
around 9 of them (Tran et al., 2012). Surprisingly, C1GalT1 has more than one homolog in 
Drosophila although the exact number is not fully accepted and depends on how in vitro tests for 
specificity are set up (Correia et al., 2003; Lin et al., 2008; Müller et al., 2005). However, C1GalTA 
is probably the main T synthase as it shows an at least 150fold higher activity for the substrate 
compared to other tested transferases (Müller et al., 2005) and was proven to have the function 
also in vivo (Lin et al., 2008). Interestingly, in Drosophila, there is no Cosmc homolog and there is 
no indication that C1GalTA needs a specific chaperone for its proper folding.    
 
O-GalNAc glycosylation in (invasive) migration and cancer progression  
Both Tn and T antigen on the cell surface are associated with cancer cells and their increased 
aggressiveness although the mechanisms by which increased Tn or T antigens appear on the 
surface and how they influence cells are independent (Fu et al., 2016). 
Tn antigen in connection with cancer cells was described for the first time in 1974 by 
Springer et al. who detected it on the majority of breast carcinomas (Fu et al., 2016; Springer et 
al., 1974). Later, it was associated with other tumors as well, e.g. colon, ovary or prostate tumors 
(Inoue et al., 1991; Itzkowitz et al., 1989; Kuwabara et al., 1997). Due to a similar structure and 
biosynthesis pathway, Tn and its sialylated version, sTn, are always overexpressed in the tumors 
at the same time (Fu et al., 2016). The exact role of Tn antigen is still unclear. Some studies point 
out that Tn antigen is bound by C-type macrophage galactose binding lectin (MGL) that is 
expressed in dendritic cells and macrophages. This way the tumor might escape 
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immunosurveillance (Higashi et al., 2002; Napoletano et al., 2007; Saeland et al., 2007; van Vliet 
et al., 2013). 
T antigen was also described by Springer et al. as an oncofetal antigen, just one year later 
than Tn antigen (Fu et al., 2016; Springer et al., 1975). The classical and intensively studied 
protein extensively decorated by T antigen in cancer cells is Mucin1 (MUC1) (Nath and 
Mukherjee, 2014). T antigen is able to mobilize Galectin-3 to the surface of endothelial cells and 
therefore mediate cancer cell adhesion to the endothelium (Glinsky et al., 2000). This way T 
antigen could play a role in the metastatic spreading of cancer cells, consistent with observations 
that T antigen is a bad prognosis marker (Baldus et al., 2000; MacLean and Longenecker, 1991; 
Schindlbeck et al., 2005; Springer, 1997; Summers et al., 1983). 
Overexpression of Tn and sTn antigen is in many cases connected to mutation in Cosmc 
(Ju et al., 2008) or hypermethylation of its promoter (Radhakrishnan et al., 2014). In this case, no 
functional C1GalT1 exists and therefore only shorter O-glycan forms, Tn and sTn antigens, are 
created. The other described mechanism of increased Tn antigen on tumors is the GALA pathway 
in which ppGalNAcTs are relocalized to the ER where they function on unfolded proteins (Gill et 
al., 2013). However, this mechanism leads only to slight if any change in T antigen (Chia et al., 
2014). The presence of T antigen on the surface of cancer cells was recently connected with 
increased Golgi pH (Rivinoja et al., 2006). The current hypothesis assumes that an increased pH 
disturbs heterodimers between transferases, resulting in inefficient glycosylation and therefore 
truncated forms reaching the surface of the cells (Kellokumpu et al., 2016). 
It was observed and described many times before that shorter forms of O-GalNAc glycans 
(Tn, sTn and T antigen) are associated with a bad prognosis and higher invasiveness of cancer 
cells (Baldus et al., 2000; MacLean and Longenecker, 1991; Schindlbeck et al., 2005; Springer, 
1997; Summers et al., 1983). However, the exact mechanism is not fully understood. The 
discovery and initial analysis of the GALA pathway revealed one possible mechanism. In vitro, ER-
localized ppGalNAcT1 increases adhesion to fibronectin and collagen and these cells are moving 
faster in a scratch wound-healing assay, thanks to bigger and more stable lamellipodia. These 
results were confirmed also in vivo in which ER-localized ppGalNAcT1 promotes efficient lung 
colonization (Gill et al., 2013). Therefore, one of the activities that is probably regulated by 
differential glycosylation in cancer cells is the adhesion/interaction with ECM components. 
 
Extracellular matrix (ECM) 
 
Effective cell motility requires cells to adapt to, interact with and potentially also modify their 
surroundings (Jacquemet et al., 2015) that consist of ECM and other cells. ECM is mainly 
composed of glycoproteins that assemble into a supramolecular structure, containing binding 
domains for growth factors and chemokines, allowing the establishment of complex adhesion 
surfaces and forming diffusion barriers (Mouw et al., 2014). Therefore, ECM components can be 
a support for the cells but also an active participant in signaling and thus regulating cell behavior. 
ECM structures are tissue or organ-specific (Mouw et al., 2014; Naba et al., 2012).  
In general, the ECM can be divided into two groups/types: interstitial matrix and 
basement membrane (Hallmann et al., 2015). While the interstitial matrix consists of fibrillar 
collagens, mainly of Collagen I and some other minor components, depending on tissue type 
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(Hallmann et al., 2015; Mouw et al., 2014), the basement membrane is more biochemically 
variable and contains mainly laminins, Collagen type IV, heparin sulfate proteoglycans and 
nidogens (Hallmann et al., 2015; Yurchenco, 2011). 
In our system (Drosophila embryos stage 11/12), ECM production is already on but the 
structure is not considered to be a basement membrane. The basement membrane was detected 
and defined in Drosophila embryos only shortly before embryo hatching (Matsubayashi et al., 
2017). The components of an embryonic basement membrane are being laid to different extents 
by embryonic hemocytes (Fessler and Fessler, 1989; Matsubayashi et al., 2017; Ratheesh et al., 
2018a), except Nidogen/entactin that is produced only by other tissues although hemocytes 
migrate through the places where Nidogen is deposited (Wolfstetter et al., 2019). The following 
nine molecules are the main components of Drosophila basement membrane, some of them 
being already known to play a role in the regulation of cell migration: 
 
Collagen type IV 
Two adjacent loci encode for type IV collagens (col4a1 and viking) (Monson et al., 1982; 
Yasothornsrikul et al., 1997). Collagen IV is being produced and laid by hemocytes and the fat 
body (Matsubayashi et al., 2017). Collagen type IV plays a role in the structure of muscles; 
mutants in col4a1 cause severe myopathy resulting in female sterility (Kelemen-Valkony et al., 
2012). Hemocyte-deposited Vkg is important for proper development of Malpighian tubules 
through enhancing BMP signaling (Bunt et al., 2010). Interestingly, a recent study (Itoh et al., 
2018) pointed out an indirect connection between O-GalNAc glycosylation and Vkg. Although 
they show that Vkg does not directly carry T antigen (the correct size band is not visible on a PNA 
blot), it can be pulled down using PNA and therefore interacts with T antigen-modified protein(s). 
Absent T antigen causes a partial loss of Vkg at the basement membrane on muscles (Itoh et al., 
2018). However, whether and how Collagen IV subunits play a direct role in immune cell 
migration and invasion is not clear and would be interesting to address this question.  
 
Laminins 
Drosophila laminin is a disulfide-linked molecule consisting of three chains. It has a cross-shaped 
appearance and contains globular domains characteristic of vertebrate laminin with closely 
similar dimensions (Fessler et al., 1987). There are four genes in Drosophila encoding for laminins: 
laminin A (lanA), wing blister (wb), laminin B1 (lanB1) and laminin B2 (lan B2). 
LanA is an α chain that has similarity to its vertebrate counterpart but the sequence that 
forms the short arm is quite different and longer (Garrison et al., 1991; Kusche-Gullberg et al., 
1992). LanA expression appeared in embryonic mesoderm and later on is heavily produced by 
hemocytes (Kusche-Gullberg et al., 1992). LanA has a whole set of roles during Drosophila 
development, including proper development of the heart, somatic mesoderm and the gut in late-
staged embryos (Yarnitzky and Volk, 1995) as well as axon pathfinding (García-Alonso et al., 
1996). Full loss-of-function mutant are embryonically lethal (García-Alonso et al., 1996). 
Wb is another α subunit that is also essential for embryonic viability (Martin et al., 1999). 
The mutant phenotypes in many cases overlap with phenotypes for lanA and integrin mutants 
(Martin et al., 1999). It was described to play a role in germband morphology and retraction 
(Martin et al., 1999; Schöck and Perrimon, 2003; Sorrosal et al., 2010) and wing development 
(Inoue and Hayashi, 2007). 
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LanB1 is a β chain that carries some similarities to its mouse counterpart, especially in its 
13 EGF domains (Montell and Goodman, 1988). It regulates tissue migration during egg 
development (Díaz de la Loza et al., 2017), cardiac development and muscle attachment 
(Hollfelder et al., 2014). LanB2 encodes a γ chain (Montell and Goodman, 1989). LanB2 plays a 
role in mesoderm development, muscle attachment (Wolfstetter and Holz, 2012), embryonic 
salivary gland development (Patel and Myat, 2013)  and adhesion dependent cell spreading 
(Gotwals et al., 1994a). 
While there are 2 genes encoding for α subunit, LanB1 is the only β chain of the laminin 
trimer and LanB2 the only γ chain. Therefore, there are only 2 forms of laminin trimer existing in 
Drosophila. Assembly of a Drosophila laminin trimer depends on the formation of disulfide bonds. 
While the β and γ chain form a stable dimer before the disulfide bond is made, the α subunit is 
not able to bind either monomeric β or γ, or the βγ dimer before the disulfide bond is made. 
Although Drosophila laminins form stable trimer, quite common detection of βγ dimer and 
monomeric α subunit in the medium of Kc167 cells was described (Kumagai et al., 1997).  
Laminins play a crucial role in the assembly of the basal membrane (Urbano et al., 2009) 
and therefore influence a whole set of functions, including cell migration. In Drosophila 
embryonic hemocytes, Sánchez-Sánchez et al. described the role of hemocyte-produced laminins 
in their migration on the ventral nerve cord (vnc). Hemocytes in lanB1 mutant embryos migrate 
slower and by stage 13, in contrast to control embryos, they do not cover the whole vnc. Using 
hemocyte transplantation, they proved that hemocyte-derived laminins are important for their 
directed migration (Sánchez-Sánchez et al., 2017).  
 
Collagen XV/XVIII 
Multiplexin encodes for the ColXV/XVIII homolog. It is a chondroitin sulfate proteoglycan 
(Momota et al., 2011). It is required for proper maintenance of the basal membrane and may be 
involved in establishing the wingless signaling gradients in Drosophila embryo (Momota et al., 
2011) and polarized enhancement of Slit/Robo signaling at the heart lumen (Harpaz et al., 2013). 
To my knowledge, a role in the embryonic hemocytes was not described. 
 
Perlecan 
terribly reduced optic lobes (trol) locus encodes the Drosophila version of Perlecan (Voigt et al., 
2002). It is known to play a role in the regulation of the activity of different types of stem cells 
(Voigt et al., 2002; You et al., 2014). In lymph glands, it influences the balance between 
proliferation and differentiation of blood progenitors (Grigorian et al., 2013). Similar to the 
mammalian Perlecan, Trol is a multidomain heparin sulphate proteoglycan that can influence 
cellular signaling by interacting with other ECM components, growth factors and receptors 
(Aviezer et al., 1994; Dragojlovic-Munther and Martinez-Agosto, 2013; Noonan et al., 1991; Voigt 
et al., 2002). The role in the invasive migration of embryonic hemocytes is not probable as based 
on in situ hybridization (Tomancak et al., 2007, 2002), trol is expressed only in late embryonic 
stages.   
 
Nidogen  
While mammals have 2 Nidogen genes (Ndg1 and Ndg2), Drosophila possesses only one 
Nidogen/entactin gene (Wolfstetter et al., 2019), that is poorly characterized, compared to other 
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ECM components. Nidogen is considered to be an ‘ECM linker protein’ that connects laminins 
and Collagen IV in basement membrane (Aumailley et al., 1993; Wolfstetter et al., 2019). 
Consistent with its function in mammals, Drosophila Nidogen was recently described to play a 
role in basement membrane stability and development of peripheral nervous system, 
demonstrated by crawling problems and decreased answer to vibrational stimuli (Wolfstetter et 
al., 2019). 
 
ECM adhesion molecules: Integrins 
 
Integrins are adhesion receptors consisting of α and β subunits with a large extracellular domain 
and a short cytoplasmic tail (Campbell and Humphries, 2011; Tamkun et al., 1986). Humans have 
18 α and 8 β subunits that can assemble into 24 receptors with different binding properties 
(Barczyk et al., 2010; Ginsberg, 2014). The α subunit defines ligand specificity while the β subunit 
influences signaling pathway inside of the cell (Barczyk et al., 2010). An important feature of the 
majority of integrin receptors is their ability to bind a wide spectrum of ligands; additionally ECM 
components and other adhesion molecules can interact with the quite high variability of integrin 
receptors (Campbell and Humphries, 2011; Plow et al., 2000). 
As integrins lack enzymatic activity, signaling is induced by the assembly of signaling 
complexes on the cytoplasmic face of the plasma membrane. Many integrins are not 
constitutively active; they are often expressed on cell surfaces in an inactive state, in which they 
do not bind ligands and do not signal. This allows rapid action when needed, for example during 
immune responses (Campbell and Humphries, 2011). It also allows temporal and spatial 
regulation of adhesion during cell migration (Lauffenburger and Horwitz, 1996). Signals from 
inside cells can increase the binding of integrin extracellular domains to ligands, a process called 
integrin activation (Ginsberg, 2014) which is achieved by either receptor clustering into oligomers 
or by conformational changes in the receptor that expose effector binding site (Shattil et al., 
2010). 
The first established molecular function of integrins was as a link between the ECM and 
cytoskeletal substituents, mainly actin (Geiger et al., 2009), but not exclusively (Bhattacharya et 
al., 2009). Some components of this mechanical linkage play a role also in integrin activation, e.g. 
talin (Barczyk et al., 2010). Integrins can also function as bi-directional signaling receptors 
involved in inside-out (namely the integrin activation, described above) and outside-in signaling. 
Outside-in signaling is triggered by conformational changes upon ligand binding. This activate 
complex and cell-specific signaling events (Barczyk et al., 2010; Gahmberg et al., 2009). 
Integrins are essential cell adhesion proteins, not playing a role only in adhesion and 
migration but also influencing cell survival and apoptosis (Desgrosellier and Cheresh, 2010). In 
Drosophila, the variability is not so high as in mammals: Drosophila has 5 α and only 2 β subnits 
that are implicated in different biological functions: 
 
 
Multiple edematous wings (mew) 
Mew encodes an α subunit of integrin (α-PS1 integrin) that binds laminin (Gotwals et al., 1994b). 
It plays a role in many processes, e.g. wing development (Brabant et al., 1996), salivary gland and 
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myoblast migration (Jattani et al., 2009), the regulation of responses to Slit repellent signals 
(Stevens and Jacobs, 2002), maintenance of intestinal stem cells (Lin et al., 2013) or migration of 
the caudal visceral mesoderm (Urbano et al., 2011). 
 
Inflated (If) 
If is a gene encoding α subunit of integrin (α-PS2 integrin) that binds Wingblister, 
Thrombospondin and Tiggrin (Fogerty et al., 1994; Gotwals et al., 1994b; Pérez-Moreno et al., 
2017). Originally, it was discovered in muscle attachment (Bogaert et al., 1987). It plays a role in 
the migration of border cells (Kókai et al., 2012) as well as hemocyte invasion into the extended 
germband (Siekhaus et al., 2010). It also has other (developmental) roles, including: axon 
guidance (Huang et al., 2007), salivary gland and myoblast migration (Jattani et al., 2009), 
maintenance of tracheal terminal branches (Levi et al., 2006), regulation of neuromuscular 
function (Wang et al., 2018) and wing development during puparization (Brabant et al., 1996). 
 
Scab (Scb) 
α-PS3 integrin is encoded in Drosophila by scab. It was discovered as a broad regulator of the 
movement and morphogenesis of tissues during development in Drosophila (Stark et al., 1997). 
After dimerization with Integrin βν, it is required for effective phagocytosis of apoptotic cells in 
Drosophila embryos and phagocytosis of S. aureus by larval hemocytes (Nonaka et al., 2013). It 
also functions in the nervous system where it regulates short-term memory (Grotewiel et al., 
1998), synaptic morphology, transmission and plasticity (Rohrbough et al., 2000) and regulation 
of response to Slit repellent signals (Stevens and Jacobs, 2002). 
 
Integrin alphaPS4 subunit (ItgaPS4) and Integrin alphaPS5 subunit (ItgaPS5) 
The last 2 α subunits are not so deeply studied and seem to have redundant functions with Scb 
in the defining final length of an egg (Dinkins et al., 2008). ItgaPS4 is used as a marker of 
lamellocytes (Makki et al., 2010).  
 
Myospheroid (Mys) 
Mys is a beta subunit of the integrin dimer (Bunch et al., 1992). It regulates migration of 
Drosophila hemocytes in two ways; by shaping the three-dimensional environment in which 
hemocytes migrate and by regulating the migration of hemocytes themselves (Comber et al., 
2013). As it dimerizes with α subunits, many of its functions are identical with previously 
described subunits. 
 
Integrin betanu subunit (Itgbn) 
Itgbn encodes the second β subunit. It was originally described to be restricted in its expression 
to the midgut endoderm and its precursors during embryonic development (Yee and Hynes, 
1993). It dimerizes with Scb to ensure effective phagocytosis of apoptotic cells in Drosophila 
embryos and phagocytosis of S. aureus by larval hemocytes (Nagaosa et al., 2011; Nonaka et al., 
2013). 
 
Glycosylation is one of the regulators of adhesion. Not only ECM components are usually highly 
glycosylated, integrins are a subject of regulation by both N- and O-glycosylation (Rogriguez et 
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al., 2018). Their abberant glycosylation may result in changes in cell behavior and properties. For 
example, terminal (hyper)sialylation interferes with cell attachment to Collagen IV and 
Fibronectin, therefore promoting migratory and invasive phenotypes (Dennis et al., 1982, Seales 
et al., 2005). In general, different types of glycosylation or their changes play very different roles 
in the regulation of cell signaling. 
 
Different effects of regulation of cell signaling by glycosylation 
 
Glycosylation is strongly context dependent and might have both inhibiting and enhancing effects 
on signaling as well as potentially modifying receptor-ligand interactions. While in the case of 
some types of integrin heterodimers, hypersialylation prevents ECM-integrin interaction (Dennis 
et al., 1982), in dendritic cells, polysialylation of CCR7 releases an autoinhibited conformation of 
CCL21 and allows its interaction with CCR7 and the ensuing signaling (Kiermaier et al., 2016). 
Another good example of the inhibitory role of glycosylation is the classical target of O-
GalNAc glycosylation – MUC1.  MUC1 is a highly glycosylated single pass transmembrane protein 
(Nath and Mukherjee, 2014). Immediately after translation, it is autoproteolytically cleaved to a 
longer MUC1-N and a shorter MUC1-C (contains transmembrane domain) that stay associated 
through stable hydrogen bonds (Hattrup and Gendler, 2008). MUC1-N in normal conditions 
roughly doubles in size after full glycosylation but depending on tissue and physiological 
conditions, glycosylation might constitute up to 90% of the total weight of the protein (Nath and 
Mukherjee, 2014). In normal conditions, MUC1 contains mainly core 2 O-glycans while in some 
types of cancer cells, e.g. breast cancer, core 1 O-glycans and hypersialylation are present 
(Whitehouse et al., 1997, Brockhausen et al., 1995, Picco et al., 2010). This hypoglycosylation 
results in unmasking of the MUC1 peptide core and therefore cleavage of MUC1-N by 
extracellular proteases (Nath and Mukherjee, 2014), conformational changes in MUC1-C and 
hyperactivation of MAPK, P13K/Akt and Wnt signaling pathways (Hollingsworth and Swanson, 
2004, Nath et al., 2013, Li et al., 1998). MUC1 hypoglycosylation has therefore broad effects on 
different cellular behaviors such as proliferation, tumor metabolism, invasion and metastasis, 
angiogenesis or chemoresistence (Nath and Mukherjee, 2014). 
An intensively studied example of how O-glycosylation regulates receptor functions is in 
Notch signaling, a conserved pathway required for both proper development and homeostasis. 
Notch consists of the Notch extracellular domain (NECD) that binds to ligand and the intracellular 
domain (NICD) that moves into the nucleus to regulate transcription (Hori et al., 2013). Notch 
carries different types of glycosylation: mainly O-fucose, O-glucose and O-GlcNAc on its EGF 
repeats on NECD, but also O-GalNAc outside of EGF domains as well as some amount of N-
glycosylation on NECD (Takeuchi and Haltiwanger, 2014, Boskovski et al., 2015). 
The O-fucose on the EGF domains of NECD plays an important role in Notch signaling. The 
first enzyme discovered to be involved is Fringe that catalyzes futher elongation of O-fucose 
(Brückner et al., 2000). It depends on Fringe connection transporter activity (Goto et al., 2001; 
Selva et al., 2001, for more details see Chapter 2). Fringe increases Notch sensitivity to respond 
to one of its ligands, Delta (Brückner et al., 2000, Panin et al., 1997, Xu et al., 2007). However, 
the situation in the step before Fringe activity is different. The addition of fucose to serine or 
threonine is in Drosophila regulated by Ofut1 (Wang et al., 2001). Proper activity of Notch in 
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general requires the presence of Ofut1 but, interestingly, its overexpression has an inhibitory 
effect on Notch (Okajima and Irvine, 2002).  
Also other types of O-glycosylation are important for Notch signaling (Takeuchi and 
Haltiwanger, 2014): for example, O-glucose is required for S2 cleavage during Notch activation 
(Acar et al., 2008), while its xylosyl extension seems to negatively regulate Notch (Lee et al., 
2013). However, the function of other types of glycosylation like O-GlcNAc, O-GalNAc or N-
glycosylation is not fully understood (Takeuchi and Haltiwanger, 2014). 
This short summary highlights how diverse the functions of glycosylation can be on 
signaling from basic on and off to modulation of the activity and ligand preferences. Therefore, 
work with glycosylation always requires looking at the cell in whole complexity and not forgetting 
that while the glycosylation regulator activates one component of the pathway, it may modulate 
or inhibit something different that intersects with the pathway later and therefore result in very 
complicated effects (or phenotypes, in the case of mutant analysis). The work described in this 
thesis clearly demonstrates this.  
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Chapter 2:  Potential players in invasive migration of 
embryonic macrophages of Drosophila melanogaster  
 
Introduction 
 
The Drosophila cell mediated immune system consists of 3 types of hemocytes (blood cells) 
(Evans et al., 2003; Honti et al., 2014; Parsons and Foley, 2016): plasmatocytes that have the 
ability to phagocytose (Franc et al., 1996; Nelson et al., 1994), crystal cells responsible for 
melanization (Ashida and Brey, 1995; Rizki and Rizki, 1959) and lamellocytes that encapsulate 
bigger objects (Rizki and Rizki, 1992). Embryonic hemocytes are born in the head mesoderm 
(Tepass et al., 1994), being defined already at the blastoderm stage (Holz et al., 2003). Embryonic 
hemocytes are specified by the transcription factor Serpent (Rehorn et al., 1996; Lebestky et al., 
2000) belonging to the GATA transcription factor family (Crozatier and Meister, 2007). Serpent is 
expressed in other tissues as well (Rehorn et al., 1996), therefore other  transcription factors are 
needed to define hemocytes: glial cells missing (gcm/gcm2) that is initially expressed in all 
prohemocytes but quickly downregulated in the precursor of crystal cells to allow expression of 
lozenge (Lebestky et al., 2000; Bataillé et al., 2005); Lozenge, a RUNX transcription factor, that  
interacts through a conserved domain with Serpent to induce crystal cell formation (Waltzer et 
al., 2003) and U-shaped (Ush), a member of the Friend-of-GATA multiple zinc-finger protein 
family that antagonizes the development of crystal cells (Fossett et al., 2001; 2003; Waltzer et 
al., 2002). Gcm plays an instructive role in plasmatocyte development (Bernardoni et al., 1997; 
Alfonso and Jones, 2002). 
Drosophila plasmatocytes, in contrast to crystal cells, migrate out of the head on the 
following defined routes (Brückner et al., 2004; Cho et al., 2002; Ratheesh et al., 2015): 
1. Towards the extended germband which they invade (Siekhaus et al., 2010) and where 
they support the development of Malpighian tubules by secreting extracellular matrix 
components (Bunt et al., 2010). Afterwards, they migrate along the ventral nerve cord 
(vnc) 
2. On the vnc where they engulf apoptotic cells and are important for vnc condensation 
(Olofsson and Page, 2005; Sears, 2003). They later merge with plasmatocytes coming 
from the posterior vnc. 
3. Along the dorsal vessel. This route has not been described yet to have an important 
developmental role but it participates in hemocyte spreading through the whole embryo 
(Ratheesh et al., 2015) 
One of the above mentioned routes requires tissue invasion (Siekhaus et al., 2010). 
Plasmatocytes enter the extended germband at specific locations between ectoderm expressing 
DE-Cadherin and mesoderm expressing DN-Cadherin and then migrate along this interface 
(Ratheesh et al., 2018). Prior to plasmatocyte entry, the ectoderm and mesoderm are close 
neighbours, without a premade space but the tissue separates during plasmatocyte entry 
(Ratheesh et al., 2018). This is in contrast with migration on the vnc where experiments with 
injecting dextran revealed premade space for migration along the vnc (Evans et al., 2010). 
Migration towards and into the extended germband depends on integrin but does not seem to 
require degradation of the ECM (Siekhaus et al., 2010). Although the Laminin A is already 
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deposited, plasmatocytes migrate on it (Ratheesh et al., 2018) and it was shown that LanA is 
needed for the proper migration of hemocytes (Sánchez-Sánchez et al., 2017). This pathway 
demonstrates molecular similarities to the transmigration of vertebrate immune cells, such as 
the modulation of integrin affinity by small GTPases (Siekhaus et al., 2010). 
Plasmatocyte migration is an interesting topic that could show us how tissue invasion is 
regulated and as it displays some similarities with the transmigration of vertebrate immune cells, 
it could potentially open new topics also in higher organisms. However, studying early steps of 
migration has been limited by the genetic tools available. Recently, our group published a paper 
(Gyoergy et al., 2018) with a toolkit that allows: 
1. Study of the early steps of migration thanks to the fusion of the srpHemo promoter 
(Brückner et al., 2004) with 3xmCherry or 2xSuperfolder GFP  
2. Specific modulation of 2 different types of tissues with tissue specific drivers thanks to 
the srpHemoQF system 
3. Specific turning off the expression only in hemocytes by the srpHemoGal80 system. 
These tools enable early observation and deep characterization of prehemocytes and hemocytes 
and therefore allow us to understand and uncover important early molecular players as well as 
to dissect complicated phenotypes. The direct fusion containing flies are used also in this work, 
mainly in Chapter 3. 
Plasmatocytes share similarities with vertebrate macrophages (Gold and Brückner, 2015) 
therefore I will address them as macrophages in this work.  
 
Results 
 
A secondary screen uncovered a gene with an effect specific for the invasive pathway 
To analyze potential players in invasive migration, a screen was performed (data not shown), 
resulting in 26 positive hits. From those, we focused on a few conserved genes: 3 transporters - 
2 members of the major facilitator superfamily (CG8602, Cln7) and 1 subunit of v-ATPase (Vha68-
2), 1 protein predicted to bind histones (l((2)09851) and 1 protein known to be involved in 
circadian rhythms (cwo).  
The major facilitator superfamily (MFS) is one of two (along with ABC transporters) 
transporter superfamilies that occur in all living organisms (Griffith et al., 1992; Pao et al., 1998). 
They are single-polypeptide secondary carriers capable of transporting only small solutes in 
response to chemiosmotic ion gradients (Pao et al., 1998). Members of this superfamily can 
transport a variety of substances (Madej and Kaback, 2013) and have very variable functions in 
different contexts, from lactose transport by the deeply studied lactose permease in Escherichia 
coli (Abramson et al., 2003; Yin et al., 2006), mediation of cellular responses to phosphate 
(Bergwitz et al., 2012) to embryo survival and fetal growth during pregnancy (Salker et al., 2017). 
CG8602 and Cln7 are predicted to be members of MFS, having the typical 12 transmembrane 
structure (Protter prediction, Fig 1A, B). MFS transporters most likely evolved from a two-
transmembrane hairpin that was duplicated several times, resulting in the most common twelve-
transmembane domain structure of MFS transporters (Reddy et al., 2012). CG8602 is an 
uncharacterized protein while CLN7 is predicted to function in the larval nervous system, being 
localized at the blood brain barrier (Mohammed et al., 2017). Both of them are highly conserved. 
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CG8602’s mammalian ortholog is called MFSD1 and has 50% identity and 68% similarity. CLN7’s 
homolog in humans is called MFSD8 and has 35% identity and 57% similarity.  
The Vacuolar-type H+-ATPase (V-ATPase) is a multicomponent complex that functions as 
a proton pumping rotary nano-motor (Marshansky and Futai, 2008). The importance of this 
complex is supported by the high degree of homology in its subunit composition and similarities 
in biochemical mechanisms that have been described from yeast to mammals (Smith et al., 2003). 
It consists of two parts. The cytoplasmic V1 sector is composed of 8 different subunits and the 
transmembrane V0 sector has of six different subunits (Fig 1C). Vacuolar-type ATPase’s well-
studied and widely accepted functions are in the acidification of endosomes and lysosomes as 
well as vesicular trafficking, especially in pH-dependent degradation (Marshansky and Futai, 
2008). However, some studies such as (Williamson et al., 2010; Zoncu et al., 2011), showed that 
some subunits (V0 subunit a1 in (Williamson et al., 2010), a few V1 subunits in (Zoncu et al., 2011) 
may play pH-independent roles in different pathways. The existence of pH-independent and 
location/timing-specific functions is supported by the fact that many subunits are encoded by 
more than one gene and many of those genes are restricted in the location as well as the 
developmental timing of their expression (Allan et al., 2005). 
 Lethal (2) 09851 contains a WD40 repeat (Fig 1D) that is known to play a role in a protein 
complex formation (Jain and Pandey, 2018). It is predicted to bind histones and could play a role 
in transcriptional regulation but the real function remains undiscovered. l(2) 09851 is a conserved 
gene; its human ortholog is called grwd1 (glutamine rich WD repeat containing 1) with 53% 
identity and 66% similarity. 
Clockwork orange (Cwo, Fig 1E) is a transcriptional regulator that plays a role in both the 
repression and activation of some genes (Richier et al., 2008). It was identified as a basic helix-
loop-helix transcriptional repressor belonging to the Orange family (Kadener et al., 2007; Lim et 
al., 2007; Matsumoto et al., 2007). In adult flies, cwo is rhythmically expressed and directly 
regulated by Clock-Cycle (CLK–CYC) through canonical E-box sequences (Matsumoto et al., 2007). 
cwo mutants display reduced amplitude of molecular and behavioral rhythms with lengthened 
periods suggesting that it acts as a transcriptional and behavioral circadian rhythm amplifier (Lim 
et al., 2007). In addition, Cwo also forms its own negative feedback loop (Matsumoto et al., 2007).  
Based on the available data, Cwo acts preferentially in the late night to help terminate CLK–CYC-
mediated transcription of direct target genes (Kadener et al., 2007). 
To analyze the effect on tissue invasion of the downregulation of these genes, we used P 
element insertion mutants (CG8602, cln7, vha68-2 and l(2) 09851) or hemocyte-specific RNAi 
(cwo) and counted the number of macrophages entering the extended germband in early stage 
12 embryos (up to a germband retraction of 41%). As shown in Fig 1F and G, there is a strong 
effect on migration into the extended germband in the CG8602 mutant. This could not be 
explained by a decreased number of macrophages (Fig 1H) or a general migration effect (Fig 1I). 
Figure 1J and K show also a strong decrease in the number of macrophages in the germband in 
the cln7 mutant but this gene seems to influence general migration as there is an effect on vnc 
as well (Fig 1L). Therefore we excluded this gene from futher analysis. We also excluded l(2) 
09851 that has a phenotype at early stage 12 (Fig 1Q, R) since homozygous embryos die at this 
stage hampering any further mutant analysis. vha68-2 also displays a decreased number of 
macrophages entering the extended germband (figure 1M, N) with no effect on the total cell 
number (Fig 1O) and a mild effect on the vnc (Fig 1P). Hemocyte-specific cwo RNAi did not confirm  
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Figure 1: Secondary screen uncovered CG8602 as a potential regulator of invasive migration 
A-B: Prediction of (A) CG8602 and (B) Cln7 structure made by Protter C: Structure of v-ATPase protein complex – V1 
subunit is blue, V0 subunit brown (modified from Smith et al., 2003) D-E: Structural prediction of (D) Lethal (2) 09851 
and (E) cwo based on InterPro F, J, M, Q, S: Representative confocal images of early stage 12 embryos of controls 
and mutants of (F) CG8602 (P{EP}CG86023102  ), (J) CLN7 (P{SUPor-P}KG05284), (M) vha68-2 (P{EP}Vha68-2EP2364), 
(Q) Lethal (2) 09851 (P{EPgy2}l(2)09851EY06365, for control see M)  and (S) RNAi of cwo; G, K, N, R, T: Number of 
macrophages entering the extended germband in control and mutant of (G) CG8602, (K) CLN7, (N) vha68-2, (R) Lethal 
(2) 09851  and (T) RNAi of cwo (v106783, v42822); H, O: Total number of macrophages in the whole embryo in 
control and mutant of (H) CG8602 and (O) vha68-2. I, L, P: Macrophage number on different segments of the vnc in 
control and mutant of (I) CG8602 and (P) vha68-2 or (L) on the whole vnc in the control and mutant of CLN7. 
Scale bar in F, J, M, Q, S is 50μm. Significance in G-I, K,L, N-P, R, T was analyzed by Student t-test. 
 
a previously observed increase in macrophage numbers in the extended germband (Fig 1S, T). 
Therefore, we decided to focus on the only candidate from our selected list that has a specific 
effect on germband invasion – CG8602. 
 
CG8602 potentially interacts with a sugar transporter, Frc 
To understand the function of CG8602 in invasive migration, we took advantage of published 
data from a two-hybrid assay (Giot et al., 2003) and the Drosophila Protein Interaction Map 
(DPiM) initiative (Guruharsha et al., 2011) which tagged nearly 5000 Drosophila genes with FLAG-
HA, expressed them in S2 R+ cells, and pulled down and analyzed interactors using mass 
spectrometry. CG8602 was one of the tagged genes. The list of proteins pulled down with CG8602 
is in Table 1 (see the end of the chapter). From those, we chose 7 candidates that could be 
expressed in macrophages at stages 9-12 (UDP-galactose 4-epimerase; CG1444; Fringe 
connection, Ataxin 2; Dodeca-satellite binding protein 1; Surfeit 4; Walrus) and did a 
macrophage-specific RNAi screen on them. Our RNAi screen (data produced and evaluated by 
Kateryna Shkarina; statistics by KV) showed that 1 line for Frc, Ataxin-2, CG1444 and 2 lines for 
Dp1 have a decreased number of macrophages in the extended germband (fig 2A). 
To see which protein(s) could interact with CG8602 to affect tissue invasion, we searched 
for those that phenocopy CG8602. Therefore we evaluated 2 RNAi lines per gene (CG1444, frc, 
dp1) not only for a germband phenotype but also for their vnc migration (Fig 2B) and total cell 
count (Fig 2C, data produced, evaluated and analyzed by Julia Biebl). Only one gene, fringe 
connection, phenocopies CG8602 while two others have significant changes in their total cell 
number (Dp1, CG1444, Fig 2C) and/or vnc (Dp1, Fig 2B) as well.  
fringe connection (frc) is a gene encoding a transmembrane protein. It is characterized as 
a UDP-GlcA, UDP-GlcNAC and potentially UDP-xylose transporter (Goto et al., 2001; Selva et al., 
2001) required for proper glycosylation. It brings in material for the proper function of a 
transferase called fringe (Goto et al., 2001; Selva et al., 2001) that is important for the 
glycosylation and therefore functionality of Notch (Irvine and Wieschaus, 1994; Moloney et al., 
2000; Brückner et al., 2000). 
To test whether Frc is a potential interactor of CG8602, we tested whether they are 
colocalized. Frc was previously shown to be localized in Golgi (Goto et al., 2001; Yano et al., 2005), 
with one study showing its very precise localization to medial Golgi (Yamamoto-Hino et al., 2012). 
Julia Biebl made a myc-tagged version of Frc and we also used the DPiM construct (FLAG-HA  
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Figure 2: Fringe connection specifically influences germband invasion and might interact with CG8602 
A: RNAi screen of the genes for 7 different proteins (Ataxin-2: v34956 v108843, Walrus: v36076, v103811, Dp1: 
v37583, v106047, UDP-galactose-4’epimerase: v47408, v106750, CG1444: v40949, v110678, Surfeit-4: v108944, Frc: 
v47543, v107816) that were pulled down together with CG8602 or were detected in a two-hybrid assay (frc). B: The 
total number of macrophages on the vnc analyzed for 2 RNAi lines of 3 candidates (frc, dp1 and CG1444). C: Total 
number of macrophages in the embryo analyzed for 2 RNAi lines of 3 candidates (frc, dp1 and CG1444). D: A 
representative image of partial co-localization of CG8602 (red) and Frc (green) in S2 R+ cells E: Manual quantification 
of co-localization of spots of CG8602 and Frc in different combination of constructs F: Number of macrophages in 
the extended germband in control and heterozygous mutant for frc. 
Scale bar in D is 5μM. Significance in A, B, C, F was analyzed by Student’s t-test. 
 
tagged). We co-expressed it with either FLAG-HA tagged (DPiM project) or a 3xmCherry tagged 
CG8602 (made by Julia Biebl) in S2 R+ cells. We conclude that Fringe connection and CG8602 are 
partially co-localized (Fig 2D, E). Co-localization and pull down does not definitively indicate a 
functional interaction, therefore we aimed to perform a genetic interaction test (double 
heterozygous mutants). Unfortunately, frc is haploinsufficient so we could not analyze the 
potential interaction between these two genes (Fig 2F). 
 
Notch might not play a role in invasive migration  
Frc was shown to be important for the proper glycosylation and therefore functionality of Notch 
(Goto et al., 2001; Selva et al., 2001). Notch was shown before to be a component of the 
hemocyte differentiation program. Notch promotes crystal cell differentiation, preventing the 
cells from adopting other cell fates and simultaneously promotes morphological characteristics 
of crystal cell differentiation (Lebestky et al., 2000; Terriente-Felix et al., 2013). However, one 
study showed that Notch is neither necessary nor sufficient for crystal cell development in 
embryos (Bataillé et al., 2005).  
We therefore wondered whether CG8602 could influence hemocyte maturation/ 
differentiation in general on a transcriptional level. To test this, we performed qPCR analysis of a 
few macrophage-specific genes (rhoL, PVR, papilin, draper and srpHemo measured through 
expression of mCherry in srpHemo-3mCherry flies) on FACS-sorted macrophages from stage 12 
embryos and showed that there is no significant change in expression on the RNA level of any of 
them (Fig 3A).  
notch is not enriched in macrophages compared to other tissues (Fig 3B). However, the 
question is whether it could function in macrophages in other pathways than only crystal cell 
differentiation. Staining with a Delta antibody shows the potential ligand to be around 
macrophages (Fig 3C). To assess the role of Notch in tissue invasion, we performed hemocyte-
specific RNAi against notch and analyzed the number of macrophages entering the extended 
germband. We got no significant change in the number of macrophages (Fig 3D). However, this 
experiment was done using RNAi what brings some limitations, e.g. RNAi not being strong enough 
to cause the phenotype or produced too late to actually influence migration, especially if 
assumed that it could function through influencing/modulating differentiation. Therefore, the 
question of Notch involvement needs to be addressed more carefully to make a firm conclusion. 
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Figure 3: Notch might not play a role in invasive migration of embryonic macrophages 
Figure 3 
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A: Expression of macrophage genes (rhoL, notch, PVR, ppn, drpr, srpHemo analyzed by expression of srpHemo-
3xmCherry construct) normalized to housekeeping gene in the control and CG8602 mutant. B: Expression of Notch 
in macrophages (mCherry positive cells) and randomly collected non-positive cells (mCherry negative cells from the 
same embryos, marked as rest) normalized to a housekeeping gene. C: Delta staining (green) in the head of early 
stage 12 embryos . Macrophages are marked with srpHemo-3xmCherry (red) D: Macrophage-specific RNAi of Notch 
(v1112, v27229 from VDRC).  
Scale bar in C is 10 μm. Significance in A and D is analyzed by Student t-test. 
 
N Cadherin degradation is delayed in CG8602 mutant  
CG8602 is co-localized and potentially interacting with a sugar transporter Frc. This raised the 
possibility that it could play a role in glycosylation (for more details see Chapter 3). One of the 
important players in cell adhesion that is known to be regulated by glycosylation is Cadherin 
(Carvalho et al., 2016; Larsen et al., 2017; Xu et al., 2017). We were therefore wondering whether 
CG8602 could potentially influence cadherins. We stained control and mutant embryos (Fig 4A) 
with DE-Cad and DN-Cad antibody and detected no obvious change in their staining, localization 
or morphology of mesoderm and ectoderm in the germband before and at the time of the 
macrophage entry. 
Drosophila macrophages are born in head mesoderm that expresses DN-Cadherin. We 
therefore checked DN-Cad dynamics in the macrophages anlage. In control embryos, there is 
strong staining at stage 8 (Fig 4B) that slowly decreases through stage 10. At stage 12, there is 
very little DN-Cad left (Fig 4B). As a next step, we stained mutant and control embryos with DN-
Cadherin antibody. In the CG8602 mutant, DN-Cadherin downregulation seems to be delayed as 
there is still a lot of staining on the macrophages that are entering the extended germbad which 
is not the case for the control (Fig 4C). To confirm this result, we use Imaris to quantify the signal 
intensity. The result shows an approximately doubling of the signal for DN-Cad staining in the 
mutant embryos compared to the control (Fig 4D). We therefore conclude that DN-Cadherin 
downregulation, internalization or degradation is delayed in the CG8602EP3102 mutant. 
 
Discussion 
 
In our secondary screen, we identified a potential player in tissue invasion that seems to be 
specific for this process as it does not influence migration on the vnc or cell proliferation. This 
protein potentially interacts with a sugar transporter called Fringe connection. As Fringe 
connection regulates Notch through glycosylation, CG8602 could potentially play a role in this 
regulation as well. However, Notch RNAi specifically in macrophages does not show a significant 
change in the number of macrophages in the extended germband therefore the role of Notch in 
hemocytes outside of differentiation is debatable.   
Another option for its function (that is not mutually exclusive with a role in the Notch 
pathway) is through regulation of DN-Cadherin degradation and or internalization. DN-Cadherin 
is expressed in the hemocyte anlage as they are of mesodermal origin but when they start to 
migrate towards the extended germband, it is downregulated. Intriguingly, it stays up in crystal 
cells that do not migrate out from the head (Fig 4E). We hypothesize that downregulation/ 
internalization/ degradation of DN-Cadherin is needed for proper migration and that DN-
Cadherin on the surface causes macrophages to stay in the head for a longer time, slows 
macrophages down and/or negatively influences their ability to enter the extended germband. 
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Figure 4: DN-Cadherin degradation is delayed in CG8602 mutant 
A: Confocal images of germband entry in stage 12 control and CG8602 mutant embryos stained with the 
ectodermal marker (DE-Cadherin, green), the mesodermal marker (DN-Cadherin, cyan) and DAPI (blue) to visualize 
nuclei. Macrophages are marked by 3xmcherry expression (red). B: DN-Cadherin staining (green) in stage 9 (top) 
and stage 12 (bottom) embryo. Macrophages are marked by 3xmCherry expression (red). White dashed line in 
stage 9 embryo shows the position of macrophages in the head. C: DN-Cadherin staining (green) in early stage 12 
embryo control (top) and CG8602 mutant (bottom). Macrophages are marked by 3xmCherry expression (red). 
White dashed line shows the position of macrophages. D: Quantification of DN-Cadherin staining in the 
macrophages normalized to the mesoderm in the germband in the control and CG8602 mutant. E: A confocal 
image of the head of a stage 13 embryo. The dashed area marks and the arrow points to the probable position of 
crystal cells. 
Scale bar is 20μm in A, 50 μm in B and 10 μm in C. Significance in D was analyzed by Student t-test. 
 
Our current working model is shown in Figure 5. We propose that CG8602 is a Golgi-
localized protein that influences the glycosylation of an unknown protein that subsequently 
localizes to the plasma membrane where it is responsible for the correct timing of DN-Cadherin 
internalization. In the mutant macrophages, incorrect glycosylation could affect the unknown 
protein’s degradation or its functionality or localization. We hypothesize that DN-Cadherin 
downregulation/ internalization in macrophages is needed to modulate their migration 
properties as well as to decrease their binding to the mesoderm in the extended germband which 
contains a large amount of DN-Cad on its surface. Excessive interaction with DN-Cadherin on the 
surface of the mesoderm could lead to macrophages being stuck at the entry site or moving 
slower inside the germband compared to wild-type macrophages.  
The model based on DN-Cadherin has an unknown component that needs to be revealed 
and assumes a role for CG8602 in glycosylation that is described more in detail in Chapter 3.  
 
Figure 5: Model 
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Material and methods 
 
In this section, I describe only material and methods that are not described in Chapter 3 
 
Fly lines  
srpHemo-GAL4 was provided by K. Brückner (UCSF, USA) (Brückner et al., 2004). The stocks 
w1118; CG86023102 (BDSC-17262), w-; P{w[+mC]=UAS-mCherry.NLS}2;MKRS/Tm6b, Tb[1] (BDSC-
38425);  y[1] w[67c23]; P{y[+mDint2] w[BR.E.BR]=SUPor-P}KG05284 ry[506] (BDSC-13990); 
w[1118]; P{w[+mC]=EP}Vha68-2[EP2364]/CyO (BDSC-17243); y1 w67c23; 
P{lacW}l(2)09851k08138/CyO (BDSC-10777) were obtained from the Bloomington Drosophila 
Stock Centre, Bloomington, USA. The RNAi lines v106783, v42822, v34956, 108843, v36076, 
v103811, v37583, v106047, v47408, v106750, v40949, v110678, v108944, v47543, v107816, 
v1112; v 27229 were obtained from the Vienna Drosophila Resource Center (VDRC), Vienna, 
Austria. Line w-; P{w[+mC; srpHemo-3xmCherry}, was published previously (Gyoergy et al., 2018).  
Exact genotype of Drosophila lines used in Figures: 
Figure 1F-I: Control: w-; srpHemo-Gal4 UAS-mCherry::nls; +. CG8602 mutant: w-; srpHemo-Gal4 
UAS-mCherry::nls; P{EP}CG86023102  Figure 1J-L: Control: w-; srpHemo-Gal4 UAS-GFP; +. CLN7 
mutant: w-; srpHemo-Gal4 UAS-GFP; P{SUPor-P}KG05284 Figure 1M-P: Control: w-; +; srpHemo-
Gal4 UAS-GFP UAS-H2A::RFP; vha68-2 mutant: w-; P{EP}Vha68-2EP2364; srpHemo-Gal4 UAS-GFP 
UAS-H2A::RFP; Figure 1Q-R: Control: w-; +; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP; l(2)09851 
mutant: w-; P P{EPgy2}l(2)09851EY06365; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP Figure 1S-T: 
Control: w-,UAS-Dcr2/+; +; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+ RNAi1: : w-,UAS-Dcr2/+; 
RNAi cwo (v106783)/+ ; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+, RNAi2: : w-,UAS-Dcr2/+; RNAi 
cwo (v42822)/+ ; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+, Figure 2 A-C: Control: w-,UAS-Dcr2/+; 
+; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+, ataxin-2_GD: : w-,UAS-Dcr2/+; +; srpHemo-Gal4 
UAS-GFP UAS-H2A::RFP/v34956, ataxin-2_KK: w-,UAS-Dcr2/+; v108843/+; srpHemo-Gal4 UAS-
GFP UAS-H2A::RFP/+, walrus_GD: w-,UAS-Dcr2/+; v36076/+; srpHemo-Gal4 UAS-GFP UAS-
H2A::RFP/+, walrus_KK: w-,UAS-Dcr2/+; v103811/+; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+, 
dp1_GD: w-,UAS-Dcr2/+; v37583/+; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+, dp1_KK: w-,UAS-
Dcr2/+; v106047/+; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+, UDP_gal4epi_GD: w-,UAS-Dcr2/+; 
+; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/v47408, UDP_gal4epi_KK: w-,UAS-Dcr2/+; v106750/+; 
srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+, CG1444_GD: w-,UAS-Dcr2/+; v40949/+; srpHemo-Gal4 
UAS-GFP UAS-H2A::RFP/+, CG1444_KK: w-,UAS-Dcr2/+; v110678/+; srpHemo-Gal4 UAS-GFP UAS-
H2A::RFP/+, surfeit4_KK: w-,UAS-Dcr2/+; v108944/+; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+, 
frc_GD: w-,UAS-Dcr2/+; +; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/v47543, frc_KK: w-,UAS-
Dcr2/+; v107816/+; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+, Figure 2F: Control: w-; srpHemo-
Gal4 UAS-mCherry::nls; +, frc heterozygous: w-; srpHemo-Gal4 UAS-mCherry::nls; 
frc00702P[Bac]/+. Figure 3A: Control: w-; +, srpHemo-3xmCherry. CG8602 mutant: w-; +, 
srpHemo-3xmCherry P{EP}CG86023102 Figure 3B: w-; +, srpHemo-3xmCherry Figure 3C: Control: 
w-; +, srpHemo-3xmCherry. CG8602  mutant: w-; +, srpHemo-3xmCherry P{EP}CG86023102, 
Figure 3D: Control: w-; srpGal4/+; srpHemo-H2A::3xmcherry/+; RNAi1: w-; srpGal4/ v1112; 
srpHemo-H2A::3xmcherry/+ ; RNAi2: w-; srpGal4/+; srpHemo-H2A::3xmcherry/v 27229. Figure 
   26 
 
4A-E: Control: w-; +, srpHemo-3xmCherry. CG8602 mutant: w-; +, srpHemo-3xmCherry 
P{EP}CG86023102 
 
qPCR 
RNA was isolated from approximately 50,000 mCherry positive or mCherry negative FACS sorted 
macrophages using RNeasy Plus Micro Kit (Qiagen, Hilden, Germany following manufacturer’s 
protocol. Further steps were according to the manufacturers protocol. The resulting RNA was 
used for cDNA synthesis using Sensiscript RT Kit (Qiagen, Hilden, Germany) and oligo dT primers. 
A Takyon qPCR Kit (Eurogentec, Liege, Belgium) was used to mix qPCR reactions based on the 
provided protocol. qPCR was run on a LightCycler 480 (Roche, Basel, Switzerland) and data were 
analyzed in the LightCycler 480 Software and Prism (GraphPad Software). Data are represented 
as relative expression to a housekeeping gene (2-Δct). Primer sequences utilized for flies were 
obtained from the FlyPrimerBank  http://www.flyrnai.org/FlyPrimerBank).  
RhoL fw 5’CCTGAGCTATCCCAGTACCAA 
rv 5’ACCACTTGCTTTTCACGTTTTC 
Notch fw 5’CGCTTCCTGCACAAGTGTC 
 rv 5’GCGCAGTAGGTTTTGCCATT 
PVR fw 5’GTGACTTTGGTCTGGCTCG 
 rv 5’GATTCCAGCGCCAGC  
Ppn fw 5’GCCTGCGAAGAGATGATCGT 
 rv 5’CCGGACAGTCTTGGGTGTTG 
Drpr fw 5’TCCACCTATCGCATTAAACACC 
 rv 5’ACAGTCCCTCACAATACGGTT 
mCh  fw 5’ACATCCCCGACTACTTGAAGC 
 rv 5’ACCTTGTAGATGAACTCGCCG 
RpL32: Fw 5’AGCATACAGGCCCAAGATCG 
Rv 5’TGTTGTCGATACCCTTGGGC 
 
Embryo Immunochemistry 
For staining, embryos were fixed with 17% formaldehyde/heptane for 20 min followed by ethanol 
devitellinization (delta staining) or hand devitellinized (DN-Cadherin and DE-Cadherin).  Fixed 
embryos were blocked in BBT (0.1M PBS + 0,1% TritonX-100 + 0,1% BSA) for 2 hours at RT. 
Antibodies were used at the following dilutions: α-Delta (C594.9B; DSHB; mouse (Qi et al., 1999)) 
1:10, α-DN-Cadherin (DN-Ex #8; DSHB; rat (Iwai et al., 1997) 1:10; α-DE-Cadherin (Santa Cruz; 
rabbit) 1:50 and incubated overnight at 4°C (α-Delta) or room temperature (α-DN-Cadherin, α-
DE-Cadherin). Afterwards, embryos were washed in BBT for 2 hours, incubated with secondary 
antibodies (Thermo Fisher Scientific, Waltham, Massachusetts, USA) at RT for 2 hours, and 
washed again for 2 hours. Vectashield with DAPI (Vector Laboratories, Burlingame, USA) was then 
added. After overnight incubation in Vectashield at 4°C, embryos were mounted on a slide and 
imaged with a Zeiss Inverted LSM700 Confocal Microscope using a Plan-Apochromat 63X/1.4 Oil 
Objective. 
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DN-Cadherin quantification 
DN-Cadherin staining on macrophages was quantified using Imaris software (Bitplane). The 
mcherry signal from macrophages was used to set up a mask; signal intensity for the 488 channel 
in the mask was then measured and normalized to the 488 signal intensity in the mesoderm 
inside of the extended germband.  
 
Table 1: Proteins pulled-down with CG8602 in S2 R+ cells (Guruharsha et al., 2011) 
 
Number Name Description Expression stage 10-12 
Unique 
peptides 
CG7393 p38b 
wing morphogenesis,immune 
response,protein amino acid 
phosphorylation,,regulation of BMP 
signaling pathway,response to stress, 
response to salt stress 
11-12: hindgut, faint 
ubiquitous, trunk 
mesoderm, midgut 
12 
CG6214 
Multidrug-
Resistance 
like Protein 
1 
transmembrane transport no data 7 
CG8385 
ADP 
ribosylation 
factor at 79F 
endosome 
transport,neurotransmitter 
secretion,cell shape regulation,cell 
adhesion,protein amino acid ADP-
ribosylation,small GTPase signal 
transduction 
ubiquitous 7 
CG1444 - oxidation reduction 
 9-10: procephalic 
ectoderm, central 
brain, VNC, mesoderm, 
germ cell, 11-12: trunk 
mesoderm, vent 
epidermis, muscle sys, 
midgut, brain, fat 
body/gonad, VNC 
6 
CG6701 - zinc ion binding, RNA interference no data 6 
CG5215 
Zinc-finger 
protein at 
72D 
phagocytosis, engulfment ubiquitous 5 
CG9012 
Clathrin 
heavy chain 
dsRNA transport,vesicle-mediated 
transport,synaptic vesicle 
coating,neurotransmitter 
secretion,sperm 
individualization,intracellular protein 
transport 
no data 5 
CG31729 - 
cation transport,phospholipid 
transport,ATP biosynthetic process 
ubiquitous 5 
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CG8258 - 
mitotic spindle organization,protein 
folding 
 9-10: endoderm,  
mesoderm, faint 
ubiquitous 11-12: 
hindgut, mesoderm, 
Malpighian tubule, anal 
pad, muscle sys, 
midgut, faint 
ubiquitous 
5 
CG13472 - spliceosome assembly ubiquitous 4 
CG6995 
Scaffold 
attachment 
factor B 
regulation of alternative nuclear 
mRNA splicing, via spliceosome 
ubiquitous 4 
CG5170 
Dodeca-
satellite-
binding 
protein 1 
heterochromatin 
formation,chromosome 
segregation,chromosome 
condensation,positive regulation of 
translation 
9-10: endoderm, 
inclusive hindgut, 11-
12: hindgut, 
mesoderm, 
midgut,salivary gland 
body 
4 
CG3584 
Quaking 
related 58E-
3 
regulation of alternative nuclear 
mRNA splicing, via 
spliceosome,apoptosis 
ubiquitous 4 
CG6647 Porin 
anion transport,transmembrane 
transport,phototransduction,ion 
transport,mitochondrial transport 
ubiquitous 3 
CG43443 Hu li tai shao 
spectrosome, centrosome and 
fusome organization;ocyte fate 
determination,germ-line cyst 
formation,cystoblast division,ring 
canal formation, actin assembly 
no data 3 
CG12030 
UDP-
galactose 4'-
epimerase 
cellular metabolic process,galactose 
metabolic process 
9-10: amnioserosa, yolk 
nuclei, 11-12: 
amnioserosa, yolk 
nuclei, post midgut, 
plasmatocytes, salivary 
gland body 
3 
CG4611 - - no data 3 
CG5655 
Repressor 
splicing 
factor 1 
negative regulation of nuclear mRNA 
splicing, via spliceosome 
ubiquitous 3 
CG14786 - oxidation reduction 11-12: midgut 3 
CG11258 L20 translation no data 3 
CG1341 
Regulatory 
particle 
triple-A 
ATPase 1 
proteolysis,cellular response to DNA 
damage stimulus 
ubiquitous 3 
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CG9159 
Kruppel 
homolog 2 
- no data 3 
CG4729 - metabolic process ubiquitous 2 
CG5166 Ataxin-2 
bristle development,oocyte 
differentiation,phagocytosis, 
engulfment,compound eye 
development,regulation of actin 
filament polymerization 
ubiquitous 2 
CG8996 Walrus 
oxidative phosphorylation; 
morphogenesis of Malpighian 
tubules,open tracheal, epithelium 
and ectodermal gut; head involution 
ubiquitous 2 
CG1483 
Microtubule
-associated 
protein 205 
microtubule-based process 
11-12: trunk 
mesoderm, dors 
pharyngeal muscle, 
visceral muscle, muscle 
sys, VNC, brain, 
somatic muscle 
2 
CG12076 YT521-B RNA metabolic process no data 2 
CG3689 - mRNA cleavage ubiquitous 2 
CG10622 Sucb tricarboxylic acid cycle 
11-12: hindgut proper, 
Malpighian tubule, ant 
midgut, post midgut 
2 
CG6643 - - no data 2 
CG17291 
Protein 
phosphatase 
2A at 29B 
phagocytosis, 
engulfment,chromosome 
segregation,spindle 
assembly,centrosome cycle,protein 
amino acid 
dephosphorylation,mitotic spindle 
organization 
no data 2 
CG3458 
Topoisomer
ase 3β 
DNA catabolic process, 
endonucleolytic,DNA unwinding 
during replication,DNA topological 
change 
no data 2 
CG9366 RhoL 
cell migration,ovarian cell and 
mesoderm development,small 
GTPase signal transduction,regulation 
of cell shape,response to DNA 
damage,cell adhesion 
4-10: head mesoderm, 
11-12: plasmatocytes 
2 
CG8231 T-cp1ζ 
protein folding,centriole 
replication,mitotic spindle 
organization 
 9-10: post endoderm,  
germ cell, ant 
endoderm, mesoderm 
2 
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CG1258 Pavarotti 
mitosis and meiosis,smoothened 
signaling pathway,microtubule-based 
movement,PNS development, 
regulation of NFAT protein import 
into nucleus 
 11-12:  neuroblasts, 
germ cell, VNC, brain, 
dorsomedial 
neurosecretory cell 
2 
CG9742 SmG 
nuclear mRNA splicing, via 
spliceosome,mitotic spindle 
organization,spliceosome assembly 
ubiquitous 2 
CG4199 - 
oxidation reduction,cell redox 
homeostasis 
 9-10: no staining, 11-
12: leading edge cell, 
ant midgut, post 
midgut 
2 
CG11505 - 
nucleotide binding; nucleic acid 
binding 
no data 2 
CG8309 TANGO7 Golgi organization ubiquitous 2 
CG15098 - -  11-12: midgut 1 
CG5479 L43 translation 
11-12: hindgut, trunk 
mesoderm, ubiquitous,  
midgut 
1 
CG13608 S24 translation no data 1 
CG5183 
KDEL 
receptor 
intra-Golgi vesicle-mediated 
transport,retrograde vesicle-
mediated transport, Golgi to 
ER,protein retention in ER lumen 
11-12: hindgut, trunk 
mesoderm, tracheal, 
foregut, midgut, 
salivary gland body, fat 
body/gonad, 
ubiquitous 
1 
CG15735 - Anticodon-binding domain ubiquitous 1 
CG4043 Rrp46 mRNA processing no data 1 
CG11271 
Ribosomal 
protein S12 
translation ubiquitous 1 
CG5497 S28 translation  11-12: midgut 1 
CG3800 - zinc ion binding; nucleic acid binding. ubiquitous 1 
CG31363 Jupiter 
positive regulation of microtubule 
polymerization 
ubiquitous 1 
CG3204 
Ras-
associated 
protein 2-
like 
small GTPase mediated signal 
transduction,germ-line stem cell 
maintenance 
no data 1 
CG11027 
ADP 
ribosylation 
factor at 
102F 
small GTPase signal 
transduction,synaptic vesicle 
endocytosis,neurotransmitter 
secretion,protein transport,protein 
amino acid ADP-ribosylation 
ubiquitous 1 
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CG10849 Sc2 lipid metabolic process no data 1 
CG8427 SmD3 
lymph gland, CNS, PNS and muscle 
development;mitotic spindle 
organization,nuclear mRNA splicing, 
neuron differentiation 
no data 1 
CG11246 Rpb8 
transcription from RNA polymerase II 
promoter 
1-10: ubiqiutous, 11-
12:  midgut 
1 
CG14981 Maggie intracellular protein transport. 
11-12: trunk 
mesoderm, dors 
pharyngeal muscle, 
muscle sys, midgut, 
somatic muscle 
1 
CG42481 - - no data 1 
CG6202 Surfeit 4 lateral inhibition 
9-10: mesoderm, 11-
12: trunk mesoderm, 
muscle sys, salivary 
gland, plasmatocytes, 
salivary gland body 
1 
CG11857 - vesicle-mediated transport ubiquitous 1 
CG9035 
Translocon-
associated 
protein δ 
protein retention in ER lumen 
9-10: head mesoderm, 
11-12: hindgut, trunk 
mesoderm, garland 
cell, tracheal, foregut, 
midgut, salivary gland 
body, fat body/gonad 
1 
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Introduction 
 
The set of proteins expressed by a cell defines much of its potential capacities. However, a diverse 
set of modifications can occur after the protein is produced to alter its function and thus 
determine the cell’s final behavior. One of the most frequent and variable of such alterations is 
glycosylation, in which sugars are added onto the oxygen (O) of a serine or threonine or onto the 
nitrogen (N) of an asparagine (Kornfeld and Kornfeld, 1985; Marshall, 1972; Ohtsubo and Marth, 
2006). O-linked addition can occur on cytoplasmic and nuclear proteins in eukaryotes (Comer and 
Hart, 2000; Hart et al., 2011), but the most extensive N- and O- linked glycosylation occurs during 
the transit of a protein through the secretory pathway. A series of sugar molecules are added 
starting in the endoplasmic reticulum (ER) or cis-Golgi and continuing to be incorporated and 
removed until passage through the trans Golgi network is complete (Aebi, 2013; Stanley et al., 
2009). N-linked glycosylation is initiated in the ER at consensus NxS/T XP site, whereas the most 
common GalNAc-type O-linked glycosylation is initiated in the early Golgi and glycosites display 
no clear sequence motifs, apart from a prevalence of neighboring prolines (Bennett et al., 2012; 
Christlet and Veluraja, 2001). Glycosylation can affect protein folding, stability and localization as 
well as serve specific roles in fine-tuning protein processing and functions such as protein 
adhesion and signaling (Goth et al., 2018; Varki, 2017). The basic process by which such 
glycosylation occurs has been well studied. However our understanding of how specific glycan 
structures participate in modulating particular cellular functions is still at its beginning. 
 The need to understand the regulation of O-glycosylation is particularly relevant for 
cancer (Fu et al., 2016; Häuselmann and Borsig, 2014). The truncated O-glycans called T and Tn 
antigen are not normally found on most mature human cells (Y Cao et al., 1996) but up to 95% of 
cells from many cancer types display these at high levels (Boland et al., 1982; Y Cao et al., 1996; 
Howard and Taylor, 1980; Limas and Lange, 1986; Orntoft et al., 1985; Springer, 1984; Springer 
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et al., 1975). The T O-glycan structure (Gal1-3GalNAc1-O-Ser/Thr) is synthesized by the large 
family of polypeptide GalNAc-transferases (GalNAc-Ts) that initiate protein O-glycosylation by 
adding GalNAc to form Tn antigen and the core1 synthase C1GalT1 that adds Gal to the initial 
GalNAc residues (Tian and Ten Hagen, 2009) to form T antigen (Figure 1A). The human C1GalT1 
synthase requires a dedicated chaperone, COSMC, for folding and ER exit (Ju and Cummings, 
2005). In adult humans these O-glycans are normally capped by sialic acids and/or elongated and 
branched into complex structures (Tarp and Clausen, 2008). However, in cancer this elongation 
and branching is reduced or absent and the appearance of these truncated T and Tn O-glycans 
correlates positively with cancer aggressiveness and negatively with long-term prognoses for 
many cancers in patients (Baldus et al., 2000; Carrasco et al., 2013; Ferguson et al., 2014; 
MacLean and Longenecker, 1991; Schindlbeck et al., 2005; Springer, 1997, 1989; Summers et al., 
1983; Yu et al., 2007). The molecular basis for the enhanced appearance of T antigen in cancers 
is not clear (Chia et al., 2016a), although higher Golgi pH in cancer cells correlates with increases 
in T antigen (Kellokumpu, Sormunen and Kellokumpu, 2002). Interestingly, T antigen is also 
observed as a transient fetal modification (Barr et al., 1989) and cancer cells frequently 
recapitulate processes that happened earlier in development (Cofre and Abdelhay, 2017; Pierce, 
1974). Identifying new mechanisms that regulate T antigen modifications developmentally has 
the potential to lead to important insights into cancer biology. 
Drosophila as a classic genetic model system is an excellent organism in which to 
investigate these questions. Drosophila displays T antigen as the predominant form of GalNAc-, 
or mucin-type, O-glycosylation in the embryo with 18% of the T glycans being further elaborated, 
predominantly by the addition of GlcA (Aoki et al., 2008). As in vertebrates, the GalNAc-T 
isoenzymes directing the initial step of GalNAc addition to serines and threonines are numerous, 
with several already known to display conserved substrate specificity in vitro with vertebrates 
(Müller et al., 2005; Schwientek et al., 2002; Ten Hagen et al., 2003b). The Drosophila GalNAc-Ts 
affect extracellular matrix (ECM) secretion, gut acidification and the formation of the respiratory 
system (Tian and Ten Hagen, 2006; Tran et al., 2012; Zhang et al., 2010). In flies the main enzyme 
adding Gal to form T antigen is C1GalTA (Müller et al., 2005) whose absence causes defects in 
ventral nerve cord (vnc) condensation during Stage 17, hematopoetic stem cell maintenance, and 
neuromuscular junction formation (Fuwa et al., 2015; Itoh et al., 2016; Lin et al., 2008; Yoshida 
et al., 2008). While orthologous to the vertebrate Core1 synthases, the Drosophila C1GALTs differ 
in not requiring a specific chaperone (Müller et al., 2005). Most interestingly, T antigen is found 
on embryonic macrophages (Yoshida et al., 2008), a cell type which can penetrate into tissues in 
a manner akin to metastatic cancer (Ratheesh et al., 2018a; Siekhaus et al., 2010). Macrophage 
invasion of the germband (Figure 1B, arrow in Figure 1C) occurs between the closely apposed 
ectoderm and mesoderm (Ratheesh et al., 2018a; Siekhaus et al., 2010) from late Stage 11 
through Stage 12.  This invasion occurs as part of the dispersal of macrophages throughout the 
embryo (Figure 1C) along other routes that are mostly noninvasive, such as along the inner 
ventral nerve cord (vnc) (arrowhead in Figure 1C) (Campos-Ortega and Hartenstein, 1997; Evans 
et al., 2010). Given these potentially related but previously unconsolidated observations, we 
sought to determine the relationship between the appearance of T antigen and macrophage 
invasion and to use the genetic power of Drosophila to find new pathways by which this 
glycophenotype is regulated.  
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Results 
 
T antigen is enriched and required in invading macrophages in Drosophila embryos 
To identify glycan structures present on fly embryonic macrophages during invasion we 
performed a screen examining FITC-labelled lectins (see Methods for abbreviations). Only two 
lectins had higher staining on macrophages than on surrounding tissues (labeled enriched): PNA, 
which primarily binds to the core1 T O-glycan, and UEA-I, which can recognize Fuc1-2Gal1-
4GlcNAc(Molin et al., 1986; Natchiar et al., 2007) (Figure 1D, Figure 1-figure supplement 1A-B). 
Both glycans are associated with the invasive migration of mammalian cancer cells (Agrawal et 
al., 2017; Hung et al., 2014). SBA, WGA, GS-II, GS-I, ConA, MPA and BPA bound at similar or lower 
levels on Drosophila macrophages compared to flanking tissues (Figure 1D, Figure 1-figure 
supplement 1C-I). We saw no staining with the sialic acid-recognizing lectin LPA, and none with 
DBA and HPA, that both recognize α-GalNAc (Piller et al., 1990) (Figure 1D, Figure 1-figure 
supplement 1J-L). Thus PNA and UEA-I display enriched macrophage binding during their 
embryonic invasive migration. 
 To confirm T antigen as the source of the upregulated PNA signal in embryonic 
macrophages during invasion and to characterize its temporal and spatial enrichment, we used a 
monoclonal antibody (mAb 3C9) to the T O-glycan structure (Steentoft et al., 2011). Through 
Stage 10, macrophages displayed very little T antigen staining, similar to other tissues (Figure 1E, 
F). However, at late Stage 11 (Figure 1-figure supplement 1A) and early Stage 12, when 
macrophages start to invade the extended germband, T antigen staining began to be enriched 
on macrophages moving towards and into the germband (Figure 1E-H). Our results are consistent 
with findings showing T antigen expression in a macrophage-like pattern in late Stage 12 
embryos, and on a subset of macrophages at Stage 16 (Yoshida et al., 2008). We knocked down 
the core1 synthase C1GalTA required for the final step of T antigen synthesis (Figure 1A) (Lin et 
al., 2008; Müller et al., 2005) using RNAi expression only in macrophages and observed strongly 
reduced staining (Figure 1I,  Figure 1-figure supplement 1M). We conclude that the antibody 
staining is the result of T antigen produced by macrophages themselves.  
 To determine if these T O-glycans on macrophages are important for facilitating their 
germband invasion, we knocked down C1GalTA in macrophages with the RNAi line utilized above 
as well as one other and used the P element excision allele C1GalTA[2.1] which removes 
conserved sequence motifs required for activity (Lin et al., 2008). We visualized macrophages 
through specific expression of fluorescent markers and observed a 25 and a 33% decrease in their 
number in the germband for the RNAis (Figure 1J,K), and a 44% decrease in the C1GalTA[2.1] 
mutant (Figure 1L). When we counted the number of macrophages sitting on the yolk next to the 
germband in the strongest RNAi we observed an increase (Figure 1-figure supplement 1N) that 
we also observed in the C1GalT mutant (Figure 1-figure supplement 1O). The sum of the 
macrophages in the yolk and germband is the same in the control, RNAi knockdown (control 
136.5±6.4, RNAi 142.3±6.6, p=0.7) and mutant (control 138.5±4.9, mutant, 142.3±7.4, p=0.87) 
arguing that macrophages in which C1GalTA levels are reduced cannot enter the germband but 
are retained on the yolk. We observed no effect on the migration of macrophages on the vnc, a 
route that does not require tissue invasion (Figure 1-figure  
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Figure 1: T antigen is enriched on Drosophila macrophages prior to and during their invasion of the extended 
germband. (A) Schematic of T antigen modification of serine (S) and threonine (T) on proteins within the Golgi lumen, 
through successive addition of GalNAc (yellow) by GalNAcTs and Gal (blue) by C1GalTs. Ugalt transports Gal into the 
Golgi. Glycosylation is shown at a much larger scale than the protein. (B) Schematic of an early Stage 12 embryo and 
a magnification of macrophages (red) entering between the germband ectoderm (dark grey), and mesoderm (light 
grey). (C) Schematic showing macrophages (red) disseminating from the head mesoderm in Stage 9. By Stage 10, 
they migrate towards the extended germband, the dorsal vessel and along the ventral nerve cord (vnc). At late Stage 
11 germband invasion (arrow) begins and continues during germband retraction. Arrowhead highlights migration 
along the vnc in late Stage 12. (D) Table summarizing a screen of glycosylation-binding lectins for staining on 
macrophages invading the germband in late Stage 11 embryos. The listed binding preferences are abbreviated 
summaries of the specificities defined with mammalian glycans or simple saccharides which may have only 
incomplete relevance to insect glycomes. Enrichment was seen for PNA which recognizes T antigen and UEA-I which 
can recognize fucose. (E) Quantification of T antigen fluorescence intensities on wild type embryos shows 
upregulation on macrophages between Stage 9/10 and Stage 11/12. Arbitrary units (au) normalized to 1 for Stage 
11) p <0.0001. (F-H) Confocal images of fixed lateral wild type embryos from (F) Stage 9 and (G-H) early Stage 12 
with T antigen visualized by antibody staining (green) and macrophages by srpHemo-3xmCherry expression (red). 
Schematics at left with black boxes showing the imaged regions. (I) Quantification of control shows T antigen 
enrichment on macrophages when normalized to whole embryo. RNAi in macrophages against C1GalTA by 
srpHemo(macrophage)>C1GalTA RNAi vdrc2826 significantly decreases this T antigen staining (n=8 embryos, p= 
0.011). (J) Representative confocal images of Stage 12 embryos from control and the aforementioned C1GalTA RNAi. 
Macrophages marked with cytoplasmic GFP (red) and nuclear RFP (green). (K,L) Quantification of macrophages in 
the germband in Stage 12 embryos for (K) control and two independent RNAis against C1GalTA (vdrc110406 or 
vdrc2826) expressed in macrophages by the srpHemo-Gal4 driver (n=21-31 embryos, p<0.0001 and 0.017) or (L) in 
control and the C1GalTA[2.1] excision mutant (n=23-24, p=0.0006). Macrophages labeled with srpHemo-
H2A::3xmCherry. The RNAis and the mutant significantly decreased the macrophage number, arguing that T antigen 
is required in macrophages for germband entry. (M) Quantification of germband macrophages in early Stage 12 
embryos in control and GlcAT-PMI05251 embryos shows no defect in macrophage invasion in the mutant (n=17-20, 
p=0.962). E analyzed by Kruskal-Wallis test I, K-M analyzed by Student’s t-test. ns=p>0.05, * p<0.05; ** p<0.01; *** 
p<0.001. Scale bars represent 10m in F-H, and 50m in J. See also Figure  1-figure supplement 1. 
 
supplement 1P) (Campos-Ortega and Hartenstein, 1997; Evans et al., 2010). 18% of T antigen in 
the embryo has been found to be further modified, predominantly by glucoronic-acid (GlcA) (Aoki 
et al., 2008). Of the three GlcA transferases found in Drosophila only GlcAT-P is robustly capable 
of adding GlcA onto the T O-glycan structure in cells (Breloy et al., 2016a; Itoh et al., 2018; Kim 
et al., 2003). To examine if the specific defect in germband invasion that we observed by blocking 
the formation of T antigen is due to the need for a further elaboration by GlcA, we utilized a lethal 
MI{MIC} transposon insertion mutant in the GlcAT-P gene. We observed no change in the 
numbers of macrophages within the germband in the GlcAT-PMI05251 mutant (Figure 1M) and a 
20% increase in the number of macrophages on the yolk (Figure 1-figure supplement 1Q). 
Therefore our results strongly suggest that the T antigen we observe being upregulated in 
macrophages as they move towards and into the germband is itself needed for efficient tissue 
invasion. 
 
An atypical MFS member acts in macrophages to increase T antigen levels  
We sought to determine which proteins could temporally regulate the increase in the appearance 
of T O-glycans in invading macrophages. We first considered proteins required for synthesizing 
the core1 structure, namely the T synthase, C1GalTA, and the UDP-Gal sugar transporter, Ugalt 
(Aumiller and Jarvis, 2002) (Figure 1A). However, q-PCR analysis of FACS sorted macrophages  
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Figure 1-figure supplement 1: Lectin screen reveals enriched staining for PNA and UEA-1 on macrophages 
(A-L) Confocal images of fixed late Stage 11/ early Stage 12 wild type embryos schematic above) stained with 
different lectins (visualized in green) indicated in green type in the lower left corner. Macrophages are detected 
through srpHemo-3xmCherry expression (red). Boxed area in schematic shows area of merged overview image at 
left. Boxed area in merged overview corresponds to the images shown magnified at right. (M) Confocal images of 
the germband from fixed early Stage 12 embryos from the control and ones in which UAS-C1GalTA RNAi is expressed 
in macrophages under srpHemo-GAL4 control. Macrophages visualized with an antibody against GFP expressed in 
macrophages (srpHemo>GFP) (red) and T antigen by antibody staining (green). Boxed area in schematic at left 
indicates embryo region imaged. (N,O) Quantification of macrophages on the yolk in fixed early Stage 12 embryos 
in (N) srpHemo>UAS-C1GalTA RNAi (vdrc 2826) and (O) the C1GalTA[2.1] excision mutant shows an increase in both 
compared to the control (n=14-24, p=0.00004 for N, p=0.0007 for O). (P) Quantification of macrophage number in 
the vnc segments shown in the schematic in fixed mid Stage 12 embryos detects no significant difference between 
control and srpHemo>UAS-C1GalTA RNAi embryos (n=10-20). (Q) Quantification of macrophages on the yolk in fixed 
early Stage 12 embryos in GlcAT-PMI05251 shows a 20% increase compared to the control (n=17-20, p=0.04). 
Significance was assessed by Mann-Whitney test in N and Student’s t-test in O-Q, ns=p>0.05, *=p<0.05, 
***=p<0.001. Scale bars are 30μm in overview images and 5μm in magnifications in A-L, 10m in M. 
 
from Stage 9-10, Stage 12, and Stage 13-17 show that though both are enriched in macrophages, 
neither is transcriptionally upregulated before or during Stage 12 (Figure 2A,B). We therefore 
examined the Bloomington Drosophila Genome Project (BDGP) in situ database looking for 
predicted sugar binding proteins expressed in macrophages with similar timing to the observed 
T antigen increase (Tomancak et al., 2007, 2002). We identified CG8602, a predicted member of 
the Major Facilitator Superfamily (MFS), a protein group defined by shared structural features, 
whose members are known to transport a diverse set of molecules across membranes (Yan, 
2015). CG8602 contains regions of homology to known sugar responsive proteins and predicted 
sugar or neurotransmitter transporters (Figure 2C) and in a phylogenetic analysis is on a branch 
neighboring the SLC29 group shown to be involved in nucleoside transport (Baldwin et al., 2004; 
Perland et al., 2017). BDGP in situ hybridizations (Tomancak et al., 2007, 2002) 
(http://insitu.fruitfly.org/cgi-bin/ex/report.pl?ftype=10&ftext=FBgn0035763) indicate that 
CG8602 RNA is maternally depo-sited, with expression throughout the embryo through Stage 4 
after which its levels decrease, with weak ubiquitous expression continuing through Stage 9-10. 
This is followed by strong enrichment in macrophages from Stage 11-12, with apparently 
equivalent levels of expression in macrophages entering the germband as in those migrating 
along other routes such as the ventral nerve cord. We confirmed this by q-PCR analysis of FACS 
sorted macro-phages, which detected seven-fold higher levels of CG8602 RNA in macrophages 
than in the rest of the embryo by Stage 9-10 and 12-fold by Stage 12 (Figure 2D). These data show 
that RNA expression of CG8602, an MFS protein with homology to sugar transporters increases 
in macrophages preceding and during the period of invasion. To determine if CG8602 could affect 
T antigen levels, we examined a viable P-element insertion mutant in the 5’UTR, CG8602EP3102 
(Figure 2- figure supplement 1A). This insertion displays strongly reduced CG8602 expression in 
FACS-sorted macrophages to 15% of wild type levels, as assessed by q-PCR (Figure 2E). We also 
created an excision allele, ∆33, removing the 5’UTR flanking the P-element, the start methionine, 
and 914 bp of the ORF (Figure 2- figure supplement 1A). This is a lethal allele, and the line carrying 
it over a balancer is very weak; exceedingly few embryos are laid and the embryos homozygous 
for the mutation do not develop past Stage 12. Therefore, we did not continue experiments with 
this allele, and instead utilized the insertion mutant. This CG8602EP3102 P-element mutant displays  
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Figure 2: An atypical MFS family member, CG8602, located in the Golgi and endosomes, is required for T antigen 
enrichment on invading macrophages. (A,B) qPCR quantification (2-ΔCt) of RNA levels in mCherry+ macrophages FACS 
sorted from srpHemo-3xmCherry wild type embryos reveals no significant change in the expression of (A) the 
C1GalTA galactose transferase or (B) the Ugalt Gal transporter during Stage 9-17 (n=7 biological replicates, 3 
independent FACS sorts). (C) Schematic made with Protter (Omasits et al., 2014) showing the predicted 12 
transmembrane domains of CG8602. Blue lines indicate regions displaying higher than 20% identity to the 
correspondingly numbered Drosophila protein indicated below, along with the homologous protein’s predicted or 
determined function. (D) Quantification by qPCR of CG8602 RNA levels in FACS sorted mCherry+ macrophages 
compared to other mCherry- cells obtained from srpHemo-3xmCherry wild type embryos at Stage 9-10, Stage 12 and 
Stage 13-17. CG8602 macrophage expression peaks at Stage 12, during macrophage germband entry (n=3-7 
biological replicates, 4 independent FACS sorts, p= 0.036). (E) qPCR quantification in FACS sorted srpHemo-
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3xmCherry labeled macrophages from control and CG8602EP3102 mutant Stage 12 embryos shows an extremely 
strong decrease in CG8602 RNA expression in the P element insertion mutant used in this study (n=7 biological 
replicates, 3 independent FACS sorts, p=0.0024). (F) Confocal images of Stage 12 control and CG8602EP3102 mutant 
embryos with macrophages (red) visualized by srpHemo-mCherry expression and T antigen by antibody staining 
(green). Schematic at left depicts macrophages (red) entering the germband. Black box indicates the region next to 
the germband imaged at right. We observe decreased T antigen staining on macrophages in the CG8602EP3102 mutant 
compared to the control. (G) qPCR quantification (2-ΔCt) of C1GalTA and Ugalt RNA levels in FACS sorted macrophages 
from Stage 12 embryos from control and mrvaEP3102 mutant embryos shows no significant change in expression of 
the Gal transferase, or the Gal and GalNAc transporter in the mutant compared to the control (n=7 biological 
replicates, 3 independent FACS sorts). (H) Quantitation using Fiji of the colocalization of transfected MT-
CG8602::FLAG::HA in fixed S2R+ cells with markers for the ER (Cnx99a), the Golgi  (Golgin 84, Golgin 245, and GMAP), 
the early endosome (Hrs), the late endosome (Rab7), and live S2R+ cells transfected with srp-CG8602::3xmCherry 
with dyes that mark the lysosome (Lysotracker) and the nucleus (DAPI). Representative images are shown in Figure 
S2B-J. n=24, 23, 23, 17, 6, 22, 6 and 13 cells analyzed per respective marker. (I) Macrophages near the germband 
extracted from srpHemo>CG8602-HA Stage 11/12 embryos show partial colocalization of the HA antibody labeling 
CG8602 (red) and a Golgin 84 or Hrs antibody marking the Golgi or endosome respectively (green). Nucleus is stained 
by DAPI (blue). For all qPCR experiments values are normalized to expression of a housekeeping gene RpL32. Scale 
bars are 5m in F, 3m in I. Significance was assessed by Kruskal-Wallis test in A, B, One way Anova in D and Student’s 
t-test in E, G. ns=p>0.05, * p<0.05, *** p<0.001. See also Figure 2-figure supplement 1. 
 
decreased T antigen staining on macrophages moving towards and entering the germband 
(Figure 2F) in Stage 11 through late Stage 12. q-PCR analysis on FACS sorted macrophages show 
that the reduction in T antigen levels in the mutant is not caused by changes in the RNA levels of 
the T synthase C1GalTA or the Ugalt Gal and GalNAc transporter (Aumiller and Jarvis, 2002; 
Segawa et al., 2002) (Figure2G). These results argue that CG8602 is required for enriched T 
antigen levels on macrophages. 
To assess if CG8602 could directly regulate T antigen addition, we examined if it is found 
in the Golgi where O-glycosylation is initiated. We first utilized the macrophage-like S2R+ cell line, 
transfecting a FLAG::HA or 3xmCherry labeled form of CG8602 under srpHemo or a copper 
inducible MT promoter control. We detected significant colocalization with markers for the cis-
Golgi marker GMAP, the Trans Golgi Network marker Golgin 245 and the endosome markers 
Rab7, Rab11 and Hrs (Riedel et al., 2016) (Figure 2H, Figure 2- figure supplement 1C-G). We 
detected no colocalization with markers for the nucleus, ER, peroxisomes, mitochondria or 
lysosomes (Figure 2H, Figure 2- figure supplement 1B,H-J). We confirmed the presence of 
CG8602 in the Golgi and endosomes in macrophages from late Stage 11 embryos through 
colocalization with Golgin 84 and Hrs, using cells extracted from positions in the head adjacent 
to the germband (Figure 2I). We conclude that the T antigen enrichment on macrophages 
migrating towards and into the germband requires a previously uncharacterized atypical MFS 
with homology to sugar binding proteins that is localized predominantly to the Golgi and 
endosomes. 
 
The MFS, Minerva, is required in macrophages for dissemination and germband 
invasion  
We examined if CG8602 affects macrophage invasive migration. The CG8602EP3102 mutant 
displayed a 35% reduction in macrophages within the germband at early Stage 12 compared to 
the control (Figure 3A-B,D, Figure 3- figure supplement 1A). The same decrease is observed when 
the mutant is placed over the deficiency Df(3L)BSC117 that removes the gene entirely (Figure  
   41 
 
Figure 2-figure supplement 1: CG8602 expression and localization 
 (A) Schematic depicting the CG8602 gene and the insertion site of the EP3102 P element and the Δ33 excision 
mutant induced by P element mobilization which removes 914 bp of the ORF. (B-J) Confocal images of S2R+ cells 
transfected with (B-G) MT-CG8602::FLAG::HA, and then fixed and visualized by HA antibody staining (red) or 
(H-J) srpHemo-CG8602::3xmCherry (red) with different parts of the endomembrane system visualized by live 
markers as indicated (green). DAPI (blue) marks the nucleus. CG8602 showed (B) no colocalization with the ER 
marker Calnexin, partial colocalization with the (C,D) Golgi markers GMAP and Golgin 245, (E) late endosomal 
marker Rab7, (F) recycling endosome marker Rab11-YFP, and (G) endosomal marker Hrs8.2, no colocalization 
with the (H) lysosome marker lysotracker, (I) mitochondrial marker mitotracker and (J) peroxisomal marker PTS1-
GFP in fixed (B-G) or live (H-J) S2R+ cells. Scale bar is 3m in B-J. 
the Ugalt Gal and GalNAc transporter (Aumiller and Jarvis, 2002; Segawa et al., 2002) (Figure 2G). These results 
argue that CG8602 is required for enriched T antigen levels on macrophages. 
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3D), arguing that CG8602EP3102 is a genetic null for macrophage germband invasion. The P element 
transposon insertion itself causes the migration defect because its precise excision restored the 
number of macrophages in the germband to wild type levels (Figure 3D). Expression of the 
CG8602 gene in macrophages can rescue the CG8602EP3102 P element mutant (Figure 3C-D, Figure 
3-figure supplement 1A), and RNAi knockdown of CG8602 in macrophages can recapitulate the 
mutant phenotype (Figure 3E, Figure 3-figure supplement 1B). Our data thus argues that CG8602 
is required in macrophages themselves for germband invasion. 
Decreased numbers of macrophages in the extended germband could be caused by 
specific problems entering this region, or by general migratory defects or a decreased total 
number of macrophages. To examine the migratory step that precedes germband entry, we 
counted the number of macrophages sitting on the yolk next to the germband in fixed embryos 
in the CG8602EP3102 mutant. We observed a 30% decrease compared to the control (Figure 3F), 
suggesting a defect in early dissemination. Entry into the germband by macrophages occurs 
between the closely apposed DE-Cadherin expressing ectoderm and the mesoderm and is 
accompanied by deformation of the ectodermal cells (Ratheesh et al., 2018). We tested if 
reductions in DE-Cadherin could ameliorate the germband phenotype. Indeed, combining the 
CG8602EP3102 mutation with shgP34 which reduces DE-Cadherin expression (Pacquelet and Røth, 
1999; Tepass et al., 1996) produced a partial rescue (Figure 3G), consistent with CG8602 playing 
a role in germband entry as well as an earlier migratory step. There was no significant difference 
in the number of macrophages migrating along the vnc in late Stage 12 compared to the control 
in fixed embryos (Figure 3H) from the CG8602EP3102 mutant or from a knockdown in macrophages 
of CG8602 by RNAi (Figure 3-figure supplement 1C), arguing against a general migratory defect. 
There was also no significant difference in the total number of macrophages in either case (Figure 
3-figure supplement 1D-E). From analyzing the CG8602 mutant phenotype in fixed embryos we 
conclude that CG8602 does not affect later vnc migration but is important for the early steps of 
dissemination and germband invasion. 
To examine the effect of CG8602 on macrophage speed and dynamics, we performed live 
imaging of macrophages labeled with the nuclear marker srpHemo-H2A::3xmCherry in control 
and CG8602EP3102 mutant embryos. We first imaged macrophages migrating from their initial 
position in the delaminated mesoderm up to the germband and detected a 33% decrease in 
speed (2.460.07 m/min in the control, 1.660.08 m/min in the mrva3102 mutant, p=0.002) 
(Figure 3I, J) and no significant decrease in persistence (0.430.02 in the control, 0.400.01 in the 
mutant, p=0.22) (Figure 3-figure supplement 1F). We then examined the initial migration of 
macrophages into the germband at late Stage 11. We observed a range of phenotypes in the six 
movies we made of the mutant, with macrophages pausing at the germband edge from twice to 
six times as long as in the control before invading into the tissue (Figure 3K shows average time 
for entry). As we observed no change in the timing of the initiation of germband retraction 
(269.6±9 min in control and 267.1±3 min in mutant, p=-0.75) but did observe a decreased speed 
of its completion in the mutant (107±12 min from start to end of retraction in control and 133±6 
min for mutant p=0.05), we only analyzed macrophages within the germband before its 
retraction begins. We observed a 43% reduction in macrophage speed within the germband 
(2.720.32 m/min in the control and 1.550.04 m/min in the mutant, p=0.02) (Figure 3L,M). 
To assess this phenotype’s specificity for invasion, we used live imaging of macrophage migration 
along the inner vnc that occurs during the same time period as germband entry; we observed no  
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Figure 3: CG8602, which we name Minerva, is required in macrophages for their efficient invasion of the 
germband  
(A-C) Representative confocal images of early Stage 12 embryos from (A) control, (B) 
P{EP}CG86023102=minerva (mrva)3102 mutant, and (C) mrva3102 mutants with macrophage expression of the 
gene rescued by srpHemo(macro)-mrva. Macrophages express srpHemo-3XmCherry (red) and the embryo 
autofluoresces (green). In the mutant, macrophages remain in the head and fail to enter the germband, hence 
we name the gene minerva. (D) Dashed ellipse in schematic at left represents the germband region in which 
macrophage (red) were counted throughout the study. Comparison of the control (n=38), mrva3102 mutants 
(n=37) and mrva3102 mutant/Df(3L)BSC117 that removes the gene (n=23) shows that the mutant significantly 
decreases migration into the extended germband (p<0.0001 for control vs mutant, p=-0002 for control vs Df 
cross). This defect can be partially rescued by expression in macrophages of srpHemo>mrva::FLAG::HA (n=18, 
p=0.222 for control vs rescue, p=.036 for mutant vs rescue) and completely rescued by precise excision 
(mrvaΔ32) of the P element (n=16, p=0.826). srpHemo>mCherry-nls labeled the macrophages. (E-G) 
Macrophage quantification in early Stage 12 embryos. (E) Fewer germband macrophages upon expression of 
mrva RNAi v101575 only in macrophages under the control of srpHemo (n=28-35 embryos, p<0.0001). (F) 
Fewer macrophages found on the yolk neighboring the germband (oval in schematic) in the mrva3102 mutant 
compared to control embryos (n=14-16 embryos, p=0.0003). (G) Increased germband macrophage numbers 
in shgP34; mrva3102 compared to the mrva3102 mutant indicates a partial rescue from reducing DE-Cadherin 
which is expressed in the germband ectoderm (n=19-29, p<0.0001, p=0.005). (H) No significant difference in 
number of macrophages labeled with srpHemo-3xmCherry in vnc segments (area in blue oval in schematic) 
between control and mrva3102 mutant embryos in fixed mid Stage 12 embryos (n=23-25, p=0.55). Images from 
two-photon movies of (I) Stage 10 and (L) late Stage 11-early Stage 12 embryos in which macrophages (red) 
are labeled with srpHemo-H2A::3xmCherry. (I) Stills at 0 and 60 min and (J) quantification of macrophage 
speed reveal 33% slower macrophage migration in the head towards the yolk neighboring the germband in 
the mrva3102 mutant compared to the control, n=3 movies for each, #tracks: control=329, mutant=340, 
p=0.002. Blue box in magnification in schematic indicates region analysed in J. (K) The first macrophage in 
mrva3102 mutants is much slower to enter the germband after macrophages reach the germband edge 
(control=22.00±1.53, n=3, mrva3102 mutant=102.0±20.35, n=4. p-value = 0.021). (L) The time when 
macrophages reached the germband in each genotype was defined as 0’. Stills at 60 and 90 min and (M) 
quantification of macrophage speed reveal 43% slower macrophage migration in the germband in the 
mrva3102 mutant compared to the control. Blue arrow in schematic indicates route analyzed. n=3 movies for 
each, #tracks: control=21, mutant=14, p=0.022. Significance was assessed by Kruskal-Wallis test with Conover 
post test comparison in D, G, Student’s t-test in E, F, H, J-K, M. ns=p> 0.05, * p<0.05, ** p<0.01, *** p<0.001, 
***p<0.0001. Scale bars are 50m in A-C, 40m in I, 30m in L. See also Figure 3-figure supplement 1 and 
Figure 1-video 1-4.. 
 
significant change in speed (2.41±0.06 m/min in the control and 2.23±0.01 m/min in the 
mutant, p=0.11) or directionality (0.43±0.03 in the control and 0.43±0.02 in the mutant, 
p=0.9742) (Figure 3-figure supplement 1G). We conclude from the sum of our experiments in 
fixed and live embryos that CG8602 is important for the initial disseminatory migration out of the 
head and for invasive migration into and within the germband, but does not alter general 
migration. We name the gene minerva (mrva), for the Roman goddess who was initially trapped 
in the head of her father, Jupiter, after he swallowed her pregnant mother who had turned 
herself into a fly. 
 
Minerva is not required for border cell invasion or germ cell migration  
To assess if Minerva only affects macrophage invasion or also other types of tissue 
penetration in Drosophila, we examined the migration of germ cells and border cells. Germ cells 
move in an Integrin-independent fashion through gaps in the midgut created by ingressing  
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Figure 3-figure supplement 1: CG8602 (Minerva) affects macrophage migration into the germband but not along 
the vnc and does not alter border cell or germ cell migration. (A) Quantification of the number of macrophages in 
the germband (dotted circle in schematic) in embryos from control, mrva23102, and mrva3102 srpHemo(macro)-
mrva::HA showing Mrva is required in macrophages for germband invasion. Macrophages visualized by srpHemo-
H2A::3xmCherry. (n=25-28, p=0.001 for mutant vs control, 0.14 for control vs rescue, 0.05 for mutant vs rescue). (B) 
Representative confocal images of early Stage 12 embryos from control and srpHemo(macro)-Gal4 driving UAS-
minerva RNAi (v101575) expression in macrophages labeled by H2A-RFP (green) and cytoplasmic GFP (red). (C) 
Quantification of the number of macrophages in vnc segments (area circled in blue in schematic) reveals no 
significant difference in macrophage migration along the vnc between control embryos and those expressing an 
RNAi against mrva (v101575) in macrophages under srpHemo(macro)-GAL4 control (n=19-20, p=0.5). (D, E) 
Quantification of the total number of macrophages visualized with (D) srpHemo>mCherry::nls or (E) 
srpHemo>H2A::RFP GFP reveals no significant difference between (D) control and mrva3102 mutant embryos (n=15, 
p>0.05) and (E) control and srpHemo(macro)>mrva RNAi embryos (n=26, p=0.1439). The area analyzed is indicated 
with the black box in the schematic above. (F) Quantification of persistence in the head from 2-photon movies with 
srpHemo-H2A::3xmCherry labeling macrophages shows no change in the mrva3102 compared to the control. n=3. # 
tracks: control=329, mutant=340, p=0.2182. The area analyzed is indicated with the blue box in the schematic above. 
(G) Macrophage speed in the inner vnc in early Stage 12 embryos (see area circled in blue in schematic above) shows 
no significant change in the mrva3102 compared to the control (n=3 movies for each, #tracks: control=180, 
mutant=180, p=0.113). (H) Dorsal confocal images of representative Stage 14 control and mrva3102 embryos stained 
with Vasa antibody to visualize primordial germ cells (PGCs) (green). White arrow in control image indicates one of 
the two gonads. (I) Quantitation of the number of mismigrated PGCs per control and mrva3102 embryo revealed no 
significant difference (n=22,28, p=0.57). (J) Quantification by qPCR of mrva RNA levels in ovaries from mrva3102 
mutant adult females compared to the control (n=3, p=0.0001). (K) Representative confocal images of border cells 
in stage 10 oocytes from control and mrva3102 adult females. DNA was labeled using DAPI (red) and actin was 
detected by phalloidin-A488 (green). Insets at upper right show enlargements of the dotted boxed area in the main 
images. Border cells are indicated with arrows. (L) Quantitation of border cell migration in stage 10 oocytes. Box 
plots show the relative percentages of migration measured for control (n=37) and mrva3102 (n=40) compared to 
complete migration to the edge of the oocyte. Whiskers in the box plot represent the distribution maximum and 
minimum. We observe no significant difference in the mutant  (p=0.05).  
Significance was assessed by One-way Anova in A and Student’s t-test in C-G, I-J, L. ns=p>0.05, * p<0.05, *** p<0.001. 
Scale bars are 50m in B,H, 20m in inset and 100 um in main image in J. 
 
formerly epithelial cells (Devenport and Brown, 2004; Seifert and Lehmann, 2012). We found no 
defect in germ cell migration when examining control and mrva3102 embryos stained with the 
Vasa Ab (Figure 3-figure supplement 1H-I). Border cells are born in the epithelia surrounding the 
ovary and then delaminate to move invasively between the nurse cells towards the oocyte 
(Montell, 2003), guided by the same receptor that macrophages use during their embryonic 
dispersal, PVR (Duchek et al., 2001). They migrate as a tumbling collective, using invadopodia and 
Cadherin-based adhesion to progress (Cai et al., 2014; Niewiadomska et al., 1999). mrva is 
expressed in dissected control ovaries and the mrva3102 mutant reduces the levels of mrva RNA 
in the ovary by 70%, similar to the reduction observed in macrophages (Figure 3-figure 
supplement 1J). We identified border cells by staining with DAPI to detect their clustered nuclei. 
We observed no change in border cell migration towards the oocyte in the mrva3102 mutant 
compared to the control (Figure 3-figure supplement 1K-L). These results support the conclusion 
that Mrva is not generally required for all migratory cells that move confined through tissues 
during development, but specifically for the invasion of macrophages, which is an Integrin-
dependent process (Siekhaus et al., 2010). 
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Minerva affects a small fraction of the Drosophila embryonic O-glycoproteome 
We set out to determine if Minerva induces T glycoforms on particular proteins. We first 
conducted a Western Blot with a mAb to T antigen on whole embryo extracts. We used the whole 
embryo because we were unable to obtain enough protein from FACS sorted macrophages or to 
isolate CRISPR-induced full knockouts of minerva in the S2R+  
macrophage-like cell line. We observed that several bands detected with the anti-T mAb were 
absent or reduced in the minerva mutant (Figure 4A), indicating an effect on the T antigen 
modification of a subset of proteins.  
We wished to obtain a more comprehensive view of the proteins affected by Minerva. 
Since there is little information about Drosophila O-glycoproteins and O-glycosites (Schwientek 
et al., 2007; Aoki and Tiemeyer, 2010), we used lectin-enriched O-glycoproteomics to identify 
proteins displaying T and Tn glycoforms in Stage 11/12 embryos from wild type and mrva3102 
mutants (Figure 4-figure supplement 1A). We labeled tryptic digests of embryonic protein 
extracts from control or mutant embryos with stable dimethyl groups carrying medium (C2H2D4) 
or light (C2H6) isotopes respectively to allow each genotype to be identified in mixed samples 
(Boersema et al., 2009; Schjoldager et al., 2012, 2015). The pooled extracts were passed over a 
Jacalin column to enrich for T and Tn O-glycopeptides; the eluate was analyzed by mass 
spectrometry to identify and quantify T and Tn modified glycopeptides in the wild type and the 
mutant sample through a comparison of the ratio of the light and medium isotope labeling 
channels for each glycopeptide (see Figure 4-figure supplement 1B-C for example spectra).  
In the wild type we identified T and Tn glycopeptides at 936 glycosites derived from 270 proteins 
(Figure 4B). 62% of the identified O-glycoproteins and 77% of identified glycosites contained only 
Tn O-glycans. 33% of the identified O-glycoproteins and 23% of glycosites displayed a mixture of 
T or Tn O-glycans, and 5% of identified O-glycoproteins and 4% of glycosites had solely T O-
glycans (Figure 4C). In agreement with previous studies (Steentoft et al., 2013b), only one 
glycosite was found in most of the identified O-glycoproteins (44%) (Figure 4D). In 20% we found 
two sites, and some glycoproteins had up to 27 glycosites. The identified O-glycosites were 
mainly on threonine residues, (78.5%) with some on serines (21.2%) and very few on tyrosines 
(0.3%) (Figure 4-figure supplement 1D). Metabolism, cuticle development, and receptors were 
the most common functional assignments for the glycoproteins (Figure 4-figure supplement 1E).  
We sought to assess the changes in glycosylation in the mrva mutant. A majority of the 
quantifiable Tn and T O-glycoproteome was unaltered between the wild type and the mrva3102 
mutant, with only 63 proteins (23%) showing more than a three-fold change and 18 (6%) a ten- 
fold shift (Figure 4F). We observed both increases and decreases in the levels of T and Tn 
modification on proteins in the mutant (Figure 4F-G, Table 1), but a greater number of proteins 
showed decreased rather than increased T antigen levels. 67% of the vertebrate orthologs of 
Drosophila proteins displaying shifts in this O-glycosylation have previously been linked to cancer 
(Figure 4H, Table 1). These proteins were affected at specific sites, with 40% of glycosites on 
these proteins changed more than three fold and only 14% more than ten fold. The glycosite 
shifts in T antigen occurred either without significant alterations in Tn (33% of glycosites had only 
decreased T antigen, 17% of glycosites had only increased T antigen) or with changes in T antigen 
occurring in the same direction as the changes in Tn (22% of glycosites both Tn and T antigen 
increased, 22% of glycosites both Tn and T decreased) (Table 1). Only 1% of glycosites displayed 
decreased T antigen with a significant increase in Tn. Interestingly, a higher proportion of the  
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Figure 4: Glycoproteomic analysis reveals Minerva is required for higher levels of T-antigen on a subset of 
proteins  
(A) Representative Western blot of protein extracts from Stage 11/12 control and mrva3102 mutant embryos 
probed with T antigen antibody. Arrows indicate decreased/missing bands in the mutant compared to the 
control. Profilin serves as a loading control (n=10 biological replicates). (B) Summary of glycomics results on 
wild type embryos. (C) Venn diagram indicating number of glycosites or proteins found with T, Tn or T and Tn 
antigen modifications in the wild type. (D) Plot showing the number of T and Tn antigen glycosites per protein 
in the total glycoproteome and on proteins that show three (blue) and ten-fold (red) altered glycopeptides in 
the mrva3102 mutant. Proteins strongly affected by Minerva have a higher number of glycosites (p = 0.005). (E) 
Summary of glycomics on mrva3102 embryos showing the numbers of proteins and glycosites exhibiting three 
(blue) or ten (red) fold changes in T and Tn antigen levels. (F) T antigen (in orange) and Tn antigen (green) 
occupied glycosites plotted against the ratio of the levels of glycopeptides found for each glycosite in 
mrva3102/control mutant. Higher positions on the plot indicate a lower level of glycosylation in the mutant. 
Blue dashed line represents the cut off for 3x changes in glycosylation, and the red dotted line the 10x one. (G) 
Venn diagram of the number of proteins with at least 3 fold change in the T antigen (T, green) or Tn antigen 
(Tn orange) glycosylation in the mrva3102 mutant. Up arrows denote increase, down arrows indicate decrease 
in levels. (H) Proteins with at least a three fold decrease in T antigen levels in the mrva3102 mutant. Glycan 
modified amino acids are highlighted in bold green font. Unchanged/Higher GS column indicates if any other 
glycosite on the protein is unchanged or increased. Table does not show the two chitin and chorion related 
genes unlikely to function in macrophages. G: Golgi, ES: Extracellular space, Endo: Endosomes, ER: Endoplasmic 
reticulum, ECM: Extracellular Matrix, PM: Plasma Membrane, GS: Glycosite. Cancer links as follows. 1) QSOX1: 
Promotes cancer invasion in vitro, overexpression worse patient outcomes (Katchman et al., 2013, 2011). 2) 
HYOU1: Overexpression associated with vascular invasion, worse patient outcomes (Stojadinovic et al., 2007) 
(Zhou et al., 2016). 3) TMEM87B: translocation breakpoint in cancer, (Hu et al., 2018). 4) ACVR2B: over 
expressed in renal cancer (Senanayake et al., 2012). 5) GANAB: inhibits cancer invasion in vitro (C. Chiu et al., 
2011). 6) LRIG1: inhibits cancer invasion in vitro, and in mice (Sheu et al., 2014), (Mao et al., 2018).  (I) 
Annotated ETD MS2 spectra of the VHQPSATPASK glycopeptide from Qsox1 with T antigen glycosylation at 
position T7. See schematic in which the yellow square represents GalNAc and the yellow circle Gal. Assigned 
fragment ions in MS2 spectra are highlighted by red for “c” type fragments (those retaining the original N 
terminus) and blue for “z” type fragments (those retaining the original C terminus). The graph at the left shows 
the relative quantification of the glycopeptide precursor ion’s peak area in the control and mrva3102 mutant 
plotted on a logarithmic scale. See also Figure 4-figure supplement 1, Figure 4-Dataset 1, Table 1 and 2. 
 
glycoproteins with altered O-glycosylation in the mrva3102 mutant had multiple glycosites than 
the general glycoproteome (Figure 4D) (P value=0.005 for ten-fold changes). We conclude that 
Minerva affects O-glycosylation occupancy on a small subset of O-glycoproteins, many of whose 
vertebrate orthologs have been linked to cancer, with both T and Tn O-glycopeptides being 
affected.  
 
Minerva raises T antigen levels on proteins required for invasion 
Given that the knockdown of the C1GalTA enzyme which blocks Tn to T conversion 
produced a germband invasion defect, we examined the known functions of the 18 proteins with 
lower T antigen in the absence of Minerva to distinguish which processes Minerva could  
influence to facilitate invasion (Figure 4H). We excluded two proteins involved in eggshell and 
cuticle production. To spot proteins whose reduced T antigen-containing glycopeptides are 
caused directly by alterations in glycosylation rather than indirectly by decreased protein 
expression in the mrva mutant, we checked if glycosylation at other identified glycosites was 
unchanged or increased. We identified ten such proteins, several of which were in pathways that  
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Figure 4-figure supplement 1: Further information on the mass spectrometry results. (A) Work flow for mass 
spectrometry analysis of T and Tn antigen modifications on proteins in Stage 11/12 control and mrva3102 mutant 
embryos. (B, C) Annotated ETD MS2 spectra of the VHQPSATPASK glycopeptides from Qsox1 in its different 
glycosylation forms in the control. Assigned fragment ions in MS2 spectra are highlighted by red for “c” type 
fragments (those retaining the original N terminus) and blue for “z” type fragments (those retaining the original C 
terminus). See schematics in upper right in which the yellow squares represent GalNAc and the yellow circles Gal. 
The insets show the relative quantification, based on the corresponding glycopeptide precursor ion’s peak area, in the 
control and mrva3102 mutant plotted on a logarithmic scale. (B) Glycopeptide with Tn antigen glycosylation at position 
S5 and T antigen glycosylation at the position T7. (C) Glycopeptide with Tn antigen glycosylation at position T7. (D) 
Similar usage of serine (S), threonine (T) and tyrosine (Y) for glycosylation in all modified proteins in the control and 
at glycosites that showed at least three fold and ten fold changes in the mrva3102 mutant. (E) Analysis of the fractional 
representation of various functions among all T and Tn antigen modified glycoproteins in Stage 11/12 Drosophila 
embryos. 
 
had been previously linked to invasion in vertebrates. Qsoz1, a predicted sulfhydryl oxidase 
required for the secretion, and thus potential folding of EGF repeats (Tien et al., 2008) showed 
the strongest alterations of any protein, with a 50-fold decrease in T antigen levels in the mrva 
mutant (Figure 4I). The mammalian ortholog QSOX1 has been shown to affect disulfide bond 
formation, is overexpressed in some cancers, promotes Matrigel invasion, and can serve as a 
negative prognostic indicator in human cancer patients (Chakravarthi et al., 2007; Katchman et 
al., 2011; Lake and Faigel, 2014). Dtg, with a 13-fold reduction in T antigen (Hodar et al., 2014), 
and Put with a five-fold reduction (Letsou et al., 1995) respond to signaling by the BMP-like 
ligand, Dpp. Dpp signaling directs histoblast invasion in the fly (Ninov et al., 2010). Gp150 shows 
a four fold decrease in T antigen and modulates Notch signaling (Fetchko et al., 2002; Li, 2003). 
Notch and BMP promote invasion and metastasis in mice (Bach et al., 2018; Garcia and Kandel, 
2012; Owens et al., 2015; Pickup et al., 2015; Sahlgren et al., 2008; Sonoshita et al., 2011). We 
conclude that Mrva is required to increase T O-glycans on a subset of the glycosites of selected 
glycoproteins involved in protein folding, glycosylation and signaling in pathways frequently 
linked to promoting cancer metastasis. Its strongest effect is on a predicted sulfhydryl oxidase, 
the Drosophila ortholog of the mammalian cancer protein, QSOX1. 
 We wished to determine how Qsox1 might affect Drosophila macrophage germband 
invasion. Embryos from the KG04615 P element insertion in the 5’UTR of the qsox1 gene 
displayed 42% fewer macrophages in the germband compared to the control (Figure 5A,B) with 
an increase in macrophages remaining on the yolk (Figure 5-figure supplement 1A). We observed 
a small decrease in migration along the vnc (Figure 5-figure supplement 1B) and no change in 
total macrophage numbers in these embryos (Figure 5-figure supplement 1C). These migration 
phenotypes were also observed in embryos in which RNAi line v108288 knocked  down qsox1 
only in macrophages (Figure 5C, Figure 5-figure supplement 1D-E). We then conducted live 
imaging (Figure 5D) to examine how the qsox1KG04615 mutant affected the dynamics of 
macrophage migration. During the movement of macrophages labeled with the nuclear marker 
srpHemo-H2A::3xmCherry from their initial position up to the germband we detected an 18% 
decrease in speed (Figure 5E) (2.460.07 m/min in the control, 2.020.03 m/min in the 
qsox1KG046152 mutant, p=0.006, n=3) and no significant decrease in persistence (Figure 5-figure  
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Figure 5: Qsox1 is required for macrophage dissemination and entry into the germband tissue 
(A) Representative confocal images of early Stage 12 embryos from control and P{SUPor-P}Qsox1KG04615 = 
qsox1KG04615. (B-C) Quantification in early Stage 12 embryos showing a significant reduction in germband 
macrophages (B) in the P-element mutant qsox1KG04615 located in the Qsox1 5’UTR (n=18, p=0.0012) and (C) 
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upon the expression in macrophages under srpHemo-GAL4 control of an RNAi line (v108288) against Qsox1 
(n=24, 23 embryos, p= 0.001). (D) Images from two-photon movies from control and qsox1KG04615. Macrophage 
nuclei (red) are labeled with srpHemo-H2A::3xmCherry. Stills at 0, 60, 90, 120, 150 and 180 minutes. (E) 
Quantification of macrophage speed reveals 18% slower macrophage migration in the head towards the yolk 
neighboring the germband in the qsox1KG04615 mutant compared to the control (n=3 movies for each, #tracks: 
control=329, mutant=396, p=0.0056). (F) Quantification of the time required for macrophage entry into the 
germband in qsox1KG04615 compared to the control. n=3 movies for each, p=0.043. (G) Quantification of 
macrophage speed in the germband in the qsox1KG04615 mutant compared to the control (n=3 movies for each, 
#tracks: control=21, mutant=19, p=0.300). (H) Pearson’s Coefficient analysis indicating the level of 
colocalisation of a MT-Qsox1::FLAG::HA construct transfected into S2R+ cells visualized with an HA antibody 
and antibodies against markers for the ER (Cnx99a), the Golgi (Golgin 84, Golgin 245, and GMAP), the early 
endosome (Hrs), the late endosome (Rab7) and the nucleus (DAPI) (n= 11-15) as well as with a srpHemo-
mrva::3xmCherry construct (n= 18). (I) Western blot of concentrated supernatant collected from S2R+ cells 
transfected with srpGal4 UAS-qsox1::FLAG::HA (first 3 lines) and S2R+ cells that are untransfected. (J) 
Quantification of intracellular LanA intensity along a 4μm line in macrophages (as indicated in schematic) from 
the control (black), minerva3102 (blue) and the qsox1KG04615 mutants (orange) (n=4-5 embryos, 80-100 cells, 240-
300 lines). For the whole graph see Figure 5-figure supplement 1G-J. Scale bars 50μm for A, 30μm in D. B-C, E-
G and J were analyzed with Student’s test. ns=p> 0.05, * p<0.05, ** p<0.01, *** p<0.001. See also Figure 5-
figure supplement 1. 
 
supplement 1F) (0.430.02 in the control, 0.390.01 in the mutant, p=0.13). Macrophages in the 
qsox1 mutant were delayed twice as long at the germband edge before entering (Figure 5F) (time 
to entry 22.001.53 min in the control and 49.679.33 min in the qsox1KG046152 mutant, n=3). 
Once in, they moved within the germband with a 17% slower speed, a reduction that was not 
statistically significant (Figure 5G) (2.720.32 m/min in the control, 2.270.20 m/min in the 
qsox1KG046152 mutant, p=0.30, n=3). We conclude that Qsox1  
aids the disseminatory migration of macrophages but is most strongly required for their initial 
invasion into the germband tissues. 
We wished to examine how Qsox1 could be exerting this effect on macrophage tissue 
entry. Vertebrate QSOX1 has been shown to localize to the Golgi and act as a sulfhydryl  
oxidase, catalyzing di-sulfide bond formation and protein folding (Alon et al., 2012; Chakravarthi 
et al., 2007; Heckler et al., 2008; Hoober et al., 1996). The Drosophila protein has been shown to 
be required for the secretion of multimerized EGF domains and was hypothesized to act 
redundantly with ER oxidoreductin-like-1 to form disulfide bonds (Tien et al., 2008). We found 
that an HA-tagged form of Qsox1 transfected into the Drosophila macrophage like cell line, S2R+, 
colocalizes little with markers for the ER, and considerably with those for Golgi and endosomes 
(Figure 5H, Figure 5, figure supplement 1G-I). We also observed significant colocalization with 
3xmCherry-tagged Mrva (Figure 5H, Figure 5-figure supplement 1J). Vertebrate QSOX1 can be 
cleaved from its transmembrane domain to allow secretion (Rudolf et al., 2013), and has been 
shown in vitro to be required extracellularly for the incorporation of laminin produced by 
fibroblasts into the extracellular matrix (ECM), thereby supporting efficient cancer cell migration 
(Ilani et al., 2013). Drosophila Qsox1 also has a transmembrane domain, yet we detected an HA-
tagged form in the media after transfection into S2R+ cells (Figure 5I), indicating that it can be 
secreted. To examine if Drosophila Qsox1 might also affect Laminin, we stained mrva3102 and 
qsox1KG046152 mutant embryos with an antibody against Laminin A (LanA) (Figure 5-figure 
supplement 1K). In both mutants we observed increased amounts of LanA inside and somewhat  
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Figure 5-figure supplement 1: Qsox1 affects germband entry and Laminin A.  
(A-B) Quantification of macrophages in fixed mid-Stage 12 embryos in control and qsox1KG04615 mutants reveals that 
in the mutant there are (A) increased numbers of macrophages on the yolk neighboring the germband (n=18, 
p=0.002) and (B) reduced numbers on some vnc segments (n= 21; p value T1= 0.357, T2 = 0.0006, T3= 0.031, 
A1=0.034, A2= 0.329). (C) Quantification of macrophages in the whole embryo in the qsox1 KG04615 mutant compared 
to the control (n=12-14, p value= 0.999) shows no change. (D-E) Quantification of macrophages in fixed mid-Stage 
12 embryos from the control and upon knockdown in macrophages of Qsox1 with RNAi (v108288) driven by 
srpHemo-GAL4 reveals that in the mutant there are (D) increased numbers of macrophages on the yolk neighboring 
the germband (n=23,24, p=0.02) and (E) reduced numbers on some vnc segments (n= 13-15; p value T1=0.024, 
T2=0.030, T3= 0.258, A1=0.445, A2=0.233). (F) Analysis of the persistence of macrophages in the head in the 
qsox1KG04615 mutant compared to the control shows no significant difference (n=3 movies for each, p=0.126). (G-J) 
Qsox1::FLAG::HA produced from an MT promoter visualized by HA-antibody staining (green) with (G-I) different 
parts of the endomembrane system as indicated visualized by antibody staining (green) and (J) Mrva::3xmCherry 
from the srpHemo promoter visualized by mCherry fluorescence. (K) Confocal images of LanA (green) staining in 
control, mrva3102 and qsox1KG04615 mutant embryos expressing cytoplasmic 3xmCherry (red) in macrophages from 
the srpHemo promoter. Dotted white lines in the LanA channel correspond to an outline traced from the mCherry 
channel. (L-N) Quantification of LanA and mCherry (red) intensity along a 4m line in macrophages from control 
(black line), mrva3102 (blue) and qsox1KG04615 mutant (orange) (n=4-5 embryos, 80-100 cells, 240-300 lines). (M-N) 
Magnified view of LanA quantification from (M) the cell edge and (N) outside the cell. Scale bar is 5m in G-K. A-F 
and L-N were analyzed with Student’s t test. ns=p>0.05, * p<0.05, ** p<0.01,  *** p<0.001.  
 
higher levels adjacent to the macrophages, but no significant alteration at the cell edges 
compared to the control (Figure 5J, Figure 5-figure supplement 1L-N). We conclude that 
Drosophila Qsox1 can be secreted but is also found in the Golgi and endosomes like Mrva, and 
that both proteins affect LanA, a component of the ECM.  
 
Conservation of Minerva’s function in macrophage invasion and T antigen 
modification by its mammalian ortholog MFSD1  
To determine if our studies could ultimately be relevant for mammalian biology and therefore 
also cancer research, we searched for a mammalian ortholog. MFSD1 from mus musculus shows 
strong sequence similarity with Mrva, with 50% of amino acids displaying identity and 68% 
conservation (Figure 6A, Figure 6-figure supplement 1A). A transfected C-terminally GFP-tagged 
form (Figure 6-figure supplement 1B) showed localization to the secretory pathway, colocalizing 
with the Golgi marker GRASP65 in murine MC-38 colon carcinoma, 4T1 breast cancer cells and 
LLC1.1 lung cancer (Figure 6B-C, Figure 6-figure supplement 1C-E) and with Golgi and endosomal 
markers in B16-BL6 melanoma cells (Figure 6C, Figure 6-figure supplement 1F). mmMFSD1 
expression in macrophages in mrva3102 mutant embryos can completely rescue the germband 
invasion defect (Figure 6D-E). This macrophage-specific expression of MFSD1 also resulted in 
higher levels of T antigen on macrophages when compared to those in mrva3102 mutants (Figure 
6F-G). Thus MFSD1 not only displays localization in the Golgi apparatus in multiple types of 
mammalian cancer but can also rescue O-glycosylation and migration defects when expressed in 
Drosophila, arguing that the functions Mrva carries out to promote invasion into the germband 
are conserved up to mammals. 
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Figure 6: Minerva’s murine ortholog, MFSD1, can substitute for Minerva’s functions in migration and T-antigen 
glycosylation  
Topology prediction of mouse MFSD1 (NP_080089.1) using the online tools TMPred (Hofman and Stoffel, 1993) and 
Protter (Omasits et al., 2014). 50% of amino acids are identical between the M. musculus MFSD1 and D. 
melanogaster sequence of mrva (CG8602) (NP648103.1) and are highlighted in dark blue, similar amino acids are in 
light blue. (B) Confocal images of MC38 colon carcinoma cells showing colocalization of MFSD1-eGFP (green) with 
the Golgi marker GRASP65 (red). DAPI labels the nucleus (blue). (C) Quantitation using Fiji of the colocalization of 
MFSD1-eGFP with the Golgi marker (GRASP65), early endosome marker (Rab5), late endosome marker (Rab7), and 
lysosome marker (LAMP1) in MC38 colon carcinoma, B16-BL6 melanoma, LLC1 Lewis lung carcinoma, and 4T1 breast 
carcinoma cells. Representative images are shown in Figure 6-figure supplement 1C-F (n=8-15, 5-9, 4-9, 5-10 cells 
per condition within the respective cancer types). (D) Confocal image of a Stage 12 fixed embryo showing that 
expression of mmMFSD1 in macrophages under the direct control of the srpHemo(macro) promoter in the mrva3102 
mutant can rescue the defect in macrophage migration into the germband. Compare to Figure 3A,B. Macrophages 
visualized with srpHemo-H2A::3xmCherry for D-E. (E) Quantitation of the number of macrophages in the germband 
of early Stage 12 embryos from the control (n=25), mrva3102 mutants (n=29), and mrva3102 srpHemo(macro)-
mmMFSD1 (n=13, p=0.0005 for mutant vs control, p<0.0001 for mutant vs rescue). (F) Quantification of T antigen 
levels on macrophages in late Stage 11 embryos from control, mrva3102mutant and mrva3102 srpHemo(macro)-
mmMFSD1 embryos. T antigen levels normalized to those observed in the control (n=8-9 embryos, 280, 333, and 
289 cells quantified respectively, p<0.0001 for both). (G) Confocal images of macrophages (red) on the germband 
border stained with T antigen antibody (green) in the control, the mrva3102 mutant, and mrva3102 srpHemo(macro)-
mmMFSD1 shows that mmMFSD1 expression in macrophages can rescue the decrease of macrophage T antigen 
observed in the mrva3102 mutant. Macrophages visualized with srpHemo-3xmCherry for F-G. (H) Model for Minerva’s 
function during macrophage invasion based on our findings and the literature: Minerva in the Golgi (grey) leads to 
increases in T antigen levels on a subset of proteins that aid invasion, including Qsox1 which regulates protein folding 
through disulfide bond isomerization. We propose that increased T antigen on Qsox1 facilitates its sulfhydryl oxidase 
activity that aids the formation of a robust crosslinked ECM which macrophages utilize during tissue entry. 
Significance was assessed by Kruskal-Wallis test with Conover post test analysis in E,F. ***p<0.001, ****p<0.0001. 
Scale bars are 10m in B, 50m in D, and 3m in G. See also Figure 6-figure supplement  
  
Discussion 
 
O-glycosylation is one of the most common posttranslational modifications, yet the intrinsic 
technical challenges involved in identifying O-glycosites and altered O-glycosylation on a 
proteome-wide level has hampered the discovery of biological functions (Levery et al., 2015). 
Here we provide two important new advances for the field. First, we identify a key regulator of 
this O-glycosylation, Minerva, with an unexpected role for a member of the major facilitator 
superfamily. Our demonstration that this conserved protein affects invasion and the appearance 
of the cancer-associated core1 T glycoform on a set of proteins connected to invasion provides a 
new perspective on T glycoform regulation and may have implications for cancer. Second, we 
define the GalNAc-type O-glycoproteome of Drosophila embryos. As O-glycosites cannot as yet 
be reliably predicted, our proteomic characterization in a highly genetically accessible organism 
will permit future studies on how glycosylation affects cell behavior; we highlight T and Tn O-
glycosylated receptors in Table 2 to further this goal.  
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Figure 6-figure supplement 1: MFSD1-eGFP localization in colon carcinoma   
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(A) Alignment of Minerva and mmMFSD1 by BLAST. The first row shows the Minerva sequence in blue type, the 
second identical (one letter symbol) or similar (+) amino acids in black, and the third the mmMFSD1 sequence in 
green. Gaps are marked with ‘-‘. The predicted twelve transmembrane domains of Minerva are shown with dark 
blue lines and numbered above. (B) Western blot of control (-) and Doxycycline induced (+) MFSD1-eGFP expression 
in MC-38 colon carcinoma cells. MFSD1-eGFP was detected with an anti-GFP antibody. GAPDH serves as a loading 
control. (C-F) Representative images from co-immunofluorescence of mouse MFSD1-eGFP (green) and the Golgi 
marker GRASP65, early endosome marker Rab5 or late endosome marker Rab7 (red) in (C) MC-38 colon carcinoma, 
(D) 4T1 breast cancer, (E) LLC1 Lewis lung carcinoma, and (F) B16 BL6 cells. Nuclei are labeled with DAPI (blue). Scale 
bars indicate 10μm in C-F. 
 
Modifications of the O-glycoproteome by an MFS family member 
Our identification of a MFS family member as a regulator of O-glycosylation is surprising. MFS 
family members can serve as transporters and shuttle a wide variety of substrates (Quistgaard et 
al., 2016; Reddy et al., 2012). Minerva displays homology to sugar transporter and is localized to 
the Golgi and endosomes. Minerva could thus affect O-glycosylation in the Golgi through 
substrate availability. However, the lower and higher levels of glycosylation in the mrva3102 
mutant we observe are hard to reconcile with this hypothesis. Given that the changes in T antigen 
on individual glycosites in the mrva mutant are found either with no significant change in Tn or 
with a change in the same direction (Table 1), regulation appears to occur at the initial GalNAc 
addition on the protein subset as well as on further T antigen elaboration. 95% of the proteins 
with 10-fold altered glycosylation in the mrva mutant had multiple O-glycosylation sugar 
modifications compared to 56% of the general O-glycoproteome. Greatly enhanced glycosylation 
of protein sequences containing an existing glycan modification is observed for some GalNAc-Ts 
due to a lectin domain (Hassan et al., 2000; Kubota et al., 2006; Revoredo et al., 2016) and 
Minerva could theoretically affect such a GalNAc-T in Drosophila. Alternatively, Minerva, while in 
the “outward open” conformation identified for MFS structures (Quistgaard et al., 2016), may 
itself have a lectin-like interaction with Tn and T glycoforms that have already been added on a 
loop of particular proteins. Minerva’s binding could open up the target protein’s conformation 
to increase or block access to other potential glycosites and thus affect the final glycosylation 
state on select glycoproteins.  
 The changes we see in O-glycosylation are also likely due to a combination of Minerva’s 
direct and indirect effects. O-GalNAc modification of vertebrate Notch can affect Notch signaling 
during development (Boskovski et al., 2015); the Drosophila ortholog of the responsible GalNAc 
transferase is also essential for embryogenesis (Bennett et al., 2010; Schwientek et al., 2002). A 
GalNAcT in Xenopus can glycosylate a peptide corresponding to the ActR IIB receptor and inhibit 
Activin and BMP type signaling (Herr et al., 2008; Voglmeir et al., 2015). Thus the changed 
glycosylation we observe on components of the Notch and Dpp pathways could alter 
transcription (Hamaratoglu et al., 2014; Ntziachristos et al., 2014), shifting protein levels and 
thereby changing the ratio of some glycopeptides in the mrva mutant relative to the wild type. 
Proteins in which glycosylation at other sites is unchanged or changed in the opposite direction 
are those most likely to be directly affected by Minerva. Such proteins include ones involved in 
protein folding and O-glycan addition and removal (Figure 4H) (Tien et al., 2008). If changes in 
the glycosylation of these proteins alters their specificity or activity, some of the shifts we observe 
in our glycoproteomic analysis could be indirect in a different way; an initial effect of Minerva on 
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the glycosylation of regulators of protein folding and glycosylation could change how these 
primary Minerva targets affect the glycosylation of a second wave of proteins. 
 
An invasion program regulated by Minerva 
The truncated immature core1 T and Tn O-glycans are not usually present in normal 
human tissues but exposure of these uncapped glycans has been found on the majority of cancers 
and serves as a negative indicator of patient outcome (Fu et al., 2016; Springer, 1984). Increases 
in Tn antigen due to a shift in GalNAcT localization to the ER promote invasion and metastasis 
(Gill et al., 2013). An antibody against T antigen has decreased the metastatic spread of cancer 
cells in mice (Heimburg et al., 2006). Here we further strengthen the case for a causative 
relationship between T antigen modification and the invasive migration that underlies 
metastasis. The transient appearance of T antigen in human fetuses (Barr et al., 1989) and the 
conserved function of Minerva lead us to propose that the change in O-glycosylation in cancer 
represents the reactivation of an ancient developmental program for invasion. Our embryonic 
glycoproteome analysis identifies 106 T antigen modified proteins, a very large set to investigate. 
However, the absence of Mrva causes invasion defects and deficits in T antigen modification on 
only 10-20 proteins; these include components involved in protein folding, glycosylation 
modification, and the signaling pathways triggered by Notch and the BMP family member, Dpp.  
Our working model is that the defect in germband tissue invasion seen in the mrva mutant 
is caused by the absence of T antigen on this group of proteins that act coordinately (Figure 6H). 
56% of these have vertebrate orthologs, and 55% of those have already been linked to cancer 
and metastasis. The vertebrate ortholog of Qsox1, the protein with the largest changes in T 
antigen in the mrva mutant, enhances cancer cell invasion in in vitro assays and higher levels of 
the protein predict poor patient outcomes (Katchman et al., 2013, 2011). We find that the 
strongest effect of Drosophila Qsox1 on macrophage migration is to reduce the time by two fold 
that macrophages take sitting at the germband edge before they successfully begin to invade 
into the germband tissues. We also observe in qsox1 and mrva mutants that LanA levels are 
higher within the macrophages and somewhat elevated near but not at the macrophage cell 
edges. This could be due to some combination of the following shifts in cellular processes: an 
increase in LanA production, a decrease in its degradation, a slowing of its secretion or a speeding 
of its diffusion. We base our model on the functions that have been previously defined for the 
Qsox1 sulfhydryl oxidase family, in integrating laminin into the ECM (Ilani et al., 2013) and aiding 
secretion of EGF domains (Tien et al., 2008) which are found in Drosophila Laminins. If Qsox1 is 
needed for the efficient secretion and integration of LanA into the ECM, its absence could result 
in a less robustly cross-linked matrix. ECM crosslinking has been shown to enhance Integrin 
signaling, focal adhesion formation, and invasion of mammalian tumor cells (Levental et al., 
2009). In its absence Drosophila macrophages which utilize Integrin during invasion (Siekhaus et 
al., 2010) and whose invasive migration is accompanied by deformation of the flanking tissue 
(Ratheesh et al, 2018), could be unable to generate sufficient traction forces to enter. Indeed, 
mutating another subunit of the Drosophila Laminin trimer, LanB1, reduces both normal LanA 
deposition and germband invasion by macrophages (Matsubayashi et al., 2017; Sánchez-Sánchez 
et al., 2017). A determination of the effect of Minerva’s regulation awaits a characterization of 
Qsox1 mutated such that it is incapable of being modified by T antigen on the Mrva-dependent 
sites. Nonetheless, the similarity of the changes in LanA we observe in the mrva3102 and 
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qsox1KG046152 mutant supports the conclusion that Mrva dependent T-antigen modification of 
Qsox1 is necessary for its activity on some substrates. Given that mrva3102 mutants take even 
longer than qsox1KG04615 to enter germband tissue and display much stronger defects thereafter, 
we propose that T antigen modifications on other proteins are also crucial for tissue entry, and 
underlie the defect in invasive migration within the germband. 
Minerva’s vertebrate ortholog, MFSD1, can rescue macrophage migration defects and 
restores higher T antigen levels. Tagged versions of Minerva’s vertebrate ortholog, MFSD1, 
detected the protein in lysosomes in HeLa and rat liver cells (Chapel et al., 2013; Palmieri et al., 
2011). In four metastasizing mouse tumor cell lines we find MFSD1 mainly in the Golgi, where O-
glycosylation is known to occur (Bennett et al., 2012). We do not yet know if invasion and 
metastasis is altered by the absence of MFSD1 but will be testing this in future work. Akin to how 
kinases add phospho-groups to affect a set of proteins and orchestrate a particular cellular 
response, we propose that Minerva in Drosophila macrophages and its vertebrate ortholog 
MFSD1 in cancer trigger changes in O-glycosylation that coordinately modulate, activate and 
inhibit a protein group to affect cellular dissemination and tissue invasion.  
 
Material and Methods 
 
Key resource table 
Designation Source or reference Identifiers 
Additional 
information 
mrva NA 
FlyBase:FBgn00357
63 
  
qsox1 NA 
FlyBase: 
FBgn0033814 
  
C1GalTA NA 
FlyBase: 
FBgn0032078 
  
srp-Gal4 PMID: 15239955     
srp-3xmCherry 
PMID: 29321168 
RRID:BDSC_78358 
and 78359 
  
srp-H2A::3xmCherry 
PMID: 29321168 
RRID:BDSC_78360 
and 78361 
  
UAS-CG8602::FLAG::HA  PMID: 22036573     
mrva3102 
Bloomington 
Drosophila Stock 
Center (BDSC), 
RRID:SCR_006457 
RRID:BDSC_17262   
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Df(3L)BSC117  
BDSC, 
RRID:SCR_006457 
RRID:BDSC_8976   
UAS-mCherry.NLS 
BDSC, 
RRID:SCR_006457 
RRID:BDSC_38425   
C1GalTA2.1 
BDSC, 
RRID:SCR_006457 
RRID:BDSC_28834   
C1GalTA RNAi 1 
Vienna Drosophila 
Resource Centre 
(VDRC), 
RRID:SCR_013805 
VDRC: 2826   
C1GalTA RNAi 2 
VDRC, 
RRID:SCR_013805 
VDRC: 110406   
CG8602 RNAi 
VDRC, 
RRID:SCR_013805 
VDRC: 101575   
qsox1RNAi  
VDRC, 
RRID:SCR_013805 
VDRC: 108288   
qsox1 KG04615 
BDSC, 
RRID:SCR_006457 
RRID:BDSC_13824   
MC-38 Other   
Gift from Borsig 
lab, Univ of Zurich 
(UZH) 
4T1  Other 
ATCC Cat# CRL-
2539, 
RRID:CVCL_0125 
Gift from Borsig 
lab, UZH 
LLC1 Other 
ATCC Cat# CRL-
1642, 
RRID:CVCL_4358 
Gift from Borsig 
lab, UZH 
B16-BL6  Other 
NCI-DTP Cat# 
B16BL-6, 
RRID:CVCL_0157 
Gift from Borsig 
lab, UZH 
S2R+ Other   
Gift from Frederico 
Mauri of the 
Knoblich lab at 
IMBA, Vienna 
srpHemo-
CG8602::3xmCherry  
this paper   CG8602 amplified 
from genome 
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cloned into  
DSPL172 (PMID:  
29321168) 
MT-CG8602::FLAG::HA 
Drosophila Genomic 
Resource Center 
(DGRC), 
RRID:SCR_002845 
DGRC:  FMO06045   
MT-Qsox1::FLAG::HA 
DGRC, 
RRID:SCR_002845 
DGRC: FMO06379   
PTS1-GFP  Other   
Gift from Dr. 
McNew 
MFSD1-eGFP this paper   
MFSD1 amplified 
from dendritic cell  
cDNA library, 
inserted into 
Doxycycline 
inducible 
expression vector 
pInducer20  
anti-GFP clone 2B6 Other   
Gift from Ogris 
lab, MFPL Vienna; 
(1:100) for WB 
anti-GFP clone 5G4 Other   
Gift from Ogris 
lab, MFPL Vienna; 
(1:50) for 
immunochemistry 
anti-T-antigen (mouse 
monoclonal) 
PMID: 23584533   
(1:5 for 
immunochemistry; 
1:10 for WB) 
anti-profilin (mouse 
monoclonal) 
Developmental 
Studies Hybridoma 
Bank (DSHB), 
RRID:SCR_013527 
DSHB Cat# chi 1J, 
RRID:AB_528439 
(1:50) 
anti-GAPDH (rabbit 
monoclonal) 
Abcam, 
RRID:SCR_012931 
Abcam Cat# 
ab181603, 
RRID:AB_2687666 
(1:10000) for WB 
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anti-GRASP65 (rabbit 
polyclonal) 
Thermo Fisher 
Scientific, 
RRID:SCR_008452 
ThermoFischer Cat# 
PA3-910, 
RRID:AB_2113207 
(1:200) for 
immunochemistry 
anti-Rab5 (rabbit 
monoclonal) 
Cell Signaling 
Technology (CST), 
RRID:SCR_004431, 
Clone C8B1 
CST Cat# 3547, 
RRID:AB_2300649 
(1:200) for 
immunochemistry 
anti-Rab7 (rabbit 
monoclonal) 
CST, 
RRID:SCR_004431, 
Clone D95F2 
CST Cat# 9367, 
RRID:AB_1904103 
(1:200) for 
immunochemistry 
anti-LAMP1 (rabbit 
polyclonal) 
Abcam, 
RRID:SCR_012931 
Abcam Cat# 
ab24170, 
RRID:AB_775978 
(1:200) for 
immunochemistry 
anti- Cnx99a (mouse 
monoclonal) 
DSHB, 
RRID:SCR_013527 
DSHB Cat# Cnx99A 
6-2-1, 
RRID:AB_2722011 
(1:5) 
anti- Hrs 27.4 (mouse 
monoclonal) 
DSHB, 
RRID:SCR_013527 
DSHB Cat# Hrs 27-
4, 
RRID:AB_2618261 
(1:5) 
anti- Golgin 84 (mouse 
monoclonal) 
DSHB, 
RRID:SCR_013527 
DSHB Cat# 
Golgin84 12-1, 
RRID:AB_2722113 
(1:5) 
anti Rab7 (mouse 
monoclonal) 
DSHB, 
RRID:SCR_013527 
DSHB Cat# Rab7, 
RRID:AB_2722471 
(1:5) 
anti-GMAP (goat 
polyclonal) 
DSHB, 
RRID:SCR_013527 
DSHB Cat# GMAP, 
RRID:AB_2618259 
(1:50) 
anti- Golgin 245 (goat 
polyclonal) 
DSHB, 
RRID:SCR_013527 
DSHB Cat# 
Golgin245, 
RRID:AB_2618260 
(1:50) 
anti- HA (rat monoclonal) 
Roche, 
RRID:SCR_001326 
Roche Cat# 3F10, 
RRID:AB_2314622 
(1:50) 
anti-LanA (rabbit 
polyclonal) 
PMID:9257722   
gift from Stefan 
Baumgartner 
anti-Vasa (rat monoclonal) 
DSHB, 
RRID:SCR_013527 
DSHB Cat# anti-
vasa, 
RRID:AB_760351 
(1:25) 
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Alexa 488- or 557- or 633- 
secondaries 
Thermo Fisher 
Scientific, 
RRID:SCR_008452 
  
(1:500 for 488 and 
557; 1:100 for 633) 
goat-anti-rabbit IgG 
(H+L)-HRP  
BioRad 
Bio-Rad Cat# 170-
6515, 
RRID:AB_2617112 
(1:10000) 
goat-anti-mouse IgG 
(H/L):HRP  
BioRad 
Bio-Rad Cat# 170-
6516, 
RRID:AB_1112554
7 
(1:10000) 
LysoTracker Green DND-
26 
Invitrogen, 
RRID:SCR_008410 
L7526 75nM 
Alexa Fluor 488 Phalloidin  
Invitrogen, 
RRID:SCR_008410 A12379 
(1:500) 
Vectashield mounting 
medium 
Vector Laboratories, 
RRID:SCR_000821 
VectorLabs: H-1000   
Vectashield mounting 
medium with DAPI 
Vector Laboratories, 
RRID:SCR_000821 
VectorLabs: H-1200   
Halocarbon Oil 27 
Sigma-Aldrich, 
RRID:SCR_008988 
Sigma Aldrich: Cat# 
H8773 
  
srpHemo-mrva this paper   
CG8602 amplified 
from genome 
cloned into 
srpHemo plasmid 
srpHemo-MFSD1 this paper   
mmMFSD1 
amplified from 
dendritic cell 
cDNA library 
cloned into 
srpHemo plasmid 
Mrva fw Fly Primer Bank   
qPCR; 
5'TGTGCTTCGTG
GGAGGTTTC 
Mrva rv Fly Primer Bank   
qPCR; 
5'GCAGGCAAAG
ATCAACTGACC 
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C1GalTA fw Fly Primer Bank   
qPCR; 
5'TGCCAACAGT
CTGCTAGGAAG 
C1GalTA rv Fly Primer Bank   
qPCR: 
5'CTGTGATGTG
CATCGTTCACG 
Ugalt fw Fly Primer Bank   
qPCR; 
5'GCAAGGATGC
CCAGAAGTTTG 
Ugalt rv Fly Primer Bank   
qPCR; 
5'GATATAGACC
AGCGAGGGGAC 
RpL32 fw Fly Primer Bank   
qPCR; 
5'AGCATACAGG
CCCAAGATCG 
RpL32 rv Fly Primer Bank   
qPCR; 
5'TGTTGTCGAT
ACCCTTGGGC 
Lectin staining kit #2 EY Laboratories EYLabs:FLK-002   
FIJI 
http://fiji.sc/ 
RRID:SCR_002285) 
    
Imaris 
http://www.bitplane.c
om/imaris/imaris, 
RRID:SCR_007370 
 
  
Matlab 
https://www.mathwor
ks.com/products/matla
b.html, 
RRID:SCR_001622 
 
  
FlowJo 
https://www.flowjo.co
m/RRID:SCR_008520 
    
LaVision ImSpector 
http://www.lavisionbi
otec.com/, 
RRID:SCR_015249 
    
Proteome Discoverer 1.4  
https://www.thermofis
her.com/order/catalog/
product/OPTON-
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30795, 
RRID:SCR_014477 
LightCycler 480 software 
https://lifescience.roch
e.com/en_at/products/l
ightcycler14301-480-
software-version-
15.html 
    
GraphPad Prism 
https://www.graphpad
.com/scientific-
software/prism/ 
RRID:SCR_002798 
    
 
Fly work 
Flies were raised on food bought from IMBA (Vienna, Austria) which contained the standard 
recipe of agar, cornmeal, and molasses with the addition of 1.5% Nipagin. Adults were placed in 
cages in a Percival DR36VL incubator maintained at 29ºC and 65% humidity; embryos were 
collected on standard plates prepared in house from apple juice, sugar, agar and Nipagin 
supplemented with yeast from Lesaffre (Marcq, France) on the plate surface. Embryo collections 
for fixation (7 hour collection) as well as live imaging (4.5 hour collection) were conducted at 
29ºC.  
 
Fly Lines utilized: srpHemo-GAL4 was provided by K. Brückner (UCSF, USA) (Brückner et al., 2004), 
UAS-CG8602::FLAG::HA (from K. VijayRaghavan National Centre for Biological Sciences, Tata 
Institute of Fundamental Research) (Guruharsha et al., 2011). The stocks w1118; minerva3102 
(BDSC-17262), (pn1;; ry503Dr1P[Δ 2-3] (BDSC-1429), Df(3L)BSC117 (BDSC-8976), Oregon R (BDSC-
2375), w-; P{w[+mC]=UAS-mCherry.NLS}2;MKRS/Tm6b, Tb[1] (BDSC-38425), w-,P{UAS-Rab11-
GFP}2 (BDSC-8506), y[1] sc[*] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.GL00069}attP2 (BDSC-35195), y[1] 
w[*]; Mi{y[+mDint2]=MIC}GlcAT-P[MI05251]/TM3, Sb[1] (BDSC-40779) were obtained from the 
Bloomington Drosophila Stock Centre, Bloomington, USA. The RNAi lines v60100, v110406, 
v2826, v101575 were obtained from the Vienna Drosophila Resource Center (VDRC), Vienna, 
Austria. Lines w-; P{w[+mC; srpHemo-3xmCherry}, w-; P{w[+mC; srpHemo-H2A::3xmCherry} were 
published previously (Gyoergy et al., 2018).  
 
Exact genotype of Drosophila lines used in Figures: 
Figure 1D-H: w-; +; srpHemo-3xmCherry. I-K: Control: w- P(w+)UAS-dicer/w-; P{attP,y[+],w[3`]/+; 
srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+. C1GalTA RNAi: w- P(w+)UAS-dicer2/w-; RNAi C1GalTA 
(v110406)/+; srpHemo-Gal4 UAS-GFP UAS-H2A:RFP/+. L: Control: w-; +; srpHemo-
H2A::3xmCherry. C1GalLTA mutant:  w-; C1GalTA2.1; srpHemo-H2A::3xmCherry. M: Control: w-; 
srpHemo-H2A::3xmCherry. GlcAT-P mutant: w-; srpHemo-H2A::3xmCherry, Mi{MIC}GlcAT-
PMI05251. Figure 1-figure supplement 1A-L: w-; +; srpHemo-3xmCherry. M, N, P: Control: w- 
UAS-Dicer2/w-; P{attP,y[+]w[3`]/+; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+ . C1GalTA RNAi: w-
UAS-Dicer2/ w-; RNAi C1GalTA (v110406)/+; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+. O: 
   68 
 
Control: w-; +; srpHemo-H2A::3xmCherry. C1GalTA mutant: w-; C1GalTA2.1; srpHemo-
H2A::3xmCherry. P: Control: w- UAS-Dicer2/w-; P{attP,y[+]w[3`]/+; srpHemo-Gal4 UAS-GFP UAS-
H2A::RFP/+ . C1GalTA RNAi: w-UAS-Dicer2/ w-; RNAi C1GalTA (v2826)/+; srpHemo-Gal4 UAS-GFP 
UAS-H2A::RFP/+. Q: Control: w-; srpHemo-H2A::3xmCherry. GlcAT-P mutant: w-; srpHemo-
H2A::3xmCherry; Mi{MIC}GlcAT-PMI05251.  
Figure 2A, B, D: w-; +; srpHemo-3xmCherry.  E, F, G: Control: w-; +; srpHemo-3xmCherry. CG8602 
mutant: w-; +; srpHemo-3xmCherry,P{EP}CG86023102. I: w-; srpHemo-Gal4; UAS-
CG8602::FLAG::HA.  
Figure 3A: w-; +; srpHemo-H2A::3xmCherry. B: w-; +; srpHemo-H2A::3xmCherry, 
P{EP}CG86023102. C: w-; srpHemo-CG8602; srpHemo-H2A::3xmCherry P{EP}CG86023102. D: 
Control: w-; srpHemo-Gal4 UAS-mCherry::nls; +. CG8602 (Mrva) mutant: w-; srpHemo-Gal4 UAS-
mCherry::nls; P{EP}CG86023102, Df cross: w-; srpHemo-Gal4 UAS-mCherry:nls; P{EP}CG86023102/ 
Df(3L)BSC117. Rescue: w-; srpHemo-Gal4 UAS-mCherry:nls; UAS-CG8602::FLAG::HA 
P{EP}CG86023102. Precise excision: srpHemo-Gal4 UAS-mCherry:nls; P{EP}CG86023102Δ32. E: 
Control: w- P(w+)UAS-dicer/+; +; srpHemo-Gal4 UAS-GFP UAS-H2A:RFP/+. Mrva RNAi: w- UAS-
dicer2/w-; RNAi CG8602 (v101575)/+; srpHemo-Gal4 UAS-GFP UAS-H2A:RFP/+. F: Control: w-; 
srpHemo-Gal4 UAS-mCherry::nls; +. mrva mutant: w-; srpHemo-Gal4 UAS-mCherry::nls; 
P{EP}CG86023102 .G: Control: w-; +; srpHemo-3xmCherry. Mrva mutant: w-; +; srpHemo-
3xmCherry P{EP}CG86023102. cadherin mrva double mutant: w-; shgP34; srpHemo-3xmCherry 
P{EP}CG86023102. H: Control: w-; +; srpHemo-3xmCherry. mrva mutant: w-; +; srpHemo-
3xmCherry P{EP}CG86023102 I-M: Control: w-; +; srpHemo-H2A::3xmCherry. mrva mutant: w-; +; 
srpHemo-H2A::3xmCherry P{EP}CG86023102.  
Figure 3-figure supplement 1A: Control: w-; +; srpHemo-H2A::3xmCherry. mrva mutant: w-; +; 
srpHemo-H2A::3xmCherry P{EP}CG86023102. Rescue: w-; srp-CG8602; srpHemo-H2A::3xmCherry 
P{EP}CG86023102.  B, C, E: Control: w-; +; srpHemo-Gal4 UAS-GFP UAS-H2A:RFP/+. mrva RNAi: w-
; RNAi CG8602 (v101575)/+; srpHemo-Gal4 UAS-GFP UAS-H2A::RFP/+. D, F-G: Control: w-; +; 
srpHemo-H2A::3xmCherry. mrva mutant:  w-; +; srpHemo-H2A::3xmCherry P{EP}CG86023102. H-L: 
Control: w-; +; srpHemo-3xmCherry. mrva mutant: w-; +; srpHemo-3xmCherry P{EP}CG86023102 
Figure 4A-I: Control: w-; +, srpHemo-3xmCherry. mrva mutant: w-; +, srpHemo-3xmCherry 
P{EP}CG86023102 .  
Figure 5A-B: Control: w-; +; srpHemo-3xmCherry. qsox1 mutant: w-;P{SUPor-P}Qsox1KG04615; 
srpHemo-3xmCherry. C: w/ y,w[1118]; P{attP,y[+],w[3`]}/srpHemo-Gal4; srpHemo-
H2A::3xmCherry/+. qsox1 RNAI: w-/ y,w[1118]; v108288/srpHemo-Gal4; srpHemo-
H2A::3xmCherry/+. D-G: Control: w-; +; srpHemo-H2A::3xmCherry. qsox1 mutant: w-;P{SUPor-
P}Qsox1KG04615; srpHemo-H2A::3xmCherry. J: Control: w-; +; srpHemo-3xmCherry. Mrva 
mutant:  w-; +; srpHemo-3xmCherry P{EP}CG86023102. qsox1 mutant: w-; P{SUPor-
P}Qsox1KG04615;srpHemo-3xmCherry. 
Figure 5-figure supplement 1A-B: Control: w-; +; srpHemo-3xmCherry. qsox1 mutant: w-
;P{SUPor-P}Qsox1KG04615; srpHemo-3xmCherry. C, F: w-; +; srpHemo-H2A::3xmCherry, w-; 
P{SUPor-P}Qsox1KG04615; srpHemo-H2A::3xmCherry. D-E: Control: w-/ y,w[1118]; 
P{attP,y[+],w[3`]}/srpHemo-Gal4; srpHemo-H2A::3xmCherry/+. qsox1 RNAi: w-/ y,w[1118]; 
v108288/srpHemo-Gal4; srpHemo-H2A::3xmCherry/+. K-N: Control: w-; +; srpHemo-3xmCherry. 
Mrva mutant: w-; +; srpHemo-3xmCherry P{EP}CG86023102, qsox1 mutant: w-; P{SUPor-
P}Qsox1KG04615; srpHemo-3xmCherry. 
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Figure 6D: w-; srpHemo-MFSD1; srpHemo-H2A::3xmCherry P{EP}CG86023102. E: Control: w-; +; 
srpHemo-H2A::3xmCherry. mrva mutant: w-; +; srpHemo-H2A::3xmCherry P{EP}CG86023102. 
MFSD1 rescue: w-; srpHemo-MFSD1; srpHemo-H2A::3xmCherry P{EP}CG86023102. F, G: Control:  
w-; +; srpHemo-3xmCherry. mrva mutant: w-; +; srpHemo-3xmCherry P{EP}CG86023102. MFSD1 
rescue: w-; srpHemo-MFSD1; srpHemo-3xmCherry P{EP}CG86023102. 
 
Embryo Fixation and Immunohistochemistry 
Embryos were collected on apple juice plates from between 6 and 8.5 hours at 29°C. Embryos 
were incubated in 50% Chlorox (DanClorix) for 5 min and washed. Embryos were fixed with 17% 
formaldehyde/heptane for 20 min followed by methanol or ethanol devitellinization except for T 
antigen analysis, when embryos were fixed in 4% paraformaldehyde/heptane. Fixed embryos 
were blocked in BBT (0.1M PBS + 0,1% TritonX-100 + 0,1% BSA) for 2 hours at RT. Antibodies were 
used at the following dilutions: α-T antigen (Steentoft et al., 2011) 1:5, α-GFP (Aves Labs Inc., 
Tigard, Oregon) 1:500; α-LanA (Kumagai C, et al., 1997) (a gift from Stefan Baumgartner) 1:500;  
α-Vasa (Aruna et al., 2009) (DSHB, deposited by A. Sprading/ D. Williams) 1:25; and incubated 
overnight at 4°C (GFP) or room temperature (T antigen, LanA). Afterwards, embryos were washed 
in BBT for 2 hours, incubated with secondary antibodies (Thermo Fisher Scientific, Waltham, 
Massachusetts, USA) at RT for 2 hours, and washed again for 2 hours. Vectashield (Vector 
Laboratories, Burlingame, USA) was then added. After overnight incubation in Vectashield at 4°C, 
embryos were mounted on a slide and imaged with a Zeiss Inverted LSM700 Confocal Microscope 
using a Plan-Apochromat 20X/0.8 Air Objective or a Plan-Apochromat 63X/1.4 Oil Objective. 
 
Ovary dissection and immunostaining 
3-5 day old females were fed with yeast for 2 days at 25°C. For ovary dissection, females were 
anesthetized using the FlyNap anesthetic kit (Carolina, Burlington, NC, USA) and further 
transferred to ice cold PBS in which ovaries were extracted with pre-cleaned forceps. Individual 
ovaries were fixed in 4% Paraformaldehyde/PBS at room temperature (RT) for 20 minutes with 
agitation. Three wash steps with PBS at RT for 10 minutes were performed and individual ovaries 
were incubated in PBS supplemented with 0.1% of Triton X-100 (PBT) for 10 minutes at RT to 
allow permeabilization of the tissue. Ovaries were incubated in phalloidin-A488 (Thermo Fisher) 
diluted in PBT (1:300) overnight at 4°C. After being washed with PBT and PBS, ovaries were 
mounted in Vectashield+DAPI (LifeTechnologies, Carlsbad, USA).  
 
Fixed ovary image analysis for border cell migration 
Ovaries were imaged as a Z-series (1µm apart) with a Plan-Apochromat 20X/0.8 Air Objective on 
a Zeiss LSM700 inverted microscope. Images were acquired from stage 10 oocytes and maximum-
intensity projections were created using ImageJ (NHI, USA). Border cells were identified by the 
clustered nuclei and their enriched actin staining. Border cell migration was quantified in the 
DAPI images as the percentage observed relative to the expected migration to the edge of the 
oocyte for these cells in stage 10 oocytes. Measurements were performed using ImageJ software 
(NIH, USA).  
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Lectin staining 
Embryos were fixed with 10% formaldehyde/heptane and devitellinized with Ethanol. Blocking 
was conducted in BBT for 2 hours at room temperature. A FITC-labeled lectin kit #2 (EY 
laboratories, San Mateo, CA, USA) was utilized (table below summarizes abbrevations of used 
lectins). Each lectin was diluted to 1:25 and incubated with fixed embryos overnight at room 
temperature (RT). Embryos were washed in BBT for 2 hours at RT and Vectashield was added. 
After overnight incubation at 4°C, embryos were mounted on a slide and imaged with a Zeiss 
Inverted LSM700 Confocal Microscope using a Plan-Apochromat 63X/1.4 Oil Objective. 
Macrophages in late Stage 11 embryos were imaged at germband entry and evaluated by eye for 
enriched staining on macrophages compared to other tissues. 
Lectin peanut 
agglutinin 
Ulex 
europaeus 
agglutinin 
Wheat 
germ 
agglutinin 
Griffonia 
simplicifolia 
agglutinin I 
Maclura 
pomifera 
agglutinin 
Griffonia 
simplicifolia 
agglutinin II 
Abbreviation PNA UEA-I WGA GS-I MPA GS-II 
Lectin Soybean 
agglutinin 
Dolichos 
biflorus 
agglutinin 
Concanava
lin A 
Helix pomatia 
agglutinin 
Limulus 
poly-phenus 
agglutinin 
Bauhinia 
purpurea 
agglutinin 
Abbreviation SBA DBA ConA HPA LPA BPA 
 
Macrophage extraction 
Embryos were bleached in 50% Chlorox in water for 5 minutes at RT. Stage late 11/early 12 
embryos were lined up and then glued to 50 mm Dish No. 0 Coverslip, 14 mm Glass Diameter, 
Uncoated dish (Zeiss, Germany). Cells from the germband margin were extracted using a ES 
Blastocyte Injection Pipet (spiked, 20μm inner diameter, 55mm length; BioMedical Instruments, 
Germany). Extracted cells were placed in Schneider’s medium (Gibco, Dublin, Ireland) 
supplemented with 20% FBS (Sigma-Aldrich, Saint Louis, Missouri, USA).  
 
Immunohistochemistry of extracted macrophages 
Extracted macrophages were collected by centrifugation at 500g for 5 min at room temperature. 
The cell pellet was resuspended in a small volume of Phospho-buffered saline (PBS) and smeared 
on a cover slip. The cell suspension was left to dry before cells were fixed with 4% 
paraformaldehyde in 0.1M Phosphate Buffer for 20 min at room temperature. Cells were washed 
3 times in 0.1M PBS and permeabilized in 0.5% Triton-X 100 in PBS. Cells were blocked for 1 hour 
at room temperature in 20% Fetal Bovine Serum + 0.25% Triton X-100 in PBS. Primary antibodies 
were diluted in blocking buffer: anti-HA (Roche, Basel, Switzerland) 1:50, anti-Golgin 84, 1:25, 
anti-Calnexin 99a 1:25, anti-Hrs.8.2 1:25 or anti-Rab7 1:25 all from DSHB (Riedel et al., 2016), and 
incubated for 1 hour at room temperature. Cells were then washed 5 times in blocking buffer. 
Secondary antibodies were diluted in blocking buffer: anti-rat 633 1:300, anti-mouse 488 1:300 
(both from ThermoFisher Scientific, Waltham, Massachusetts, USA). Secondary antibodies were 
incubated for 1 hour at room temperature. Cells were washed 5 times in PBS + 0.1% Triton X-100 
and mounted in VectaShield+DAPI (LifeTechnologies, Carlsbad, USA) utilized at 1:75. 
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S2 cell work 
S2R+ cells (a gift from Frederico Mauri of the Knoblich laboratory at IMBA, Vienna) were grown 
in Schneider’s medium (Gibco) supplemented with 10% FBS (Gibco) and transfected with PTS1-
GFP (a gift from Dr. McNew) and/or the srpHemo-CG8602::3xmCherry construct using Effectene 
Tranfection Reagent (Qiagen, Hilden, Germany) following the manufacturer’s protocol. 
Transfected S2R+ cells were grown on Poly-L-Lysine coated coverslips (ThermoFisher Scientific, 
Waltham, Massachusetts, USA) in complete Schneider’s medium (Gibco) supplemented with 10% 
FBS (Sigma-Aldrich, Saint Louis, Missouri, USA) and 1% Pen/Strep (Gibco) to a confluency of 60%. 
To visualize lysosomes, cells were incubated with Lysotracker 75nM Green DND-26 (Invitrogen) 
in complete Schneider’s medium for 30 minutes at 25°C. Cells were washed in complete 
Schneider’s medium 3 times before imaging on an inverted LSM-700 (Zeiss). To visualize 
mitochondria, mitotracker Green FM (Invitrogen, Carlsbad, CA, USA) was diluted in prewarmed 
Schneider’s medium supplemented with 1% Pen/Strep to a concentration of 250nM. Cells were 
incubated in the Mitotracker solution for 45 minutes at 25°C. Cells were then washed 3 times in 
complete Schneider’s medium before imaging. 
To visualize Golgi, ER, early and late endosomes as well as the nucleus, S2R+ cells were 
transfected with MT-CG8602::FLAG::HA (DGRC: FMO06045) or MT-Qsox1::FLAG::HA (DGRC: 
FMO06379) with Effectene Tranfection Reagent (Qiagen) following the manufacturer’s protocol. 
24 hours after transfection gene expression was induced by addition of 1mM Cu2SO4 (Sigma) 
and cells were incubated for an additional 24 hours. Cells were then fixed in 4% PFA (Sigma) in 
0.1M PB for 20 min at room temperature, permeabilized in 0.5% Triton X-100 (Sigma) in PBS for 
15 min and blocked for 2 hours in 20% FBS (Sigma), 0.25% Triton X-100 in PBS at room 
temperature.   
Cells were then stained with anti-HA antibody 1:50 (Roche) and either anti-Cnx99a (1:5), 
anti-Hrs 8.2 (1:5), anti- Golgin 84 (1:5), anti-Rab7 (1:5), anti- GMAP (1:50) or anti- Golgin 245 
(1:50) (all antibodies from DSHB) (Riedel et al. 2011). Cells were washed in 20% FBS (Sigma), 
0.25% Triton X-100 in PBS 5 times and then incubated with anti-rat Alexa Fluor 633 1:50 and 
either anti- mouse Alexa Fluor 488 or anti-goat Alexa Fluor 488 1:100 (Thermo Fisher) for 2 hours 
at room temperature. Cells were washed again 5 times and then mounted in Vectashield 
Mounting Medium + DAPI (Vector Laboratories) and imaged with Zeiss LSM 700 or 800 confocal 
microscopes. Quantitation of colocalization was performed as indicated below.  
The cell line was routinely tested for Mycoplasm infection and found to be negative.  
 
DNA Isolation from Single Flies 
Single male flies were frozen for at least 3 hours before grinding them in 100mM Tris-HCl, 100mM 
EDTA, 100mM NaCL and 0.5% SDS. Lysates were incubated at 65°C for 30 minutes. Then 5M KAc 
and 6M LiCl were added at a ratio of 1:2.5 and lysates were incubated on ice for 10 min. Lysates 
were centrifuged for 15 minutes at 20,000xg, supernatant was isolated and mixed with 
Isopropanol. Lysates were centrifuged again for 15 minutes at 20.000xg, supernatant was 
discarded and the DNA pellet was washed in 70% EtOH and subsequently dissolved in ddH20.  
 
FACS sorting 
Embryos were collected for 1 hour and aged for an additional 5 hours, all at 29°C. Embryos 
collected from w- flies were processed in parallel and served as a negative control. Embryos were 
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dissociated as described previously (Gyoergy et al., 2018). The cells were sorted using a FACS Aria 
III (BD) flow cytometer. Emission filters were 600LP, 610/20 and 502 LP, 510/50. Data was 
analyzed with FlowJo software (Tree Star). The cells from the dissociated negative control w- 
embryos were sorted to set a baseline plot. 
 
qPCR 
RNA was isolated from approximately 50,000 mCherry positive or mCherry negative FACS sorted 
macrophages using RNeasy Plus Micro Kit (Qiagen, Hilden, Germany following manufacturer’s 
protocol. RNA was also isolated from 50-100 mg of ovaries (about 15-20 pairs of ovaries extracted 
as indicated above).  Ovaries were homogenized with a pellet homogenizer (VWR, Radnor, USA) 
and plastic pestles (VWR, Radnor, USA) in 1ml of Trizol (Thermo Fisher Scientific, Waltham, MA, 
USA) and centrifuged at 12,000xg for 5 min at 4°C. Further steps were according to the 
manufacturers protocol. The resulting RNA was used for cDNA synthesis using Sensiscript RT Kit 
(macrophages) or Omniscript (ovaries) (Qiagen, Hilden, Germany) and oligo dT primers. A Takyon 
qPCR Kit (Eurogentec, Liege, Belgium) was used to mix qPCR reactions based on the provided 
protocol. qPCR was run on a LightCycler 480 (Roche, Basel, Switzerland) and data were analyzed 
in the LightCycler 480 Software and Prism (GraphPad Software). Data are represented as relative 
expression to a housekeeping gene (2-Δct) or fold change in expression (2-ΔΔct). Primer sequences 
utilized for flies were obtained from the FlyPrimerBank (http://www.flyrnai.org/FlyPrimerBank). 
Minerva/CG8602: Fw pr TGTGCTTCGTGGGAGGTTTC, Rv pr GCAGGCAAAGATCAACTGACC. 
C1GalTA: Fw pr TGCCAACAGTCTGCTAGGAAG, Rv pr CTGTGATGTGCATCGTTCACG. Ugalt: Fw pr 
GCAAGGATGCCCAGAAGTTTG, Rv pr GATATAGACCAGCGAGGGGAC. RpL32: Fw pr 
AGCATACAGGCCCAAGATCG, Rv pr TGTTGTCGATACCCTTGGGC 
 
Protein preps from embryos for Western 
Embryos were collected for 7 hours at 29ºC, bleached and hand-picked for the correct Stage. 50-
200 embryos were smashed in RIPA buffer (150mM NaCl, 0,5% Sodiumdeoxychalat, 0,1% SDS, 
50mM Tris, pH 8) with Protease inhibitor (Complete Mini, EDTA free, Roche, Basel, Switzerland) 
using a pellet homogenizer (VWR, Radnor, USA) and plastic pestles (VWR, Radnor, USA) and 
incubated on ice for 30 min. Afterwards, samples were centrifuged at 4ºC, 16,000g for 30 min 
and the supernatant was collected and used for experiments. The protein concentration was 
quantified using the Pierce BCA Protein Assay Kit (ThermoFisher Scientific).  
 
Western Blots 
30 μg of protein samples were loaded on a 4-15% Mini-PROTEAN TGX Precast Protein Gel (Bio-
Rad, Hercules, USA) and run at 100V for 80 min in 1x running buffer (25mM Tris Base, 190mM 
glycine and 0.1%SDS) followed by transfer onto Amersham Protran Premium 0.45 μm NC (GE 
Healthcare Lifescience, Little Chalfont, UK) or Amersham Hybond Low Fluorescence 0.2 μm PVDF 
(GE Healthcare Lifescience, Little Chalfont, UK) membrane using a wet transfer protocol with 
25mM Tris Base, 190 mM Glycine + 20% MeOH at either 100 Volts for 60 min or 200mA for 90 
min at Mini Trans-Blot Cell Module (Bio-Rad, Hercules, USA). Membranes were blocked in PBS-T 
(0.1% Triton X-100 in PBS) containing 2% BSA or Pierce Clear Milk Blocking Buffer (ThermoFisher 
Scientific) for 1 hour at RT. Primary antibodies were incubated overnight at 4ºC at the following 
concentrations: α-T antigen (Copenhagen) 1:10, α-profilin (Verheyen and Cooley, 1994, DSHB) 
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1:50, anti-GFP (clone 2B6, Ogris lab, MFPL), anti-GAPDH (ab181603, Abcam, Cambridge, UK). 
Afterwards, blots were washed 3x for 5 min in blocking solution and incubated with Goat anti 
Mouse IgG (H/L):HRP (Bio-Rad, Hercules, USA) or goat-anti-rabbit IgG (H+L)-HRP (Bio-Rad, 
Hercules, USA) at 1:5 000 - 10,000 for 1-2 hours at room temperature. Blots were washed 2x 5 
min in blocking solution and 1x 5 min with PBS-T. Blots were developed using SuperSignal West 
Femto Maximum Sensitivity Substrate (ThermoFisher Scientific, Waltham, Massachusetts, USA) 
according to manufacturer’s instructions. Chemiluminescent signal was detected using the 
Amersham Imager 600 (GE Healthcare Lifescience) or VersaDoc (Bio-Rad). Images were 
processed with ImageJ. 
 
Western Blot analysis of S2R+ supernatant  
S2R+ cells were transfected as described previously with srpGal4 UAS-Qsox1::FLAG::HA. 2 days 
post-transfection, medium was removed and cells were washed with PBS. Afterwards, serum-
free S2 medium was added and incubated for approximately 40 hours. Afterwards, supernatant 
was collected and concentrated using Amicon Ultra-4 10K Centrifugal Filter Device (Merck, 
Kenilworth, New Jersey, United States) to gain 80μl of concentrated supernatant. 20μl of 
supernatant was loaded on gel and analyzed by anti-HA (1:200, Roche). Images were processed 
with ImageJ. 
 
Time-lapse imaging, tracking, speed, persistence and germband entry analysis 
Embryos were dechorionated in 50% bleach for 5 min, washed with water, and mounted in 
halocarbon oil 27 (Sigma-Aldrich, Saint Louis, Missouri, USA) between a coverslip and an oxygen 
permeable membrane (YSI). The anterior dorsolateral region of the embryo was imaged on an 
inverted multiphoton microscope (TrimScope II, LaVision) equipped with a W Plan-Apochromat 
40X/1.4 oil immersion objective (Olympus). mCherry was imaged at 1100 nm excitation 
wavelengths, using a Ti-Sapphire femtosecond laser system (Coherent Chameleon Ultra) 
combined with optical parametric oscillator technology (Coherent Chameleon Compact OPO). 
Excitation intensity profiles were adjusted to tissue penetration depth and Z-sectioning for 
imaging was set at 1µm for tracking and segmentation respectively. For long-term imaging, 
movies were acquired for 132 - 277 min with a frame rate of 40 sec. All embryos were imaged 
with a temperature control unit set to 28.5°C.  
Images acquired from multiphoton microscopy were initially processed with InSpector 
software (LaVision Bio Tec) to compile channels from the imaging data, and the exported files 
were further processed using Imaris software (Bitplane) to visualize the recorded channels in 3D. 
Macrophage speed and persistence were calculated by using embryos in which the macrophage 
nuclei were labeled with srpHemo-H2A::3XmCherry (Gyoergy et al., 2018). The movie from each 
imaged embryo was rotated and aligned along the AP axis for tracking analysis. Increasing the 
gain allowed determination of germband position from the autofluorescence of the yolk. Movies 
for vnc analysis were analyzed for 2 hours from the time point that cells started to dive into the 
channels to reach the outer vnc. Macrophage nuclei were extracted using the spot detection 
function and nuclei positions in xyz-dimensions were determined for each time point and used 
for further quantitative analysis. Cell speeds and directionalities were calculated in Matlab (The 
MathWorks Inc., Natick, Massachusetts, USA) from single cell positions in 3D for each time frame 
measured in Imaris (Bitplane). Instantaneous velocities from single cell trajectories were 
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averaged to obtain a mean instantaneous velocity value over the course of measurement. To 
calculate directionality values, single cell trajectories were split into segments of equal length (10 
frames) and calculated via a sliding window as the ratio of the distance between the macrophage 
start-to-end location over the entire summed distance covered by the macrophage between 
successive frames in a segment. Calculated directionality values were averaged over all segments 
in a single trajectory and all trajectories were averaged to obtain a mean directionality value for 
the duration of measurement, with 0 being the lowest and 1 the maximum directionality. To 
estimate the time for entry into the germband, we increased the gain to visualize the germband 
position from the autofluorescence of the yolk. We assessed the time point when the first 
macrophage nucleus reached the edge of the germband (taken as T0) and the time point when 
the first cell nucleus was just within the germband (taken as T1). T1-T0 was defined as the time 
for macrophage entry.  
 
Fixed embryo image analysis for T antigen levels 
Embryos were imaged with Plan-Apochromat 63X/1.4 Oil Objective on a Zeiss LSM700 inverted. 
10µm stacks (0.5µm intervals) were taken for properly staged and oriented embryos, starting 
10µm deep in the tissue. These images were converted into Z-stacks in Fiji. ROIs were drawn 
around macrophages (signal), copied to tissue close by without macrophages (background) and 
the average intensity in the green channel of each ROI was measured. For each pair of ROIs 
background was subtracted from signal individually. The average signal from control ROIs from 
one imaging day and staining was calculated and all data point from control, mutant and rescue 
from the same set was divided by this value. This way we introduced an artificial value called 
Arbitrary Unit (AU) that makes it possible to compare all the data with each other, even if they 
come from different imaging days when the imaging laser may have a different strength or from 
different sets of staining. Analysis was done on anonymized samples. 
 
Macrophage cell counting 
Transmitted light images of the embryos were used to measure the position of the germband to 
determine the stages for analysis. The extent of germband retraction away from the anterior 
along with the presence of segmentation was used to classify embryos. Embryos with germband 
retraction of between 29-31% were assigned to late Stage 11. Those with 29-41% retraction for 
all experiments except the punt RNAi (Figure 4J) in which 35-45% was used (both early Stage 12) 
were analyzed for the number of macrophages that had entered the germband and those with 
50-75% retraction (late Stage 12) for the number along the ventral nerve cord (vnc), and in the 
whole embryo. Macrophages were visualized using confocal microscopy with a Z-resolution of 
3μm and the number of macrophages within the germband or the segments of vnc was calculated 
in individual slices (and then aggregated) using the Cell Counter plugin in FIJI.  
To check that this staging allows embryos from the control and mrva3102 mutant to be 
from the same time during development, embryos were collected for 30 minutes and then 
imaged for a further 10 hours using a Nikon-Eclipse Wide field microscope with a Plan-
Apochromat 20X/ 0.5 DIC water Immersion Objective. Bright field images were taken every 
5 minutes, and the timing of the start of the movies was aligned based on when cellularization 
occurred. We found no significant difference in when germband retraction begins (269.6±9 min 
in control and 267.1±3 min in mrva3102, p=0.75) or in when the germband retracts to 41% (300±9 
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min for control, 311±5 min in mrva3102, p=0.23) , or in when the germband retraction is complete 
(386.5±10 min for control, 401.6±8 min for mrva3102, p=0.75). n=10 embryos for control and 25 
embryos for mrva3102. 
 
Cloning  
Standard molecular biology methods were used and all constructs were sequenced by Eurofins 
before injection into flies. Restriction enzymes BSiWI, and AscI were obtained from New England 
Biolabs, Ipswich, Massasuchetts, USA (Frankfurt, Germany). PCR amplifications were performed 
with GoTaq G2 DNA polymerase (Promega, Madison, USA) using a peqSTAR 2X PCR machine from 
PEQLAB, (Erlangen, Germany). All Infusion cloning was conducted using an Infusion HD Cloning 
kit obtained from Clontech’s European distributor (see above); relevant oligos were chosen using 
the Infusion primer Tool at the Clontech website.  
Construction of srpHemo-minerva: A 1467 bp fragment containing the Minerva (CG8602) ORF 
was amplified from the UAS-CG8602:FLAG:HA construct (DGRC) using primers Fw 
GAAGCTTCTGCAAGGATGGCGCGCGAGGACGAGGAAC, Rv 
CGGTGCCTAGGCGCGCTATTCAAAGTTCTGATAATTCTCG. The fragment was cloned into the 
srpHemo plasmid (a gift from Katja Brückner, (Brückner et al., 2004)) after its linearization with 
AscI, using an Infusion HD cloning kit. 
Construction of srpHemo-MFSD1: A 1765 bp fragment containing the MFSD1 ORF was amplified 
from cDNA prepared from dendritic cells (a gift from M. Sixt lab) with Fw primer 
TAGAAGCTTCTGCAACTTTGCTTCCTGCTCCGTTC, Rv primer 
ATGTGCCTAGGCGCGAAGGAAAGGCTTCATCCGCA). The fragment was cloned into the srpHemo 
plasmid (a gift from Katja Brückner, (Brückner et al., 2004)]) using an Infusion HD cloning kit 
(Clontech) after its linearization with AscI (NEB).  
Construction of srpHemo-mrva::3xmCherry: Minerva (CG8602) was amplified from a DNA prep 
from Oregon flies (Fw primer: AGAGAAGCTTCGTACGCGACAACCCTGCTCTACAGAG; Rv primer 
CGACCTGCAGCGTACGACCCGATCCTTCAAAGTTCTG). The vector, PCasper4 containing a 
3xmCherry construct under the control of the srpHemo promoter (Gyoergy et al., 2018), was 
digested with BsiWI according to the manufacturer’s protocol. The vector and insert were 
homologously recombined using the In-Fusion HD Cloning Kit.  
Generation of pInducer20-MFSD1-eGFP constructs: For C-terminal tagging MFSD1 was PCR 
amplified from cDNA prepared from dendritic cells (a gift from M. Sixt lab) with the following 
primers; fw: GATCTCGAGATGGAGGACGAGGATG; rev: CGACCGGTAACTCTGGATGAGAGAGC and 
digested with XhoI and AgeI (both New England Biolabs, Ipswich, Massasuchetts, USA). This 
MFSD1 fragment was cloned into XhoI/AgeI digested peGFP-N1 (Addgene, Cambridge, 
Massachusetts, USA). C-terminally eGFP tagged MFSD1 was further PCR amplified with following 
primers; fw: GGGGACAAGTTTGTACAAAAAAGCAGGCTTAATGGAGGACGAGGAT; rev: 
GGGGACCACTTTGTACAAGAAAGCTGGGTATTACTTGTACAGCTC. This fragment was cloned using 
Gateway BP Clonase II Enzyme mix and Gateway LR Clonase II Enzyme Mix (ThermoFisher 
Scientific, Waltham, Massachusetts, USA) via donor vector pDonR211 into the final Doxycyclin 
inducible expression vector pInducer20 (Meerbrey et al., 2011) according to manufacturer’s 
instructions. pInducer20-MFSD1-eGFP was amplified in stbl3 bacteria (ThermoFisher Scientific, 
Waltham, Massachusetts, USA).  
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Precise excision 
mrva3102 flies which contain the 3102 P element insert in the 5’ region of CG8602 were crossed 
to a line expressing transposase (BL-1429 (pn1; ry503Dr1P[Δ 2-3]). To allow excision of the P 
Element, males from the F1 generation containing both the P element and the transposase, were 
crossed to virgins with the genotype Sp/Cyo; PrDr/TM3Ser (gift from Lehmann lab). In the F2 
generation white eyed males were picked and singly crossed to Sp/Cyo; PrDr/TM3Ser virgins.  
 
LanA quantification 
Images were taken with a Z-resolution of 0.5μm from the head of late stage 12 embryos using a 
Zeiss LSM800 confocal microscope and a 40x/1.4 Oil DIC objective. A 4μm long line was drawn 
over a macrophage with the middle of the line located approximately at the edge of the cell. 
mCherry and LanA (488) intensities were measured using the Multichannel Plot Profile Plugin in 
Fiji. Three lines were drawn on each cell to catch the variability of secretion. Only cells standing 
alone or in small groups that have at least some small visible amount of extracellular LanA 
analyzed. From each embryo, 20 cells were analyzed. Images were anonymized before 
quantification. 
 
Mammalian cell culture 
MC-38 colon carcinoma cells, 4T1 breast carcinoma (ATCC, CRL-2539), Lewis Lung carcinoma LLC1 
(ATCC, CRL-1642) and B16-BL6 melanoma (NCI-DTP; B16BL-6)  (all gifts from the Borsig lab) were 
kept in DMEM supplemented with 10% FCS (Sigma-Aldrich, Saint Louis, Missouri, USA), Non-
essential Amino Acids, and Na-Pyruvate (Thermo Fisher Scientific, Waltham, Massachusetts, 
USA). All cells were kept in a humidified incubator at 37°C with 5% CO2. Cells were infected with 
lentiviral particles containing pInducer20-MFSD1-eGFP. Expression of MFSD1-eGFP was induced 
with 20ng/ml (for MC-38) and 100ng/ml (for 4T1, LLC, B16-BL6) of Doxycycline for 24 hours prior 
subsequent analysis. Cell lines were routinely tested for Mycoplasm infection and found to be 
negative. The identity of the cell lines was confirmed by STR analysis by the cell bank from which 
they were obtained.  
 
Mammalian Cell lysis 
Cells were lysed in lysis buffer (25mM Tris, 150mM NaCl, 1mM EDTA, 1% Triton X-100) 
supplemented with protease inhibitor cocktail (Complete, Roche, Basel, Switzerland) for 20 min 
on ice, followed by centrifugation at 14,000x g, 4°C for 5 min. The protein lysates were stored at 
-80°C. Protein concentration was determined with the Pierce BCA Protein Assay Kit (Thermo 
Fisher Scientific). 
 
Mammalian Cell Immunofluorescence 
Cells were fixed with 4% formaldehyde (Thermo Fisher Scientific) in PBS for 15 minutes at room-
temperature. Cells were washed three times with PBS followed by blocking and permeabilization 
with 1% BSA (Sigma-Aldrich, Saint Louis, Missouri, USA)/0.3% Triton X-100 in PBS for 1 hour. 
Antibodies were diluted in blocking/permeabilization buffer and incubated for 2 hours at room 
temperature. Primary antibodies used were: anti-GFP (clone 5G4, Ogris lab, MFPL), anti-GRASP65 
(Thermo Fisher, PA3-910), anti-Rab5 (Cell Signaling Technology, #C8B1), anti-Rab7 (Cell Signaling 
Technology, #D95F2) and anti-LAMP1 (Abcam, Cambridge, UK, #ab24170). Cells were washed 
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three times with PBS-Tween20 (0.05%) for 5 minutes each, followed by secondary antibody 
incubation in blocking/permeabilization buffer for 1 hour at room-temperature. Secondary 
antibodies used were: goat anti-mouse IgG (H+L) Alexa Fluor 488 (Thermo Fisher A11001), goat 
anti-rabbit IgG (H+L) Alexa Fluor 555 (Thermo Fisher, A21428), Cells were counterstained with 
DAPI (Thermo Fisher) for 10 minutes in PBS. Cells were mounted with ProLong Gold Antifade 
Mountant (Thermo Fisher  #P36930). Images were acquired using a Plan-Apochromat 40x/1.4 Oil 
DIC objective M27 on a Zeiss LSM880 confocal microscope. Pictures were processed with ImageJ.  
 
Quantification of Secretory Pathway Marker Colocalization with Mrva, MFSD1 and 
Qsox1 
Colocalization analysis was performed by ImageJ’s (NIH) Coloc 2 plugin and determined with the 
pixel intensity spatial correlation analysis (Pearson’s correlation coefficient). 
 
Embryonic Protein Prep for Glycoproteomics 
150 mg fly embryos were homogenized in 2 ml 0.1% RapiGest, 50mM ammonium bicarbonate 
using a dounce homogenizer. The lysed material was left on ice for 40 min with occasional 
vortexing followed by probe sonication (5 sec sonication, 5 sec pause, 6 cycles at 60% amplitude). 
The lysate was cleared by centrifugation (1,000× g for 10 min). The cleared lysate was heated at 
80°C, 10 min followed by reduction with 5mM dithiothreitol (DTT) at 60°C, 30 min and alkylation 
with 10mM iodoacetamide at room temperature (RT) for 30 min before overnight (ON) digestion 
at 37°C with 25µg trypsin (Roche). The tryptic digests were labeled with dimethyl stable isotopes 
as described (Boersema et al., 2009). The digests were acidified with 12µL trifluoroacetic acid 
(TFA), 37°C, 20 min and cleared by centrifugation at 10,000g, 10 min. The cleared acidified digests 
were loaded onto equilibrated SepPak C18 cartridges (Waters) followed by 3× CV 0.1% TFA wash. 
Digests were labeled on column by adding 5 mL 30 mM NaBH3CN and 0.2% formaldehyde (COH2) 
in 50mM sodium phosphate buffer pH 7.5 (Light, mrva3102), or 30mM NaBH3CN and 0.2% 
deuterated formaldehyde (COD2) in 50mM sodium phosphate buffer pH 7.5 (Medium, control). 
Columns were washed using 3 CV 0.1% FA and eluted with 0.5 mL 50% MeOH in 0.1% FA. The 
eluates were mixed in 1:1 ratio, concentrated by evaporation, and resuspended in Jacalin loading 
buffer (175mM Tris-HCl, pH 7.4) Glycopeptides were separated from non-glycosylated peptides 
by Lectin Weak Affinity Chromatography (LWAC) using a 2.8 m column packed in-house with 
Jacalin-conjugated agarose beads. The column was washed with 10 CVs Jacalin loading buffer 
(100 µL/min) before elution with Jacalin elution buffer (175mM Tris- HCl, pH 7.4, 0.8M galactose) 
4 CVs, 1 mL fractions. The glycopeptide-containing fractions were purified by in-house packed 
Stage tips (Empore disk-C18, 3M). 
 
Quantitative O-glycoproteomic Strategy 
The glycopeptide quantification based on M/L isotope labeled doublet ratios was evaluated to 
estimate a meaningful cut-off ratio for substantial changes (Schjoldager et al., 2015). The labeled 
glycopeptides produced doublets with varying ratios of the isotopic ions as well as a significant 
number of single precursor ions without evidence of ion pairs. Labeled samples from control 
srpHemo-3xmCherry embryos and mrva3102 srpHemo-3xmCherry mutant embryos were mixed 
1:1 and subjected to LWAC glycopeptide enrichment. The distribution of labeled peptides from 
the LWAC flow-through showed that the quantitated peptide M/L ratios were normally 
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distributed with 99.7% falling within +/-0.55 (Log10). We selected doublets with less/more than 
+/-0.55(Log10) value as candidates for isoform-specific O-glycosylation events. 
 
Mass spectrometry 
EASY-nLC 1000 UHPLC (Thermo Scientific) interfaced via nanoSpray Flex ion source to an -
Orbitrap Fusion mass spectrometer (Thermo Scientific) was used for the glycoproteomic study. 
A precursor MS1 scan (m/z 350–1,700) of intact peptides was acquired in the Orbitrap at a 
nominal resolution setting of 120,000. The five most abundant multiply charged precursor ions 
in the MS1 spectrum at a minimum MS1 signal threshold of 50,000 were triggered for sequential 
Orbitrap HCD-MS2 and ETD-MS2 (m/z of 100–2,000). MS2 spectra were acquired at a resolution 
of 50,000. Activation times were 30 and 200 ms for HCD and ETD fragmentation, respectively; 
isolation width was 4 mass units, and 1 microscan was collected for each spectrum. Automatic 
gain control targets were 1,000,000 ions for Orbitrap MS1 and 100,000 for MS2 scans. 
Supplemental activation (20 %) of the charge-reduced species was used in the ETD analysis to 
improve fragmentation. Dynamic exclusion for 60 s was used to prevent repeated analysis of the 
same components. Polysiloxane ions at m/z 445.12003 were used as a lock mass in all runs. The 
mass spectrometry glycoproteomics data have been deposited to the ProteomeXchange 
Consortium (Vizcaino et al., 2016) via the PRIDE partner repository with the dataset identifier 
PXD011045. 
 
Mass spectrometry Data analysis 
Data processing was performed using Proteome Discoverer 1.4 software (Thermo Scientific) 
using Sequest HT Node as previously described (Schjoldager et al., 2015).  
Briefly, all spectra were initially searched with full cleavage specificity, filtered according to the 
confidence level (medium, low and unassigned) and further searched with the semi-specific 
enzymatic cleavage. In all cases the precursor mass tolerance was set to 6 ppm and fragment ion 
mass tolerance to 20 mmu. Carbamidomethylation on cysteine residues was used as a fixed 
modification. Methionine oxidation as well as HexNAc and HexHexNAc attachment to serine, 
threonine and tyrosine were used as variable modifications for MS2 data. All spectra were 
searched against a concatenated forward/reverse Drosophila melanogaster-specific database 
(UniProt, March 2018, containing 39034 entries with 3494 canonical reviewed entries) using a 
target false discovery rate (FDR) of 1%. FDR was calculated using target decoy PSM validator 
node. The resulting list was filtered to include only peptides with glycosylation as a modification. 
Glycopeptide M/L ratios were determined using dimethyl 2plex method as previously described 
(Schjoldager et al., 2015)  
 
Statistics and Repeatability 
Statistical tests as well as the number of embryos/ cells assessed are listed in the Figureure 
legends. All statistical analyses were performed using GraphPad Prism and significance was 
determined using a 95% confidence interval. Data points from individual experiments / embryos 
were pooled to estimate mean and standard error of the mean. Sample size refers to biological 
replicates. No statistical method was used to predetermine sample size and the experiments 
were not randomized. For major questions, data were collected and analyzed masked. Normality 
was evaluated by D’Agostino & Pearson or Shapiro-Wilk normality test. Unpaired t-test or Mann-
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Whitney test was used to calculate the significance in differences between two groups and One-
Way Anova followed by Tukey post-test or Kruskal-Wallis test followed by Conover or Dunn’s 
post-test for multiple comparisons.  
All measurements were performed in 3-38 embryos and at least 37 oocytes. 
Representative images shown in Figure 1E-G, I, Figure 2F, I, I Figure 3A-C Figure 5A, Figure 5B, D 
and G and Supplementary Figureures S2B-J, S3B,G,J, S5G-K were from separate experiments 
repeated 3 to 6 times. The stainings underlying Figure S1A-M, Figure 2H and S6 C-F are from 
separate experiments that were repeated at least twice. Stills shown in Figure 3I, K and Figure 5D 
are representative images from two-photon movies, which were repeated at least 3 times. 
 
Tables 
 
Table 1 (see Appendix 1): All candidate proteins from the O-glycoproteome with at least 3-fold 
changes in T and Tn antigen in the mrva3102 mutant. Columns list the gene name, the predicted 
or known function of the gene, if other T or Tn glycosites on the protein are unchanged or 
changed in the opposite direction, any known human ortholog (identified by BLAST), the precise 
site altered, the T and Tn antigen changes observed at a particular glycosylation site, the number 
of glycosites on the peptide, the peptide sequence and if the glycosylation site is conserved. The 
site is considered conserved if the human ortholog has a serine or threonine +/- 5 amino acids 
from the Drosophila glycosite.  
 
Table 2: T or Tn antigen modified receptors from the wild-type St 11-12 Drosophila melano-
gaster embryo O-glycoproteome. Columns list the gene name for the receptor, its reported 
function, what kind of glycosylation we identified to be present on the receptors in the wild type 
sample, and what kind of glycosylation change we observed in the mrva3102 mutant. 
 
Receptor Function Glycosylation 
Changes 
in 
mrva3102 
Babo Activin signaling 2 glyco sites, T antigen only no 
Boi Regulation of Hh-dependent processes 3 glyco sites, Tn antigen only no 
CG12121 Unknown 3 glyco sites, Tn antigen only no 
CG15765 Carbohydrate binding, nervous system 
development 1 glycosite, T antigen 
no 
CG5888 Unknown 1 glyco site, T or Tn antigen no 
CG9095 Carbohydrate binding 1 glyco site, Tn antigen no 
Cirl Calcium independent receptor for a-
latrotoxin, adult locomotory behavior 1 glyco site, T or Tn antigen 
no 
Crb epithelial morphogenesis, apico-basal cell 
polarity,  negative regulator of Notch 
activity 
1 glyco site, Tn antigen no 
Dg non-integrin ECM receptor, connects ECM 
to the actin cytoskeleton 
1 glycosite, T or Tn antigen no 
Drl axon guidance through Wnt5 1 glyco site, T or Tn antigen no 
Hbs Muscle cell fusion 2 glycosites, T and Tn antigen no 
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Hmu Hydrolase activity 15 glycosites, both T and Tn 
antigen Tn inc. 
LpR1 Regulation of immune responses 2 glycosites, Tn antigen Tn inc. 
LpR2 Cellular uptake of neutral lipids 3 sites, T and Tn antigen T & Tn inc. 
LRP1 LDL receptor, works with megalin 4 glycosites, T and Tn antigen no 
Mgl Lipid regulation 2 glycosites, Tn antigen Tn dec. 
Mthl5 GPCR, heart morphogenesis 1 glyco site, T or Tn antigen no 
NimB2 Defense response to bacterium 1 glycosite, Tn antigen no 
NimC4 Recognition and engulfment of apoptotic 
cells during development 1 glycosite, T or Tn antigen 
no 
Nrx-IV Septate junction formation, glial neural 
interaction 1 glyco site, Tn antigen 
no 
PlexB Axon guidance 1 glyco site, Tn antigen no 
Put Dpp signaling  5 glyco sites, T and Tn antigen T&Tn dec. 
Sas Pathfinding, glial neuron interaction  T dec. 
Sdc Robo neural pathfinding, synapse at 
neuromascular junction 
1 glyco site, Tn antigen no 
Sema-1b Neural pathfinding 1 glyco site, Tn antigen no 
Sli Neural pathfinding, robo interaction 2 glyco sites, T and Tn antigen T & Tn inc. 
Sr-CII Scavenger receptor, immune response 6 glyco sites, T and Tn antigen no 
Syb Synaptic vesicle, SNAP receptor activity 1 glyco site, T or Tn antigen no 
Tequila Scavenger receptor, serine protease, 
glucose homeostasis, long and short term 
memory 5 glycosite, Tn antigen 
no 
Unc-5 Neural pathfinding, netrin receptor 1 glycosite, Tn antigen no 
Verm Cuticle development and tracheal tube 
size control 1 glycosite, T or Tn antigen 
T & Tn inc. 
 
Table 3: Summary of contribution of authors based on type of experiment and figure panels that 
represent the data (KV: Katarína Valošková, JB: Julia Biebl, MR: Marko Roblek, SE: Shamsi 
Emtenani, MM: Michaela Mišová, AR: Aparna Ratheesh, PRR: Patrícia Reis-Rodrigues, ISBL: Ida 
S.B. Larsen, SYV: Sergey Y. Vakhrushev, HC: Henrik Clausen, DES: Daria E. Siekhaus) 
 
Experiment Figure panels Work  done by 
Lectin screen Fig 1D, Fig1-S1A-L Staining and imaging: KV, MM; Analysis: KV 
T antigen changes 
during development 
Fig 1E-H Staining and imaging: KV, JB; Quantification: 
JB 
C1GalTA 
downregulation 
Fig 1I-L;  
Fig 1-S1 M-P 
RNAi: KV 
Null mutant: JB 
GlcAT-P 
downregulation 
Fig 1M, Fig1-S1Q KV 
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qPCR (C1GAlTA, Ugalt, 
CG8602) 
Fig 2A,B,D,E,G FACS, cDNA synthesis, qPCR, analysis: KV 
RNA extraction: MR 
T antigen staining on 
the CG8602 mutant 
Fig 2F KV 
Mrva co-localization  Fig 2I,H,  Fig 2-S1B-J S2 cells: KV, JB; Extracted hemocytes: JB 
Mrva phenotype – 
fixed embryos 
Fig 3A-F, H; Fig 3-
S1A-E 
KV 
Shg rescue Fig 3G KV 
Mrva phenotype – live 
embryos 
Fig 3I-M, Fig 3-
S1F,G 
Movies: JB, KV; Analysis: AR, SE 
PGCs migration Fig 3-S1 H-I KV 
Border cell migration Fig 3-S1J-L PRR 
T antigen WB Fig 4A KV, except blotting: JB 
Glycoproteomics Fig 4AB-I, Fig 4-S1A-
E 
Sample collection and freezing: KV, JB 
Glycoproteomics: ISBL, SYV 
Data analysis and statistics: SYV 
Data interpretation: KV, DES, HC 
Qsox1 phenotype-fixed Fig5 A-C, Fig5-S1A-E JB 
Qsox1 phenotype-live Fig 5D-G, Fig 5-S1F Movies:JB; Analysis: SE 
Qsox1 co-localization Fig 5H; Fig 5-S1G-J JB 
Qsox1 secretion Fig 5I KV, except blotting: JB 
LamininA 
quantification 
Fig 5J, Fig 5-S1K-N KV 
MFSD1 co-localization 
in cancer cells 
Fig 6B,C; Fig 6-S1B-
F 
MR 
MFSD1 rescue Fig 6D-G Migration phenotype: KV; Glycosylation 
phenotype:JB 
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Developmental movies n.a., numbers in 
text  
KV 
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Chapter 4: Future directions 
 
The above described research provokes many interesting questions. In the following chapter, I 
will discuss some of them, including some spin-off projects that are already running in our lab 
and topics being investigated by my colleagues. 
 
Minerva’s molecular function 
 
Although we show in our work that Minerva influences migration, probably by regulating the 
whole set of other molecules such as LanA, Qsox1 or NCad, we do not actually uncover what 
Minerva is doing on the molecular level. We work with a few different hypotheses that needs to 
be tested: 
 
Is Minerva a transporter? 
Based on predictions, Minerva belongs to the MFS which is a big family consisting of transporters 
(Griffith et al., 1992; Pao et al., 1998). Therefore from the beginning, we’ve approached Minerva 
as a transporter and have been trying to figure out the transported material. As we found out, it 
is localized in Golgi so our collaborators (group of Mariusz Olczak, University of Wrocław, Poland) 
attempted to test whether it could transport UDP-GlcNAc, UDP-Gal, UDP-GlcA or UDP-GalNAc. 
However, the constructs made in our lab (prepared by Julia Biebl) killed the yeast. Therefore only 
mouse MFSD1 (made by Marko Roblek) was tested, with negative results for all of these 
substances (unpublished data, Olczak lab). This argues against the direct influence on O-GalNAc 
glycosylation through transported material but does not mean that Minerva is not acting as a 
transporter when regulating tissue invasion. 
MFS transporters are known to be symporters or antiporters, often anti/symporting H+ 
which could influence pH homeostasis. As Minerva seems to have quite a broad localization, this 
could have an extensive effect on protein modifications, transport and localization. In mammals, 
it was shown that even a slight but significant change in the medial/trans Golgi pH is a marker of 
cancer cells and increase in pH Golgi is associated with massive T antigen expression on the cell 
surface (Rivinoja et al., 2006). Therefore we hypothesize that Minerva could transiently modify 
the pH of Golgi or other parts of the protein sorting system in order to correctly time the whole 
process of initial migration and invasion into the extended germband. To test it, we would need 
to construct and optimize a Golgi-localized pH sensor and measure, preferably in live cells 
whether there are changes in the control compare to the mutant macrophages as well whether 
there is potentially a temporal change in the pH to allow invasive migration. 
 
Potential lectin-like function 
When small parts of Minerva sequences were BLASTed (mainly those predicted to form a 
translocone, based on InterPro prediction) against the Drosophila genome, many of them carried 
similarities to sugar transporters or sugar binding proteins. Although a sugar-transporting 
function related to O-GalNAc glycosylation was not confirmed (but cannot be fully excluded), we 
hypothesize that Minerva instead of having a function as a transporter, could use the ability to 
bind some sugar structure and therefore having lectin-like function: allowing formation of local 
and transient protein interactions between modified proteins and transferase(s) to allow or 
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prevent modification on some sites. Interestingly, glycoproteomic analysis showed that the 
majority of the candidates have more glycosylation sites compared to the whole set (where the 
most common number of glycosites is 1, see figure 4, Chapter 3). At the same time, many of the 
candidates have some glycosites differently modified and some of them not changed at all (see 
tables, Chapter 3). Transporters were previously shown to interact with lectins to influence 
transporter function or conformation (Fernández-Calotti et al., 2016; Molnár et al., 2009). 
However, to my knowledge, there is no previous study showing a predicted (sugar) transporter 
functioning as a lectin instead of a transporter. 
 
Direct/indirect influence on GalNAc-Ts 
Minerva has predicted long C- and N-terminal tails (Figure 1, Chapter 2) that could fulfill an 
anchoring function. For some glycosylation enzymes, it was shown that sequential acting medial-
Golgi enzymes form pH-sensitive heterodimers (Hassinen and Kellokumpu, 2014; Kellokumpu et 
al., 2016). Although the existence of such complexes for O-GalNAc glycosylation related enzymes 
in Drosophila was not shown before, we hypothesize that these quite prevalent complexes could 
exist in Drosophila and Minerva could potentially play a role in their formation, maintenance or 
trafficking. Our analysis of T and Tn antigen in the embryos shows that there is only a subgroup 
of proteins changed and only some glycosites on these glycoproteins show a significant change. 
As it was demonstrated before that some glycosyltransferases are site-specific and need a 
presence of another occupied glycosite for their activity (Hassan et al., 2000; Kubota et al., 2006; 
Revoredo et al., 2016), modulation of transferase activity through complex formation thanks to 
the anchoring function of Minerva or indirectly by transiently influencing conditions in the Golgi 
through the transported material would fit our results.  
 
Glycosylation-related questions 
 
Our work identifies not only a role of Minerva in tissue invasion but also proves that short forms 
of O-GalNAc glycosylation are needed for proper tissue invasion. This fits very well with short 
forms of O-GalNAc glycosylation being known for a long time to be associated with metastasis 
and being considered a bad prognosis marker (Yi Cao et al., 1996). However, as the presence of 
Tn and T on the surface of tumors seems to be independently regulated as well as tumor specific 
(Chia et al., 2016b; Fu et al., 2016; Nguyen et al., 2017), the important questions are related to 
the function of each short form of O-GalNAc glycosylation as we see the whole set of changes in 
our glycoproteomic analysis of the control and mutant embryos (see Chapter 3 for more details) 
 
Which glycosylation step is actually needed? 
The short forms of O-GalNAc glycosylation were previously associated with the higher 
invasiveness of some types of tumors ((Fu et al., 2016; Hua et al., 2012; Hung et al., 2014)). It 
includes Tn and T antigen, as well as their sialylated versions (Fu et al., 2016; Springer, 1984). In 
Drosophila, except in a few very specific neurons, sialylation does not occur during embryonic 
development (Islam et al., 2013; Repnikova et al., 2010). Instead T and Tn antigen can be futher 
modified by glucuronylation, a sugar moiety with similar properties to sialic acid. Therefore GlcA 
addition could be considered as an insect replacement for sialyation, although some 
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glucuronylated proteins were detected in a context/function where sialylated proteins were 
never present therefore GlcA should not be seen as only replacement of sialic acid (Aoki and 
Tiemeyer, 2010a). We tested a mutant in a transferase GlcAT-P that is known to glucuronylate T 
antigen (Breloy et al., 2016a) and which is expressed in macrophages. We showed that this 
enzyme is not needed for tissue invasion (see Figure 1, Chapter 3). However, missing tools to 
analyze glucuronylation did not allow us to test whether the mutant we used fully removed 
glucuronylation from the embryo. As there are 2 other enzymes that are able to add glucuronic 
acid (Kim et al., 2003), although with at least 12fold lower expression in macrophages that GlcAT-
P (unpublished data, V Belyaeva), deeper analysis (preferentially including null mutants for all 3 
enzymes) would be needed.  
 
Are T and Tn needed for different steps (initiation vs. invasion)? 
The glycoproteomics results showed that minerva mutant has changes both in Tn and T antigen. 
Analysis of fixed embryos showed that downregulating C1GalTA strongly reduces T antigen 
staining on macrophages and leads to results in impaired migration into the extended germband 
without obvious deficits in migration towards the extended germband (Figure 1, Chapter 3). We 
therefore hypothesize that T antigen is needed for proper invasive migration. However, a proper 
live imaging could shed more light on the whole process and point out the exact step(s) that are 
regulated by T antigen (or theoretically glucuronylated version) modified proteins.  
Minerva seems to affect more processes than just invasion into the extended germband. 
These processes could be on the one side dependent on the glycosylation unrelated functions 
we propose, such as the regulation of trafficking or related to other types of glycosylation 
influenced by its potential interaction with Frc (for more details, see Chapter 2). However, the 
other option would be a role for Tn antigen in initiating migration and regulating its early steps. 
To test this hypothesis, we first have to figure out which GalNAc-Ts are functional in macrophages 
by conducting macrophage-specific RNAi on the candidates whose RNA we have found expressed 
in macrophages. Afterwards, a deeper live imaging analysis could dissect the role of Tn antigen 
and different GalNAc-Ts (as some could be very specific for one or few proteins).  
Glycoproteomics showed both increase and decrease in Tn antigen. Whether early 
migration requires higher or lower Tn antigen could be tested by downregulation or 
overexpression of some of the GalNAc-Ts (the ones that were detected before to be functional 
in the process) in the background of the minerva mutant.  
 
What are the targets? 
 
While Minerva is localized to the secretory pathway we never detected it on the surface of S2 
cells or migrating macrophages. Minerva thus must function through some targets, possibly some 
indirectly affected in what we call a ‘second wave’. This fits also with the whole range of effects 
Minerva has not only on macrophage migration but also on development in general as well as 
lower movement of larvae and adults and reduced fertility that we noticed while propagating our 
flies. In this part, I will talk about our analysis of potential targets – both tested with preliminary 
results as well as those planned to be tested. 
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Interaction with Qsox1  
As described in Chapter 3, the strongest target from the glycoproteomics is Qsox1. We confirmed 
that qsox1 mutant partly phenocopies minerva phenotype in migration into the germband as well 
as in its effect on LanA. However, qsox1 mutant does not show the exactly same phenotype as 
minerva mutant (see the vnc analysis and live imaging of the qsox1 mutant, Figure 5, Chapter 3) 
therefore the question of the direct interaction of these proteins is still opened. A genetic test is 
not possible, as qsox1 is haploinsufficient (only 41-50 macrophages in the germband compared 
to around 70 in the control). In any case, the difference could be caused by the fact that the qosx1 
mutant has low/no expression of normally glycosylated Qsox1 while in minerva mutant, Qsox1 is 
present but incorrectly glycosylated what could change the substrate specificity or efficiency of 
the protein. 
We propose to more deeply test whether the defect in the molecular function of Qsox1 
is repeated in the minerva mutant. It was shown before that in S2 cells, Qsox1 influences the 
proper folding of EGF domains (Tien et al., 2008). We want to test whether minerva RNAi in S2 
cells shows the same phenotype as was described for qsox1 RNAi and therefore if Minerva could 
influence the proper folding of EGF domains. As we detected LanA as one of potential effectors 
of the migration phenotype, we hypothesize that improper folding of its EGF domains could result 
in problems with its incorporation into the ECM and therefore observed upregulation of LanA 
production as a result of a feedback loop.  
 
On the hunt for the mysterious band on T antigen Western blot 
In Figure 4 in Chapter 3, we show a T antigen Western blot that displays decreases in few different 
bands with the strongest effect on a high molecular weight band that is almost fully missing on a 
majority of the western blots from mutant embryos that we did (and also on the qsox1 western 
blot although we know that the band is not Qsox1 itself, Figure 1A, done by Julia Biebl). In order 
to discover which high molecular weight protein it is, we took a few different approaches that 
helped us to exclude some candidates: 
1. We tested by Western blot the whole set of proteins potentially involved in the migration 
that could be differently glycosylated in the mutant, e.g. DN-Cadherin, Notch, Integrin; with 
no positive results (Fig 1B-D) 
2. We did a mass spectrometry analysis of the high molecular band cut from a gel run with 
samples from the control and mrva mutant (work done by Julia Biebl and Marko Roblek). The 
analysis revealed a whole set of candidates (see Table 1) from which we directly tested few 
candidates for which antibodies existed (Dhc64c, Shot, GP210, Tango, Fig 1E-H) and indirectly 
tested some candidates using RNAi in macrophages (done by Julia Biebl, Michaela Misova and 
Shamsi Emtenani). RNAi in macrophages did not confirm any of the tested candidates. 
However, the Western blot based analysis pointed to an unexpected result. Dynein heavy 
chain 64c (Dhc64c) that is known to be a subunit of the dynein motor complex (Hays et al., 
1994) is increased  in the mutant compared to the control (Fig 1E). Dhc64c is a protein 
localized to the cytoplasm which excludes the option of it being directly regulated by Minerva 
and O-GalNAc glycosylation. The detected difference (both in the mass spectrometry and 
confirmed by Western blot) could be a result of a ‘second wave’ or a feedback compensation, 
however it is intriguing and would deserve proper characterization of potential defects in 
vesicular trafficking, especially in the light of results on delayed DN-Cadherin degradation and 
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increased LanA staining inside of macrophages, as a change in the amount of the motor 
protein could move the balance of trafficking and therefore slow down secretion of the 
protein or their internalization. 
3. As glycoproteomic approach gave us more than 60 candidates which we plan to test, 
including 14 those that have decreased T antigen (see Fig 4, Chapter 3). This could tell us 
whether these candidates could be considered as an invasive program that is triggered by 
Minerva’s increasing T antigen modification on them. 
Based on our results with LanA (see Fig 5, Chapter 3), we currently guess that the high 
molecular weight missing band is a component of the ECM. To test this, we need to do T antigen 
Western blot on null mutants/deficiency lines of candidate ECM components such as LanA, 
LanB1, LanB2 or Collagen IV. 
 
 Figure 1: Western blot analysis of potential candidates for the missing high-molecular weight band 
A: Anti-T antigen WB on control and qsox1 mutant embryos stage early 12 B-H: WB on control and mrva mutant 
embryos stage early 12 probed against (B) Integrin, (C) DN-Cadherin, (D) Notch, (E) Dhc64c, (F) Shot, (G) GP210 and 
(H) Tango. In A, E, F and H Profilin is used as a loading control.    
 
Conservation of Minerva function 
 
As shown in Figure 6, Chapter 3, mouse MFSD1 can fully rescue the phenotype. This result 
is very interesting suggests that we can use our results from flies to gain insight into mammals. 
However, to prove that our system is a good way to uncover regulators and components of tissue 
invasion, we still need to better characterize the rescue itself as well as the function of 
mammalian MFSD1. These questions are already being analyzed by my colleagues. 
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Where is the rescue of Minerva mutant happening? 
In Drosophila macrophages, Minerva is quite broadly localized into the main parts of the 
secretory system (except ER, see Chapter 3). However, as shown in Fig6 in Chapter 3, MFSD1 
seems to be more strictly localized and its localization depends on the cell type. Therefore, we 
would like to determine where the MFSD1 which is rescuing the minerva mutant phenotype, is 
localized. The current version of the rescue construct is not tagged and we do not have a good 
antibody that could detect mouse MFSD1 in Drosophila embryos. To test it, a new line with a 
tagged version of MFSD1 has to be made and tested for its ability to rescue the mutant 
phenotype, followed by a localization study. 
 
Is MFSD1 functioning in immune cells of mammals the same way as of flies? Is MFSD1 
important for invasion/metastasis? 
If the results from our work will get confirmed in mammals, MFSD1 could become an interesting 
target for cancer treatment or the prevention of metastasis. However, this part of the project is 
being addressed by my colleagues who might make the whole project into the realm of medical 
relevance. 
 
Table 1: Candidate from mass spectrometric analysis of the missing high-molecular weight protein. Red highlights 
proteins that are increased in the mutant, blue those that are decreased 
 
Name Mol. weight [kDa] Unique peptides Ratio mutant/ control 
Shot 989.5 48 5.81 
CG13185  631.3 11 1.30 
spen 593.5 47 1.69 
kis 593.4 120 0.90 
poe 590.7 87 0.85 
CG8184 553.1 92 13.99 
Bruce 537.9 27 1.00 
Dhc64C 530.8 28 0.80 
CG32113 445.0 13 1.68 
Nipped-A 429.9 4 0.80 
mv 399.9 6 1.51 
CG42232 378.6 80 0.29 
Vps13 374.5 18 0.98 
Rfabg 372.7 120 1.02 
pcx 365.3 1 0.68 
rg 358.6 7 0.40 
tefu 318.0 3 1.33 
faf 309.9 3 0.85 
Ppn 299.5 5 6.31 
Nup358 296.4 6 1.10 
CG17514 293.9 26 1.20 
Piezo 288.3 2 0.63 
CG43367 286.5 3 0.73 
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Tor 281.2 1 0.00 
Prp8 279.6 12 1.16 
FASN1 266.4 2 0.89 
Mtor 262.4 1 0.69 
Not1 249.8 2 1.61 
CG5205  249.0 20 0.99 
Ubr3 247.0 11 0.78 
l(3)72Ab 244.5 48 0.94 
rod 239.7 19 0.94 
CG14215 235.2 9 0.72 
Nup205 232.7 12 1.15 
shtd 227.3 10 2.25 
zip 226.8 4 0.67 
ana3 225.6 1 1.00 
PlexA 216.4 5 1.13 
yl 215.0 9 3.93 
sti 211.3 40 0.64 
CG8771 210.3 3 1.69 
Gp210 209.8 36 1.20 
gig 203.8 6 0.75 
Mcr 202.8 4 1.31 
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Increased T antigen 
Protein  Function 
Unch
ange
d GS 
Human 
orthol
og 
Site T change 
Tn 
change 
# Sites 
on 
peptide 
Peptide sequence 
Site 
conser
vation 
Sli 
Cue for 
migration and 
differentiation 
no SLIT2 
S1908 4x inc. 4x inc. 2 1903-TSAGKSSPVAS no 
S1909 4x inc. 4x inc. 2 1904-SAGKSSPVAST no 
26-29kD-
proteina
se 
cysteine-type 
endopeptidase
, proteolysis 
no CTSK T315 18x inc. 4x inc. 1 310-SGIYNTGKPFP yes 
CG14834 unknown yes no 
T40 
not 
present 
5x inc. 3 35-TKPPSTLATST no 
T43 
not 
present 
5-9x inc. 3 38-PSTLATSTKAS no 
S44 9x inc. 
not 
change
d 
3 39-STLATSTKASR no 
T45 
not 
present 
5-9x inc. 3 40-TLATSTKASRN no 
Cp1 
cysteine-type 
endopeptidase 
no CTSV T266 6x inc. 4x inc. 1 261- TDRGFTDIPQG yes 
LpR2 
LDL receptor, 
positive 
regulation of 
lipid transport 
yes VLDLR 
S234 
not 
present 
12x inc. 1 233-CKFTESTCSQE yes 
S274 4x inc. 4-5x inc. 1 269-TSQCRSHTCSP no 
T276 4x inc. 4x inc. 1 271-QCRSHTCSPEE yes 
S278 
not 
present 
5x inc. 1 273-RSHTCSPEEFAC no 
LpR1 
LDL receptor, 
necrotic 
clearence 
from 
hemolymph 
no VLDLR 
T70 5x inc. 4-7x inc. 1 66-FIEATCSSDQ no 
S73 
not 
present 
4x inc. 1 68-EATCSSDQFR yes 
Tango1 
Golgi 
organization, 
protein 
secretion 
yes 
CTAGE
8 
T688 5xdec. 5x inc. 1 683-VALPATASPVS no 
S693 6x inc. 5x inc. 2 688-TASPVSEVPIK no 
GCS2alp
ha 
hydrolyse 
activity (O-
glycosyl 
components) 
no GANAB 
T175 
42x inc., 
4x dec. 
not 
change
d 
1 171-AQEPTSHPAEN yes 
S176 4x dec. 
not 
change
d 
1 170-KAQEPTSHPAE no 
CG9911 
protein 
disulfide 
isomerase 
yes ERP44 T350 5x inc. 
not 
change
d 
1 345-HTGKGTSPPE yes 
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activity, ER 
stress T346 5x inc. 
not 
change
d 
1 341-EPDPHTGKGTS no 
S337 4x inc. 
not 
present 
1 332-YGPDPSNDIEP yes 
CG10217 wound healing no no T433 4x inc. 
not 
change
d 
1 428-LGGVTLSPRP no 
Increased Tn antigen without changes in T antigen 
Protein  Function 
Unch
ange
d GS 
Human 
orthol
og 
Site T change 
Tn 
change 
# Sites 
on 
peptide 
Peptide sequence 
Conser
vation 
of the 
site 
Scaf 
proteolysis, 
regulation of 
development 
yes no T331 
not 
present 
20x inc. 1 326-PQIFPTPQPAN no 
Hmu 
hydrolase 
activity on 
ester bonds, 
receptor  
yes APMAP 
S398 
not 
present 
4x inc. 2 393-IGVPPSKATPK no 
 T401 
not 
present 
4x inc. 2 396-PPSKATPKPK no 
T430 
not 
present 
4x dec., 
29x inc. 
1, 2 425-PKPKKTTTPTT no 
T431 
not 
present 
29x inc. 2 426-KPKKTTTPTTP no 
T436 
not 
present 
4-29x 
inc. 
1, 2 431-TTPTTPTPEP no 
T438 
not 
present 
29x inc. 2 433-TPTTPTPEPSK no 
CG14309 
hydrolase 
activity on 
glycan bonds 
yes HPSE2 T609 
not 
present 
6x inc. 1 604-EIPTYTRLPEG no 
Gp93 
heat shock 
protein, 
unfolded 
protein 
binding 
yes 
HSP90
B1 
T26 
not 
changed 
5x inc. 2 21-DDEAATTETID no 
T27 
not 
present 
5x inc. 2 22-DEAATTETIDL no 
Fon 
hemolymph 
coagulation, 
metamorphosi
s 
yes no 
T258 
not 
present 
8x inc. 1 253-IVEQPTQVTQT 
no 
T261 
not 
present 
4x inc. 1 256-QPTQVTQTVPV 
Dpy 
ECM, 
transcription 
factor activity 
yes LTBP1 
T1172
4 
not 
present 
4x inc. 2 11719-TNDNTTPSPA no 
T1172
5 
not 
present 
4xinc. 2 11720-NDNTTPSPAP no 
Hyx 
transcription 
factor binding  
no CDC73 S129 
not 
present 
182x 
inc. 
2 124-AEGEPSSVEVA no 
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S130 
not 
present 
182x 
inc. 
2 125-EGEPSSVEVAA no 
ImpL1 unknown yes no 
T310 
not 
present 
22-216x 
inc. 
1 305-MPLKDTPTPKP 
no 
 T312 
not 
present 
22-143x 
inc. 
1 307-LKDTPTPKPLE 
CG6409 unknown yes no 
T46 
not 
present 
6x inc. 1 41-VDPKPTAKVVL 
no T298 
not 
present 
10x inc. 1 293-DIPVPTQTKAT 
T300 
not 
present 
21x inc. 2 295-PVPTQTKATTT 
CG7453 unknown yes 
C11orf
24 
T183 
not 
present 
4x inc. 3 178- TATTKTVNSTI no 
S186 
not 
present 
4x inc. 3 181-TKTVNSTIIAT no 
T187 
not 
present 
4x inc. 3 182-KTVNSTIIATT no 
CG32241 unknown yes no 
T149 
not 
present 
4-6x inc. 2 144-KKVIYTPPPPP 
no 
 T156 
not 
present 
7x inc. 1 151-PPPPPPTKKVVY 
CG12964 unknown yes no Y221 
not 
present 
4x inc. 1 216-EEVIQYPVTPL no 
CG15022 unknown yes no 
S112 
not 
present 
6x dec 1 107-LPPKVSLPPPP 
no 
S152 
not 
present 
18x dec. 1 147-PKVAPSLPPPP 
S205 
not 
present 
21x 
dec., 4x 
inc. 
1 199-PKVAPSLPPPP 
Decreased Tn antigen without changes in T antigen 
Protein  Function 
Unch
ange
d GS 
Human 
orthol
og 
Site T change 
Tn 
change 
# Sites 
on 
peptide 
Peptide sequence 
Conser
vation 
of the 
site 
Ndg 
cell-matrix 
adhesion 
no NID1 S656 
not 
present 
4x dec. 1 651-PTSEPSPNPSP no 
CG8399 
ferric-chelate 
reductase 
activity 
no FRRS1 
T192 
not 
changed 
4x dec. 3 187-APPLPTQSPSA yes 
 T201  
not 
changed 
4x dec. 3 196-SAPAGTTR yes 
T202 
not 
changed 
4x dec. 3 197-APAGTTR no 
CG2145 
endoribonucle
ase activity 
yes ENDOU T84 
not 
changed 
6x dec. 1 80-VVVTPTAANKP no 
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S95 
not 
present 
6x dec. 1 87-PPLVISHAPLM no 
CG6357 
cysteine-type 
endopeptidase 
yes CTSB 
S223 
not 
present 
4x dec. 2 218-TIEERSSPAPE no 
S224 
not 
present 
4x dec. 2 219-IEERSSPAPEI no 
S26 
not 
present 
4-5x 
dec. 
2 20-LGVPVSTSSPA no 
S27 
not 
present 
4-5x 
dec. 
2 21-GVPVSTSSPAT no 
Neo 
regulation of 
embryonic cell 
shape 
yes no 
T64 
not 
present 
4-6x 
dec. 
3 58-PGAKETSTEIN 
no T66 
not 
present 
4-6x 
dec. 
3 60-GAKETSTEINRT 
T71 
not 
present 
4-6x 
dec. 
3 66-TEINRTERPVE 
CG8420 unknown no no 
T212 
not 
changed 
6x dec. 2 217-GEAKVTTEYIH 
no 
T213 
not 
changed 
6x dec. 2 E218AKVTTEYIHN 
CG12213 unknown yes 
RNF21
4 
S299 
not 
changed 
5x dec. 1 293-DAPNASVAPK yes 
CG13159 unknown no no 
T53 
not 
present 
4x dec. 5 48-PTYTYTTDTTT 
no 
T54 
not 
present 
4x dec. 5 49-TYTYTTDTTTT 
T56 
not 
present 
4x dec. 5 51-TYTTDTTTTKP 
T57 
not 
present 
4x dec. 5 52-YTTDTTTTKPI 
 T58 
not 
present 
4 dec. 5 53-TTDTTTTKPIK 
CG12991 unknown no no 
T218 
not 
present 
13x dec. 3 213-AKVLATSPAAA 
no T225 
not 
present 
13x dec. 3 220-PAAAITPRAGG 
S219 
not 
present 
13x dec. 3 214-KVLATSPAAAIT 
CG13722 unknown yes no T265 
not 
present 
6x dec. 1 260-YVPPPTPTYIP no 
CG15225 unknown no no 
T74 
not 
present 
27x dec. 6 69-VSFPQTTTTTTK 
no 
 T75 
not 
present 
27x dec. 6 70-SFPQTTTTTTKK 
 T76 
not 
present 
27x dec. 6 71-FPQTTTTTTKK 
T77 
not 
present 
27x dec. 6 72-PQTTTTTTKKK 
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T78 
not 
present 
27x dec. 6 73-QTTTTTTKKKS 
T79 
not 
present 
27x dec. 6 74-TTTTTTKKKSK 
CG1161 unknown no 
TMEM
9 
S66 
not 
present 
4x dec. 1 61-LAKQVSAPTAA no 
CG12011 unknown no no T301 
not 
changed 
4x dec. 1 296-LPNPFTDFPKV no 
CG13992 unknown no no S145 
not 
present 
7x dec. 1 140-AFEGGSYPQQP no 
CG32694 unknown no no T179 
not 
present 
10x dec. 1 174-KIDLPTFAPQS no 
CG15239 unknown yes no 
T440 
not 
present 
5x dec. 2 435-VAAAVTPATTA 
no 
T444 
not 
present 
5x dec. 2 439-VTPATTAAADE 
S451 
not 
present 
5x dec. 2 446-AADEDSTTPK 
T452 
not 
present 
5x dec. 2 447-ADEDSTTPK 
Hmu 
hydrolase 
activity on 
ester bonds, 
receptor  
yes APMAP 
S398 
not 
present 
4x inc. 2 393-IGVPPSKATPK no 
 T401 
not 
present 
4x inc. 2 396-PPSKATPKPK no 
T430 
not 
present 
4x dec., 
29x inc. 
1, 2 425-PKPKKTTTPTT no 
T431 
not 
present 
29x inc. 2 426-KPKKTTTPTTP no 
T436 
not 
present 
4-29x 
inc. 
1, 2 431-TTPTTPTPEP no 
T438 
not 
present 
29x inc. 2 433-TPTTPTPEPSK no 
CG15022 unknown yes no 
S112 
not 
present 
6x dec 1 107-LPPKVSLPPPP 
no 
S152 
not 
present 
18x dec. 1 147-PKVAPSLPPPP 
S205 
not 
present 
21x 
dec., 4x 
inc. 
1 199-PKVAPSLPPPP 
Gbp1 cytokine yes no 
T85 
not 
present 
4x dec. 2 80-LVNENTTVLPV 
no 
T86 
not 
present 
4x dec. 2 81-VNENTTVLPVI 
Mgl 
regulation of 
endocytosis, 
cuticule 
development 
yes LRP2 Y2864 
not 
present 
4x dec. 1 2859-PNYCAYHSCSP yes 
Decreased T antigen 
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Protein  Function 
Unch
ange
d GS 
Human 
orthol
og 
Site T change 
Tn 
change 
# Sites 
on 
peptide 
Peptide sequence 
Conser
vation 
of the 
site 
CG4670 
protein 
disulfide 
isomerase  
yes QSOX1 
S298 52x dec. 43x dec. 1 294-VHQPSATPA yes 
T300 
12-52x 
dec. 
43x dec. 1 296-QPSATPASKI yes 
Dtg 
development 
(dpp target 
gene) 
yes no 
T326 13x dec. 
4-7x 
dec. 
1, 3, 4 321-EAPAKTSTTAG   
no 
S327 4-7x dec. 
4-7x 
dec. 
3, 4 322-APAKTSTTAGP   
T328 4x dec. 
4-7x 
dec. 
3, 4 323-PAKTSTTAGPL 
T329 8x dec. 7x dec. 1, 4 324-AKTSTTAGPLV 
T335 7x dec. 
4-9x 
dec. 
4, 1 330-AGPLVTVEPTK 
S341 
not 
present 
4x inc. 1 336-VEPTKSITEPN 
T343 
not 
changed 
4x inc. 1 338-PTKSITEPNEE 
S437 7x dec. 
not 
change
d 
1 432-SNRQASPTEEP 
T439 
not 
changed 
6x dec. 1 434-RQASPTEEPIK 
CG17667 axonogenesis no no 
S292 
not 
present 
11x dec. 1 287-TPFNGSLIYPT 
no 
T297 
not 
present 
4x dec. 1 292-SLIYPTEPPLK 
S312 
not 
present 
10x dec. 4 307-PPIVASITSTA 
T314 10x dec. 
not 
change
d 
4 309-IVASITSTAKP 
S315 
not 
changed 
10x dec. 4 310-VASITSTAKPV 
T316 10x dec. 
not 
change
d 
4 311-ASITSTAKPVT 
CG2918 
 heat-shock 
protein, 
chaperone 
no HYOU1 
T908 8x dec. 
4-8x 
dec. 
2 903-PVDEITPTPAE no 
T910 
not 
present 
4-8x 
dec. 
2 905-DEITPTPAEEE no 
CG17660 
lung 7TM 
receptor-like 
no 
TMEM
87B 
S131 6x dec. 
not 
present 
1 126-KVVEGSAIPTP yes 
T135 4x dec. 
not 
change
d 
1 130-GSAIPTPEPKH yes 
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CG7884 unknown no no 
T838 5x dec. 
not 
present 
1 834-KVYVVTPQPRH 
no 
T879 
not 
changed 
15x dec. 1 876-PRMRPTPAGEV 
GCS2bet
a 
N-glycan 
processing 
yes GLU2B 
T321 
not 
changed 
7x dec. 2 316-QQPEVTTESIQ no 
T322 
not 
changed 
7x dec. 2 317-QPEVTTESIQP no 
T376 5x dec. 
4-7x 
dec. 
1 371-DAEEATPPNYD no 
Put 
receptor, dpp 
signaling 
yes 
ACVR2
B 
S129 5x dec. 
not 
change
d 
2 124-QKYIKSTTEAT no 
T130 5x dec. 5x dec. 2 125-KYIKSTTEATT no 
T131 
not 
changed 
5x dec. 2 126-YIKSTTEATTQ no 
Nplp2 
humoral 
immune 
response 
no no T35 5x dec. 
not 
present 
1 30-AQEFLTKAQGD no 
CG8027 
transferase 
activity  
yes 
GNPTA
B 
S492 
not 
present 
5x dec. 2 487-DTVEHSTLVYER yes 
T493 5x dec. 
not 
change
d 
2 488-TVEHSTLVYER yes 
CG4194 unknown no no T226 4x dec. 
not 
present 
1 221-ATGLATPKPTH no 
CG1273 unknown yes no T1089 4-6x dec. 
not 
change
d 
1 1084-VHKLVTLLPVR no 
Gp150 
regulates 
Notch 
signaling 
yes LRIG1 
T47 
not 
changed 
4x dec. 2 42-LPVETTTRSPTK no 
T48 4x dec. 
not 
change
d 
2 43-LPVETTTRSPTKK no 
Sas 
receptor 
activity 
yes no T1387 4x dec. 
not 
change
d 
1 1382-PERTITPPPPF no 
Chitin and Chorion Proteins 
Protein  Function 
Unch
ange
d GS 
Human 
orthol
og 
Site T change 
Tn 
change 
# Sites 
on 
peptide 
Peptide sequence 
Conser
vation 
of the 
site 
Cpr49Ah 
chitin-based 
cuticule 
development 
yes no T113 
not 
present 
10x dec. 1 108-GDHIPTPPAIP no 
Cpr49Aa 
chitin-based 
cuticule 
development 
no no T127 
not 
present 
6x dec. 1 122-LAYLATAPPPP no 
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Cht6 
chitinase 
activity, chitin 
catabolic 
process 
yes CHIA 
T3542 
not 
present 
10x dec. 3 3537-TKAPLTFSTSR no 
T3545 
not 
present 
10x dec. 3 3540-PLTFSTSRPTA no 
T3549 
not 
present 
10x dec. 3 3544-STSRPTAKFVR no 
T3986 
not 
present 
4x inc. 1 3981-TVRLYPTIQTEV no 
Verm 
chitin 
deacetylase, 
cuticle 
development 
no no T103 
4x inc., 
4x dec. 
4-5x inc. 1 98-KPILKTDEPIC no 
Cp7Fb 
chorion-
containing 
eggshell 
formation 
yes no 
T48 4x inc. 
8-14x 
inc. 
1 43-LNVPNTPKPKK 
no 
Y41 4x inc. 
not 
change
d 
1 36-CPTQLGYQLNVP 
Serp 
chitin 
deacetylase 
no no T120 5-9x inc. 
not 
change
d 
1 115-PLLLHTDEPLC no 
Cpr67B 
chitin-based 
cuticule 
development 
no no T159 
not 
present 
4-6x inc. 1 154-LKLPATKTPAV no 
Cpr31A 
chitin-based 
cuticule 
development 
no no 
T325  
not 
present 
5x inc. 7 320-PEASSTTTTAA 
no 
T326 
not 
present 
5x inc. 7 321-EASSTTTTAAP 
T327 
not 
present 
5x inc. 7 322-ASSTTTTAAPV 
T328 
not 
present 
5x inc. 7 323-SSTTTTAAPVT 
T333 
not 
present 
5x inc. 7 328-TAAPVTEENKK 
S323 
not 
present 
5x inc. 7 318-SAPEASSTTTT 
S324 
not 
present 
5x inc. 7 319-APEASSTTTTA 
